Legal status in Finland

Per-substance legal status for Finland, from sourced statutes where available. Legal information, not legal advice; drug laws change, so confirm with the destination’s embassy or drug authority before you travel.

88 confirmed substances0 not individually verifiedLast updated September 21, 2026

Confirmed legal status

1P-LSD

Legal status: Controlled, though not as a narcotic. Section 1 of valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014 makes the substances in its annex psychoactive substances banned from the consumer market, and 1P-LSD is named there. The entry reads «1p-LSD (N,N-dietyyli-6-metyyli-1-propanoyyli-9,10-didehydroergoliini-8-karboksamidi)». That annex stands as substituted by 650/2026. Section 5 subsection 2 of huumausainelaki 373/2008 bans manufacture, import into Finland, storage, keeping for sale and transfer, and leaves research and industrial use to be permitted separately, so possession for one's own use and use itself are not among the banned acts. Section 3 subsection 3 of the same Act defines the category as substances used for intoxication that may be dangerous to health, notified for control, and that are neither medicines nor narcotics. It is not named in any annex of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, as those annexes stand after 651/2026, 1119/2025 and 650/2026.
Consequences if caught: Capital exposure: none. Criminal Code chapter 44 section 5 a carries the separate consumer market offence. It sets a fine or up to one year for manufacturing, importing, storing, keeping for sale or transferring a psychoactive substance banned from the consumer market, contrary to the Narcotics Act. Possession for one's own use and use itself are not among the acts it names. Section 33 a of huumausainelaki 373/2008 adds import and storage duties, and section 23 b allows a university, a research institute or a trader to import and store on prior notice to the Finnish Medicines Agency. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. This row is placed outside that regime, so they are recorded as Finland's published drug penalties and not as this substance's exposure. This row in particular. Its entry sits in the annex to valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, as that annex was substituted by 650/2026, at printed line 16 of the Finnish annex text Finlex serves, and it reads «1p-LSD». In the printed order of that annex the line above it reads 1P-ETH-LAD and the line below it reads karboksamidi). Section 1 of that decree is one sentence and it does all of the work: «Kuluttajamarkkinoilta kiellettyjä psykoaktiivisia aineita ovat liitteessä mainitut aineet.». The penalty limb that placement engages is not chapter 50. It is Criminal Code chapter 44 section 5 a, which opens «Joka huumausainelain vastaisesti tahallaan tai törkeästä huolimattomuudesta valmistaa, tuo maahan, varastoi, pitää myynnissä tai luovuttaa kuluttajamarkkinoilta kiellettyä psykoaktiivista ainetta, on tuomittava» and sets a fine or up to one year, and only where no heavier penalty is provided elsewhere. Section 5 subsection 2 of huumausainelaki 373/2008 states the prohibition this row breaches, «Kuluttajamarkkinoilta kielletyn psykoaktiivisen aineen valmistus, tuonti Suomen alueelle, varastointi, myynnissä pitäminen ja luovuttaminen on kielletty.», and that list of acts does not include possession or use, so the huumausaineen käyttörikos in chapter 50 section 2 a does not reach this row. No quantity threshold and no fine figure is printed for this row in either the decree or chapter 44 section 5 a.
If prescribed / medical: A substance banned from the consumer market is by definition not a medicine, which is what section 3 subsection 3 of huumausainelaki 373/2008 says, so no prescription route follows from this listing. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. Section 24 of huumausainelaki 373/2008 writes its traveller carve out by reference to the convention lists and this row is in neither decree's convention annexes at all, so the carve out has nothing to attach to. The route in for this category is section 23 b instead, which reads «Elinkeinonharjoittaja saa tuoda maahan ja varastoida kuluttajamarkkinoilta kiellettyjä psykoaktiivisia aineita perustellusta syystä teollista toimintaansa varten, jos aineesta ja toiminnasta on tehty ennen maahantuontia ilmoitus Lääkealan turvallisuus- ja kehittämiskeskukselle.», and that is a research and industry route, not a prescription route.
Documentation: The traveller carve out in section 24 of huumausainelaki 373/2008 is written for medicinal products containing convention listed narcotics and does not describe this row. Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. What a traveller is carrying, if this row is in the bag, is a substance banned from the consumer market by name at printed line 16 of the annex to 1130/2014, reading «1p-LSD», and import into Finland is one of the acts section 5 subsection 2 of huumausainelaki 373/2008 forbids. There is no traveller allowance to state for this row because the Act provides none for this category: the only import routes are the university and the industry notifications in section 23 b. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, 1P-LSD, a named entry of the annex to valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014 at printed line 16 of the Finnish annex text, that annex as substituted by 650/2026 · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · Updated September 21, 2026

1P-LSD in Finland, full detail →

2-FDCK

Legal status: Controlled. 2-FDCK is a narcotic in Finland by name. Section 1 of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 makes the substances, preparations and plants in annexes I to V narcotics, and this row's entry sits in Liite II, the annex headed as the substances and preparations in lists I to IV of the 1971 Convention on Psychotropic Substances, under list II, which the instrument itself heads as a schedule of the 1971 Convention on Psychotropic Substances, an attribution read off the annex heading and not checked against the INCB list in this pass. The entry reads «2-Fluoridesklooriketamiini (2-FDCK) (2-(2-fluorifenyyli)-2-(metyyliamino)sykloheksan-1-oni)». Section 5 subsection 1 of huumausainelaki 373/2008 then forbids production, manufacture, import into Finland, export from Finland, transport, transit, distribution, trade, handling, possession and use, and allows departure from that ban only for medical, research, supervisory and industrial purposes as separately provided. The same list closes by extending itself, in the words «tämän luettelon aineiden suolat, mukaan luettuna edellä mainittujen isomeerien suolat, jos sellaisten olemassaolo on mahdollista; sekä». That annex stands as amended by 4.12.2025/1119.
Consequences if caught: Capital exposure: none. The ceiling anywhere in this regime is the ten year maximum that Criminal Code chapter 50 section 2 sets for an aggravated narcotics offence. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. This row sits in Liite II under list II of the decree, so those are the provisions its placement engages. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. They describe the offences that this row's placement brings into play. This row in particular. Its entry sits in Liite II, which the decree heads as the substances and preparations in the lists of the 1971 Convention on Psychotropic Substances, under list II of that annex, at printed position 34 of the 68 entries that list carries in the consolidated text read here, and the entry reads «2-Fluoridesklooriketamiini (2-FDCK) (2-(2-fluorifenyyli)-2-(metyyliamino)sykloheksan-1-oni)». In the printed order of that list the entry above it is 4-Fluoriamfetamiini and below it comes FUB-AMB. The same list closes by extending itself beyond its named entries, in the words «tässä luettelossa mainittuja aineita sisältävät valmisteet.». The annex that carries this row stands as amended by 4.12.2025/1119, which is the amendment that last touched this row's annex rather than the decree as a whole. Section 5 subsection 1 of huumausainelaki 373/2008 is the prohibition that placement engages, «Huumausaineen tuotanto, valmistus, tuonti Suomen alueelle, vienti Suomen alueelta, kuljetus, kauttakuljetus, jakelu, kauppa, käsittely, hallussapito ja käyttö on kielletty.», and chapter 50 section 5 subsection 1 of the Criminal Code makes the word huumausaine in those offences mean a narcotic under huumausainelaki, so the annex entry above is what puts this row inside them. Criminal Code chapter 50 section 2 a is the small quantity limb and it opens «Joka laittomasti käyttää taikka omaa käyttöä varten pitää hallussaan tai yrittää hankkia vähäisen määrän huumausainetta, on tuomittava», so the käyttörikos reaches this row on its own terms. No quantity figure is printed anywhere in chapter 50: whether a quantity is a suuri määrä, and whether the substance is an erittäin vaarallinen huumausaine under chapter 50 section 5 subsection 2, are findings of fact and the annex position does not settle either of them. No fine figure is printed either, because a Finnish fine is a day fine set on the offender's income.
If prescribed / medical: Section 24 of huumausainelaki 373/2008 disapplies the import and export rules for a medicinal product a traveller carries for personal medication where the substance is in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, and this row is inside that carve out. Section 19 of lääkelaki 395/1987 then governs. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. This row sits in list II of the 1971 Convention annex, and section 24 of huumausainelaki 373/2008 reaches exactly that: it disapplies the import and export provisions of the Act for medicinal products containing a substance in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, the products being those «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä», and then hands the traveller to section 19 of lääkelaki 395/1987.
Documentation: Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The locator a traveller or an official would be checking is Liite II list II entry 34 of 543/2008, as that annex stands after 4.12.2025/1119, and the entry printed there reads «2-Fluoridesklooriketamiini (2-FDCK) (2-(2-fluorifenyyli)-2-(metyyliamino)sykloheksan-1-oni)». Because the row is in that part of the convention annexes, section 24 of huumausainelaki 373/2008 takes a traveller's own prescribed medicine out of the Act's import and export provisions and leaves section 19 of lääkelaki 395/1987 to govern how much may be carried, which is the provision this cell did not read. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, 2-FDCK, a named entry of Liite II list II of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 at printed position 34, that annex as amended by 4.12.2025/1119 · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · Updated September 21, 2026

2-FDCK in Finland, full detail →

25I-NBOMe

Legal status: Controlled. 25I-NBOMe is a narcotic in Finland by name. Section 1 of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 makes the substances, preparations and plants in annexes I to V narcotics, and this row's entry sits in Liite II, the annex headed as the substances and preparations in lists I to IV of the 1971 Convention on Psychotropic Substances, under list I, which the instrument itself heads as a schedule of the 1971 Convention on Psychotropic Substances, an attribution read off the annex heading and not checked against the INCB list in this pass. The entry reads «25I-NBOMe (4-jodo-2,5-dimetoksi- N -(2-metoksibentsyyli)etaaniamiini)». The instrument italicises part of that entry and the spacing around the italicised locants is as Finlex serves it. Section 5 subsection 1 of huumausainelaki 373/2008 then forbids production, manufacture, import into Finland, export from Finland, transport, transit, distribution, trade, handling, possession and use, and allows departure from that ban only for medical, research, supervisory and industrial purposes as separately provided. The same list closes by extending itself, in the words «tämän luettelon aineiden suolat, jos sellaisen suolan muodostaminen on mahdollista; sekä». That annex stands as amended by 4.12.2025/1119.
Consequences if caught: Capital exposure: none. The ceiling anywhere in this regime is the ten year maximum that Criminal Code chapter 50 section 2 sets for an aggravated narcotics offence. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. This row sits in Liite II under list I of the decree, so those are the provisions its placement engages. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. They describe the offences that this row's placement brings into play. This row in particular. Its entry sits in Liite II, which the decree heads as the substances and preparations in the lists of the 1971 Convention on Psychotropic Substances, under list I of that annex, at printed position 3 of the 41 entries that list carries in the consolidated text read here, and the entry reads «25I-NBOMe (4-jodo-2,5-dimetoksi-N-(2-metoksibentsyyli)etaaniamiini)». In the printed order of that list the entry above it is 25C-NBOMe and below it comes Brolamfetamiini, dimetoksibromiamfetamiini. The same list closes by extending itself beyond its named entries, in the words «tässä luettelossa mainittuja aineita sisältävät valmisteet.». The annex that carries this row stands as amended by 4.12.2025/1119, which is the amendment that last touched this row's annex rather than the decree as a whole. Section 5 subsection 1 of huumausainelaki 373/2008 is the prohibition that placement engages, «Huumausaineen tuotanto, valmistus, tuonti Suomen alueelle, vienti Suomen alueelta, kuljetus, kauttakuljetus, jakelu, kauppa, käsittely, hallussapito ja käyttö on kielletty.», and chapter 50 section 5 subsection 1 of the Criminal Code makes the word huumausaine in those offences mean a narcotic under huumausainelaki, so the annex entry above is what puts this row inside them. Criminal Code chapter 50 section 2 a is the small quantity limb and it opens «Joka laittomasti käyttää taikka omaa käyttöä varten pitää hallussaan tai yrittää hankkia vähäisen määrän huumausainetta, on tuomittava», so the käyttörikos reaches this row on its own terms. No quantity figure is printed anywhere in chapter 50: whether a quantity is a suuri määrä, and whether the substance is an erittäin vaarallinen huumausaine under chapter 50 section 5 subsection 2, are findings of fact and the annex position does not settle either of them. No fine figure is printed either, because a Finnish fine is a day fine set on the offender's income.
If prescribed / medical: Section 24 of huumausainelaki 373/2008 disapplies the import and export rules for a traveller's personal medication only where the substance is in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention. This row is in list I of the 1971 Convention, which that carve out does not reach. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. This row sits in list I of the 1971 Convention annex, which is the one list section 24 of huumausainelaki 373/2008 leaves out. The carve out covers lists I to III of the 1961 Convention and lists II to IV of the 1971 Convention, for the products «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä», and a list I entry of the 1971 Convention annex is outside it.
Documentation: Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The locator a traveller or an official would be checking is Liite II list I entry 3 of 543/2008, as that annex stands after 4.12.2025/1119, and the entry printed there reads «25I-NBOMe (4-jodo-2,5-dimetoksi-N-(2-metoksibentsyyli)etaaniamiini)». Because the row is outside the lists section 24 names, that section does not take a traveller's own medicine out of the Act's import and export provisions for this row, and nothing read here supplies a carriage allowance in its place. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, 25I-NBOMe, a named entry of Liite II list I of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 at printed position 3, that annex as amended by 4.12.2025/1119 · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · Updated September 21, 2026

25I-NBOMe in Finland, full detail →

2C-B

Legal status: Controlled. 2C-B is a narcotic in Finland by name. Section 1 of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 makes the substances, preparations and plants in annexes I to V narcotics, and this row's entry sits in Liite II, the annex headed as the substances and preparations in lists I to IV of the 1971 Convention on Psychotropic Substances, under list II, which the instrument itself heads as a schedule of the 1971 Convention on Psychotropic Substances, an attribution read off the annex heading and not checked against the INCB list in this pass. The entry reads «2C-B (4-bromo-2,5-dimetoksifenetyyliamiini)». Section 5 subsection 1 of huumausainelaki 373/2008 then forbids production, manufacture, import into Finland, export from Finland, transport, transit, distribution, trade, handling, possession and use, and allows departure from that ban only for medical, research, supervisory and industrial purposes as separately provided. The same list closes by extending itself, in the words «tämän luettelon aineiden suolat, mukaan luettuna edellä mainittujen isomeerien suolat, jos sellaisten olemassaolo on mahdollista; sekä». That annex stands as amended by 4.12.2025/1119.
Consequences if caught: Capital exposure: none. The ceiling anywhere in this regime is the ten year maximum that Criminal Code chapter 50 section 2 sets for an aggravated narcotics offence. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. This row sits in Liite II under list II of the decree, so those are the provisions its placement engages. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. They describe the offences that this row's placement brings into play. This row in particular. Its entry sits in Liite II, which the decree heads as the substances and preparations in the lists of the 1971 Convention on Psychotropic Substances, under list II of that annex, at printed position 19 of the 68 entries that list carries in the consolidated text read here, and the entry reads «2C-B (4-bromo-2,5-dimetoksifenetyyliamiini)». In the printed order of that list the entry above it is Amineptiini and below it comes 4-CMC. The same list closes by extending itself beyond its named entries, in the words «tässä luettelossa mainittuja aineita sisältävät valmisteet.». The annex that carries this row stands as amended by 4.12.2025/1119, which is the amendment that last touched this row's annex rather than the decree as a whole. Section 5 subsection 1 of huumausainelaki 373/2008 is the prohibition that placement engages, «Huumausaineen tuotanto, valmistus, tuonti Suomen alueelle, vienti Suomen alueelta, kuljetus, kauttakuljetus, jakelu, kauppa, käsittely, hallussapito ja käyttö on kielletty.», and chapter 50 section 5 subsection 1 of the Criminal Code makes the word huumausaine in those offences mean a narcotic under huumausainelaki, so the annex entry above is what puts this row inside them. Criminal Code chapter 50 section 2 a is the small quantity limb and it opens «Joka laittomasti käyttää taikka omaa käyttöä varten pitää hallussaan tai yrittää hankkia vähäisen määrän huumausainetta, on tuomittava», so the käyttörikos reaches this row on its own terms. No quantity figure is printed anywhere in chapter 50: whether a quantity is a suuri määrä, and whether the substance is an erittäin vaarallinen huumausaine under chapter 50 section 5 subsection 2, are findings of fact and the annex position does not settle either of them. No fine figure is printed either, because a Finnish fine is a day fine set on the offender's income.
If prescribed / medical: Section 24 of huumausainelaki 373/2008 disapplies the import and export rules for a medicinal product a traveller carries for personal medication where the substance is in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, and this row is inside that carve out. Section 19 of lääkelaki 395/1987 then governs. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. This row sits in list II of the 1971 Convention annex, and section 24 of huumausainelaki 373/2008 reaches exactly that: it disapplies the import and export provisions of the Act for medicinal products containing a substance in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, the products being those «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä», and then hands the traveller to section 19 of lääkelaki 395/1987.
Documentation: Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The locator a traveller or an official would be checking is Liite II list II entry 19 of 543/2008, as that annex stands after 4.12.2025/1119, and the entry printed there reads «2C-B (4-bromo-2,5-dimetoksifenetyyliamiini)». Because the row is in that part of the convention annexes, section 24 of huumausainelaki 373/2008 takes a traveller's own prescribed medicine out of the Act's import and export provisions and leaves section 19 of lääkelaki 395/1987 to govern how much may be carried, which is the provision this cell did not read. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, 2C-B, a named entry of Liite II list II of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 at printed position 19, that annex as amended by 4.12.2025/1119 · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · Updated September 21, 2026

2C-B in Finland, full detail →

2C-E

Legal status: Controlled, though not as a narcotic. Section 1 of valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014 makes the substances in its annex psychoactive substances banned from the consumer market, and 2C-E is named there. The entry reads «2C-E (2-(2,5-dimetoksi-4-etyylifenyyli)etaaniamiini)». That annex stands as substituted by 650/2026. Section 5 subsection 2 of huumausainelaki 373/2008 bans manufacture, import into Finland, storage, keeping for sale and transfer, and leaves research and industrial use to be permitted separately, so possession for one's own use and use itself are not among the banned acts. Section 3 subsection 3 of the same Act defines the category as substances used for intoxication that may be dangerous to health, notified for control, and that are neither medicines nor narcotics. It is not named in any annex of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, as those annexes stand after 651/2026, 1119/2025 and 650/2026.
Consequences if caught: Capital exposure: none. Criminal Code chapter 44 section 5 a carries the separate consumer market offence. It sets a fine or up to one year for manufacturing, importing, storing, keeping for sale or transferring a psychoactive substance banned from the consumer market, contrary to the Narcotics Act. Possession for one's own use and use itself are not among the acts it names. Section 33 a of huumausainelaki 373/2008 adds import and storage duties, and section 23 b allows a university, a research institute or a trader to import and store on prior notice to the Finnish Medicines Agency. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. This row is placed outside that regime, so they are recorded as Finland's published drug penalties and not as this substance's exposure. This row in particular. Its entry sits in the annex to valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, as that annex was substituted by 650/2026, at printed line 80 of the Finnish annex text Finlex serves, and it reads «2C-E (2-(2,5-dimetoksi-4-etyylifenyyli)etaaniamiini)». In the printed order of that annex the line above it reads 2C-D and the line below it reads 2C-EF. Section 1 of that decree is one sentence and it does all of the work: «Kuluttajamarkkinoilta kiellettyjä psykoaktiivisia aineita ovat liitteessä mainitut aineet.». The penalty limb that placement engages is not chapter 50. It is Criminal Code chapter 44 section 5 a, which opens «Joka huumausainelain vastaisesti tahallaan tai törkeästä huolimattomuudesta valmistaa, tuo maahan, varastoi, pitää myynnissä tai luovuttaa kuluttajamarkkinoilta kiellettyä psykoaktiivista ainetta, on tuomittava» and sets a fine or up to one year, and only where no heavier penalty is provided elsewhere. Section 5 subsection 2 of huumausainelaki 373/2008 states the prohibition this row breaches, «Kuluttajamarkkinoilta kielletyn psykoaktiivisen aineen valmistus, tuonti Suomen alueelle, varastointi, myynnissä pitäminen ja luovuttaminen on kielletty.», and that list of acts does not include possession or use, so the huumausaineen käyttörikos in chapter 50 section 2 a does not reach this row. No quantity threshold and no fine figure is printed for this row in either the decree or chapter 44 section 5 a.
If prescribed / medical: A substance banned from the consumer market is by definition not a medicine, which is what section 3 subsection 3 of huumausainelaki 373/2008 says, so no prescription route follows from this listing. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. Section 24 of huumausainelaki 373/2008 writes its traveller carve out by reference to the convention lists and this row is in neither decree's convention annexes at all, so the carve out has nothing to attach to. The route in for this category is section 23 b instead, which reads «Elinkeinonharjoittaja saa tuoda maahan ja varastoida kuluttajamarkkinoilta kiellettyjä psykoaktiivisia aineita perustellusta syystä teollista toimintaansa varten, jos aineesta ja toiminnasta on tehty ennen maahantuontia ilmoitus Lääkealan turvallisuus- ja kehittämiskeskukselle.», and that is a research and industry route, not a prescription route.
Documentation: The traveller carve out in section 24 of huumausainelaki 373/2008 is written for medicinal products containing convention listed narcotics and does not describe this row. Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. What a traveller is carrying, if this row is in the bag, is a substance banned from the consumer market by name at printed line 80 of the annex to 1130/2014, reading «2C-E (2-(2,5-dimetoksi-4-etyylifenyyli)etaaniamiini)», and import into Finland is one of the acts section 5 subsection 2 of huumausainelaki 373/2008 forbids. There is no traveller allowance to state for this row because the Act provides none for this category: the only import routes are the university and the industry notifications in section 23 b. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, 2C-E, a named entry of the annex to valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014 at printed line 80 of the Finnish annex text, that annex as substituted by 650/2026 · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · Updated September 21, 2026

2C-E in Finland, full detail →

2C-I

Legal status: Controlled. 2C-I is a narcotic in Finland by name. Section 1 of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 makes the substances, preparations and plants in annexes I to V narcotics, and this row's entry sits in Liite III, the annex headed as the substances brought into the narcotics definition by Council Framework Decision 2004/757/JHA as amended by Directive (EU) 2017/2103, which is a European Union addition and not a United Nations schedule. The entry reads «2C-I (2,5-dimetoksi-4-jodifenetyyliamiini)». Section 5 subsection 1 of huumausainelaki 373/2008 then forbids production, manufacture, import into Finland, export from Finland, transport, transit, distribution, trade, handling, possession and use, and allows departure from that ban only for medical, research, supervisory and industrial purposes as separately provided. That annex stands as amended by 25.6.2026/651.
Consequences if caught: Capital exposure: none. The ceiling anywhere in this regime is the ten year maximum that Criminal Code chapter 50 section 2 sets for an aggravated narcotics offence. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. This row sits in Liite III of the decree, so those are the provisions its placement engages. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. They describe the offences that this row's placement brings into play. This row in particular. Its entry sits in Liite III, the annex the decree heads as the substances brought inside the narcotic definition by European Union Council decisions on the criminal law of illicit drug trafficking, at printed position 1 of the 11 entries that annex carries in the consolidated text read here, and the entry reads «2C-I (2,5-dimetoksi-4-jodifenetyyliamiini)». It is the first entry printed in that list and below it comes 2C-T-2. The annex that carries this row stands as amended by 25.6.2026/651, which is the amendment that last touched this row's annex rather than the decree as a whole. Section 5 subsection 1 of huumausainelaki 373/2008 is the prohibition that placement engages, «Huumausaineen tuotanto, valmistus, tuonti Suomen alueelle, vienti Suomen alueelta, kuljetus, kauttakuljetus, jakelu, kauppa, käsittely, hallussapito ja käyttö on kielletty.», and chapter 50 section 5 subsection 1 of the Criminal Code makes the word huumausaine in those offences mean a narcotic under huumausainelaki, so the annex entry above is what puts this row inside them. Criminal Code chapter 50 section 2 a is the small quantity limb and it opens «Joka laittomasti käyttää taikka omaa käyttöä varten pitää hallussaan tai yrittää hankkia vähäisen määrän huumausainetta, on tuomittava», so the käyttörikos reaches this row on its own terms. No quantity figure is printed anywhere in chapter 50: whether a quantity is a suuri määrä, and whether the substance is an erittäin vaarallinen huumausaine under chapter 50 section 5 subsection 2, are findings of fact and the annex position does not settle either of them. No fine figure is printed either, because a Finnish fine is a day fine set on the offender's income.
If prescribed / medical: Section 24 of huumausainelaki 373/2008 writes its traveller carve out by reference to the convention lists, and this row is not placed in one of them, so the carve out does not describe it. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. This row is placed in Liite III, which is a national annex and not a convention list, so section 24 of huumausainelaki 373/2008 has no list to match it against. The carve out is written by reference to lists I to III of the 1961 Convention and lists II to IV of the 1971 Convention, for the products «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä», and this row is in neither.
Documentation: Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The locator a traveller or an official would be checking is Liite III entry 1 of 543/2008, as that annex stands after 25.6.2026/651, and the entry printed there reads «2C-I (2,5-dimetoksi-4-jodifenetyyliamiini)». Because the row is outside the lists section 24 names, that section does not take a traveller's own medicine out of the Act's import and export provisions for this row, and nothing read here supplies a carriage allowance in its place. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, 2C-I, a named entry of Liite III of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 at printed position 1, that annex as amended by 25.6.2026/651 · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · Updated September 21, 2026

2C-I in Finland, full detail →

2C-T-7

Legal status: Controlled. 2C-T-7 is a narcotic in Finland by name. Section 1 of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 makes the substances, preparations and plants in annexes I to V narcotics, and this row's entry sits in Liite III, the annex headed as the substances brought into the narcotics definition by Council Framework Decision 2004/757/JHA as amended by Directive (EU) 2017/2103, which is a European Union addition and not a United Nations schedule. The entry reads «2C-T-7 (2,5-dimetoksi-4-(n)-propyylitiofenetyyliamiini)». The instrument italicises part of that entry and the spacing around the italicised locants is as Finlex serves it. Section 5 subsection 1 of huumausainelaki 373/2008 then forbids production, manufacture, import into Finland, export from Finland, transport, transit, distribution, trade, handling, possession and use, and allows departure from that ban only for medical, research, supervisory and industrial purposes as separately provided. That annex stands as amended by 25.6.2026/651.
Consequences if caught: Capital exposure: none. The ceiling anywhere in this regime is the ten year maximum that Criminal Code chapter 50 section 2 sets for an aggravated narcotics offence. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. This row sits in Liite III of the decree, so those are the provisions its placement engages. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. They describe the offences that this row's placement brings into play. This row in particular. Its entry sits in Liite III, the annex the decree heads as the substances brought inside the narcotic definition by European Union Council decisions on the criminal law of illicit drug trafficking, at printed position 3 of the 11 entries that annex carries in the consolidated text read here, and the entry reads «2C-T-7 (2,5-dimetoksi-4-(n)-propyylitiofenetyyliamiini)». In the printed order of that list the entry above it is 2C-T-2 and below it comes 4-Bromimetkatinoni. The annex that carries this row stands as amended by 25.6.2026/651, which is the amendment that last touched this row's annex rather than the decree as a whole. Section 5 subsection 1 of huumausainelaki 373/2008 is the prohibition that placement engages, «Huumausaineen tuotanto, valmistus, tuonti Suomen alueelle, vienti Suomen alueelta, kuljetus, kauttakuljetus, jakelu, kauppa, käsittely, hallussapito ja käyttö on kielletty.», and chapter 50 section 5 subsection 1 of the Criminal Code makes the word huumausaine in those offences mean a narcotic under huumausainelaki, so the annex entry above is what puts this row inside them. Criminal Code chapter 50 section 2 a is the small quantity limb and it opens «Joka laittomasti käyttää taikka omaa käyttöä varten pitää hallussaan tai yrittää hankkia vähäisen määrän huumausainetta, on tuomittava», so the käyttörikos reaches this row on its own terms. No quantity figure is printed anywhere in chapter 50: whether a quantity is a suuri määrä, and whether the substance is an erittäin vaarallinen huumausaine under chapter 50 section 5 subsection 2, are findings of fact and the annex position does not settle either of them. No fine figure is printed either, because a Finnish fine is a day fine set on the offender's income.
If prescribed / medical: Section 24 of huumausainelaki 373/2008 writes its traveller carve out by reference to the convention lists, and this row is not placed in one of them, so the carve out does not describe it. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. This row is placed in Liite III, which is a national annex and not a convention list, so section 24 of huumausainelaki 373/2008 has no list to match it against. The carve out is written by reference to lists I to III of the 1961 Convention and lists II to IV of the 1971 Convention, for the products «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä», and this row is in neither.
Documentation: Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The locator a traveller or an official would be checking is Liite III entry 3 of 543/2008, as that annex stands after 25.6.2026/651, and the entry printed there reads «2C-T-7 (2,5-dimetoksi-4-(n)-propyylitiofenetyyliamiini)». Because the row is outside the lists section 24 names, that section does not take a traveller's own medicine out of the Act's import and export provisions for this row, and nothing read here supplies a carriage allowance in its place. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, 2C-T-7, a named entry of Liite III of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 at printed position 3, that annex as amended by 25.6.2026/651 · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · Updated September 21, 2026

2C-T-7 in Finland, full detail →

3-MMC

Legal status: Controlled. 3-MMC is a narcotic in Finland by name. Section 1 of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 makes the substances, preparations and plants in annexes I to V narcotics, and this row's entry sits in Liite II, the annex headed as the substances and preparations in lists I to IV of the 1971 Convention on Psychotropic Substances, under list II, which the instrument itself heads as a schedule of the 1971 Convention on Psychotropic Substances, an attribution read off the annex heading and not checked against the INCB list in this pass. The entry reads «3-Metyylimetkatinoni (3-MMC) (2-(metyyliamino)-1-(3-metyylifenyyli)propan-1-oni)». Section 5 subsection 1 of huumausainelaki 373/2008 then forbids production, manufacture, import into Finland, export from Finland, transport, transit, distribution, trade, handling, possession and use, and allows departure from that ban only for medical, research, supervisory and industrial purposes as separately provided. The same list closes by extending itself, in the words «tämän luettelon aineiden suolat, mukaan luettuna edellä mainittujen isomeerien suolat, jos sellaisten olemassaolo on mahdollista; sekä». That annex stands as amended by 4.12.2025/1119.
Consequences if caught: Capital exposure: none. The ceiling anywhere in this regime is the ten year maximum that Criminal Code chapter 50 section 2 sets for an aggravated narcotics offence. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. This row sits in Liite II under list II of the decree, so those are the provisions its placement engages. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. They describe the offences that this row's placement brings into play. This row in particular. Its entry sits in Liite II, which the decree heads as the substances and preparations in the lists of the 1971 Convention on Psychotropic Substances, under list II of that annex, at printed position 54 of the 68 entries that list carries in the consolidated text read here, and the entry reads «3-Metyylimetkatinoni (3-MMC) (2-(metyyliamino)-1-(3-metyylifenyyli)propan-1-oni)». In the printed order of that list the entry above it is 4-Metyylietkatinoni and below it comes Metyylifenidaatti. The same list closes by extending itself beyond its named entries, in the words «tässä luettelossa mainittuja aineita sisältävät valmisteet.». The annex that carries this row stands as amended by 4.12.2025/1119, which is the amendment that last touched this row's annex rather than the decree as a whole. Section 5 subsection 1 of huumausainelaki 373/2008 is the prohibition that placement engages, «Huumausaineen tuotanto, valmistus, tuonti Suomen alueelle, vienti Suomen alueelta, kuljetus, kauttakuljetus, jakelu, kauppa, käsittely, hallussapito ja käyttö on kielletty.», and chapter 50 section 5 subsection 1 of the Criminal Code makes the word huumausaine in those offences mean a narcotic under huumausainelaki, so the annex entry above is what puts this row inside them. Criminal Code chapter 50 section 2 a is the small quantity limb and it opens «Joka laittomasti käyttää taikka omaa käyttöä varten pitää hallussaan tai yrittää hankkia vähäisen määrän huumausainetta, on tuomittava», so the käyttörikos reaches this row on its own terms. No quantity figure is printed anywhere in chapter 50: whether a quantity is a suuri määrä, and whether the substance is an erittäin vaarallinen huumausaine under chapter 50 section 5 subsection 2, are findings of fact and the annex position does not settle either of them. No fine figure is printed either, because a Finnish fine is a day fine set on the offender's income.
If prescribed / medical: Section 24 of huumausainelaki 373/2008 disapplies the import and export rules for a medicinal product a traveller carries for personal medication where the substance is in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, and this row is inside that carve out. Section 19 of lääkelaki 395/1987 then governs. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. This row sits in list II of the 1971 Convention annex, and section 24 of huumausainelaki 373/2008 reaches exactly that: it disapplies the import and export provisions of the Act for medicinal products containing a substance in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, the products being those «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä», and then hands the traveller to section 19 of lääkelaki 395/1987.
Documentation: Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The locator a traveller or an official would be checking is Liite II list II entry 54 of 543/2008, as that annex stands after 4.12.2025/1119, and the entry printed there reads «3-Metyylimetkatinoni (3-MMC) (2-(metyyliamino)-1-(3-metyylifenyyli)propan-1-oni)». Because the row is in that part of the convention annexes, section 24 of huumausainelaki 373/2008 takes a traveller's own prescribed medicine out of the Act's import and export provisions and leaves section 19 of lääkelaki 395/1987 to govern how much may be carried, which is the provision this cell did not read. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, 3-MMC, a named entry of Liite II list II of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 at printed position 54, that annex as amended by 4.12.2025/1119 · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · Updated September 21, 2026

3-MMC in Finland, full detail →

4-AcO-DMT

Legal status: Controlled, though not as a narcotic. Section 1 of valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014 makes the substances in its annex psychoactive substances banned from the consumer market, and 4-AcO-DMT is named there. The entry reads «4-AcO-DMT (3-[2-(dimetyyliamino)etyyli]-1H-indol-4-yyli-asetaatti)». That annex stands as substituted by 650/2026. Section 5 subsection 2 of huumausainelaki 373/2008 bans manufacture, import into Finland, storage, keeping for sale and transfer, and leaves research and industrial use to be permitted separately, so possession for one's own use and use itself are not among the banned acts. Section 3 subsection 3 of the same Act defines the category as substances used for intoxication that may be dangerous to health, notified for control, and that are neither medicines nor narcotics. It is not named in any annex of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, as those annexes stand after 651/2026, 1119/2025 and 650/2026.
Consequences if caught: Capital exposure: none. Criminal Code chapter 44 section 5 a carries the separate consumer market offence. It sets a fine or up to one year for manufacturing, importing, storing, keeping for sale or transferring a psychoactive substance banned from the consumer market, contrary to the Narcotics Act. Possession for one's own use and use itself are not among the acts it names. Section 33 a of huumausainelaki 373/2008 adds import and storage duties, and section 23 b allows a university, a research institute or a trader to import and store on prior notice to the Finnish Medicines Agency. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. This row is placed outside that regime, so they are recorded as Finland's published drug penalties and not as this substance's exposure. This row in particular. Its entry sits in the annex to valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, as that annex was substituted by 650/2026, at printed line 244 of the Finnish annex text Finlex serves, and it reads «4-AcO-DMT (3-[2-(dimetyyliamino)etyyli]-1H-indol-4-yyli-asetaatti)». In the printed order of that annex the line above it reads 4-AcO-DIPT and the line below it reads 4-AcO-DPT. Section 1 of that decree is one sentence and it does all of the work: «Kuluttajamarkkinoilta kiellettyjä psykoaktiivisia aineita ovat liitteessä mainitut aineet.». The penalty limb that placement engages is not chapter 50. It is Criminal Code chapter 44 section 5 a, which opens «Joka huumausainelain vastaisesti tahallaan tai törkeästä huolimattomuudesta valmistaa, tuo maahan, varastoi, pitää myynnissä tai luovuttaa kuluttajamarkkinoilta kiellettyä psykoaktiivista ainetta, on tuomittava» and sets a fine or up to one year, and only where no heavier penalty is provided elsewhere. Section 5 subsection 2 of huumausainelaki 373/2008 states the prohibition this row breaches, «Kuluttajamarkkinoilta kielletyn psykoaktiivisen aineen valmistus, tuonti Suomen alueelle, varastointi, myynnissä pitäminen ja luovuttaminen on kielletty.», and that list of acts does not include possession or use, so the huumausaineen käyttörikos in chapter 50 section 2 a does not reach this row. No quantity threshold and no fine figure is printed for this row in either the decree or chapter 44 section 5 a.
If prescribed / medical: A substance banned from the consumer market is by definition not a medicine, which is what section 3 subsection 3 of huumausainelaki 373/2008 says, so no prescription route follows from this listing. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. Section 24 of huumausainelaki 373/2008 writes its traveller carve out by reference to the convention lists and this row is in neither decree's convention annexes at all, so the carve out has nothing to attach to. The route in for this category is section 23 b instead, which reads «Elinkeinonharjoittaja saa tuoda maahan ja varastoida kuluttajamarkkinoilta kiellettyjä psykoaktiivisia aineita perustellusta syystä teollista toimintaansa varten, jos aineesta ja toiminnasta on tehty ennen maahantuontia ilmoitus Lääkealan turvallisuus- ja kehittämiskeskukselle.», and that is a research and industry route, not a prescription route.
Documentation: The traveller carve out in section 24 of huumausainelaki 373/2008 is written for medicinal products containing convention listed narcotics and does not describe this row. Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. What a traveller is carrying, if this row is in the bag, is a substance banned from the consumer market by name at printed line 244 of the annex to 1130/2014, reading «4-AcO-DMT (3-[2-(dimetyyliamino)etyyli]-1H-indol-4-yyli-asetaatti)», and import into Finland is one of the acts section 5 subsection 2 of huumausainelaki 373/2008 forbids. There is no traveller allowance to state for this row because the Act provides none for this category: the only import routes are the university and the industry notifications in section 23 b. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, 4-AcO-DMT, a named entry of the annex to valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014 at printed line 244 of the Finnish annex text, that annex as substituted by 650/2026 · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · Updated September 21, 2026

4-AcO-DMT in Finland, full detail →

4-HO-MET

Legal status: Controlled, though not as a narcotic. Section 1 of valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014 makes the substances in its annex psychoactive substances banned from the consumer market, and 4-HO-MET is named there. The entry reads «4-HO-MET (3-{2-[etyyli(metyyli)amino]etyyli}-1H-indol-4-oli)». That annex stands as substituted by 650/2026. Section 5 subsection 2 of huumausainelaki 373/2008 bans manufacture, import into Finland, storage, keeping for sale and transfer, and leaves research and industrial use to be permitted separately, so possession for one's own use and use itself are not among the banned acts. Section 3 subsection 3 of the same Act defines the category as substances used for intoxication that may be dangerous to health, notified for control, and that are neither medicines nor narcotics. It is not named in any annex of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, as those annexes stand after 651/2026, 1119/2025 and 650/2026.
Consequences if caught: Capital exposure: none. Criminal Code chapter 44 section 5 a carries the separate consumer market offence. It sets a fine or up to one year for manufacturing, importing, storing, keeping for sale or transferring a psychoactive substance banned from the consumer market, contrary to the Narcotics Act. Possession for one's own use and use itself are not among the acts it names. Section 33 a of huumausainelaki 373/2008 adds import and storage duties, and section 23 b allows a university, a research institute or a trader to import and store on prior notice to the Finnish Medicines Agency. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. This row is placed outside that regime, so they are recorded as Finland's published drug penalties and not as this substance's exposure. This row in particular. Its entry sits in the annex to valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, as that annex was substituted by 650/2026, at printed line 619 of the Finnish annex text Finlex serves, and it reads «4-HO-MET (3-{2-[etyyli(metyyli)amino]etyyli}-1H-indol-4-oli)». In the printed order of that annex the line above it reads 7-HO-McPT and the line below it reads 4-HO-MIPT. Section 1 of that decree is one sentence and it does all of the work: «Kuluttajamarkkinoilta kiellettyjä psykoaktiivisia aineita ovat liitteessä mainitut aineet.». The penalty limb that placement engages is not chapter 50. It is Criminal Code chapter 44 section 5 a, which opens «Joka huumausainelain vastaisesti tahallaan tai törkeästä huolimattomuudesta valmistaa, tuo maahan, varastoi, pitää myynnissä tai luovuttaa kuluttajamarkkinoilta kiellettyä psykoaktiivista ainetta, on tuomittava» and sets a fine or up to one year, and only where no heavier penalty is provided elsewhere. Section 5 subsection 2 of huumausainelaki 373/2008 states the prohibition this row breaches, «Kuluttajamarkkinoilta kielletyn psykoaktiivisen aineen valmistus, tuonti Suomen alueelle, varastointi, myynnissä pitäminen ja luovuttaminen on kielletty.», and that list of acts does not include possession or use, so the huumausaineen käyttörikos in chapter 50 section 2 a does not reach this row. No quantity threshold and no fine figure is printed for this row in either the decree or chapter 44 section 5 a.
If prescribed / medical: A substance banned from the consumer market is by definition not a medicine, which is what section 3 subsection 3 of huumausainelaki 373/2008 says, so no prescription route follows from this listing. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. Section 24 of huumausainelaki 373/2008 writes its traveller carve out by reference to the convention lists and this row is in neither decree's convention annexes at all, so the carve out has nothing to attach to. The route in for this category is section 23 b instead, which reads «Elinkeinonharjoittaja saa tuoda maahan ja varastoida kuluttajamarkkinoilta kiellettyjä psykoaktiivisia aineita perustellusta syystä teollista toimintaansa varten, jos aineesta ja toiminnasta on tehty ennen maahantuontia ilmoitus Lääkealan turvallisuus- ja kehittämiskeskukselle.», and that is a research and industry route, not a prescription route.
Documentation: The traveller carve out in section 24 of huumausainelaki 373/2008 is written for medicinal products containing convention listed narcotics and does not describe this row. Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. What a traveller is carrying, if this row is in the bag, is a substance banned from the consumer market by name at printed line 619 of the annex to 1130/2014, reading «4-HO-MET (3-{2-[etyyli(metyyli)amino]etyyli}-1H-indol-4-oli)», and import into Finland is one of the acts section 5 subsection 2 of huumausainelaki 373/2008 forbids. There is no traveller allowance to state for this row because the Act provides none for this category: the only import routes are the university and the industry notifications in section 23 b. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, 4-HO-MET, a named entry of the annex to valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014 at printed line 619 of the Finnish annex text, that annex as substituted by 650/2026 · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · Updated September 21, 2026

4-HO-MET in Finland, full detail →

5-MeO-DMT (Bufo / Toad)

Legal status: Controlled. 5-MeO-DMT is a narcotic in Finland by name. Section 1 of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 makes the substances, preparations and plants in annexes I to V narcotics, and this row's entry sits in Liite IV, a bare national list opening only with the words seuraavat aineet, which is Finland's own addition and rests on no convention schedule. The entry reads «5-MeO-DMT (5-metoksidimetyylitryptamiini, 2-(5-metoksi-1 H -indol-3-yyli)- N,N -dimetyylietaaniamiini)». The instrument italicises part of that entry and the spacing around the italicised locants is as Finlex serves it. Section 5 subsection 1 of huumausainelaki 373/2008 then forbids production, manufacture, import into Finland, export from Finland, transport, transit, distribution, trade, handling, possession and use, and allows departure from that ban only for medical, research, supervisory and industrial purposes as separately provided. The same list closes by extending itself, in the words «sen suolat mukaan luettuna edellä mainittujen esterien, eetterien ja isomeerien suolat, jos sellaisten suolojen olemassaolo on mahdollista; sekä». That annex stands as amended by 25.6.2026/651.
Consequences if caught: Capital exposure: none. The ceiling anywhere in this regime is the ten year maximum that Criminal Code chapter 50 section 2 sets for an aggravated narcotics offence. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. This row sits in Liite IV among the substances of the decree, so those are the provisions its placement engages. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. They describe the offences that this row's placement brings into play. This row in particular. Its entry sits in Liite IV, the annex of substances and plants Finland controls nationally rather than by convention list, at printed position 43 of the 66 substance entries that follow the heading «Seuraavat aineet:», and the entry reads «5-MeO-DMT (5-metoksidimetyylitryptamiini, 2-(5-metoksi-1H-indol-3-yyli)-N,N-dimetyylietaaniamiini)». In the printed order of that list the entry above it is Meklonatsepaami and below it comes Metitsolaami. The same list closes by extending itself beyond its named entries, in the words «tässä liitteessä mainittuja aineita sisältävät valmisteet.». The annex that carries this row stands as amended by 25.6.2026/651, which is the amendment that last touched this row's annex rather than the decree as a whole. Section 5 subsection 1 of huumausainelaki 373/2008 is the prohibition that placement engages, «Huumausaineen tuotanto, valmistus, tuonti Suomen alueelle, vienti Suomen alueelta, kuljetus, kauttakuljetus, jakelu, kauppa, käsittely, hallussapito ja käyttö on kielletty.», and chapter 50 section 5 subsection 1 of the Criminal Code makes the word huumausaine in those offences mean a narcotic under huumausainelaki, so the annex entry above is what puts this row inside them. Criminal Code chapter 50 section 2 a is the small quantity limb and it opens «Joka laittomasti käyttää taikka omaa käyttöä varten pitää hallussaan tai yrittää hankkia vähäisen määrän huumausainetta, on tuomittava», so the käyttörikos reaches this row on its own terms. No quantity figure is printed anywhere in chapter 50: whether a quantity is a suuri määrä, and whether the substance is an erittäin vaarallinen huumausaine under chapter 50 section 5 subsection 2, are findings of fact and the annex position does not settle either of them. No fine figure is printed either, because a Finnish fine is a day fine set on the offender's income.
If prescribed / medical: Section 24 of huumausainelaki 373/2008 writes its traveller carve out by reference to the convention lists, and this row is not placed in one of them, so the carve out does not describe it. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. This row is placed in Liite IV, which is a national annex and not a convention list, so section 24 of huumausainelaki 373/2008 has no list to match it against. The carve out is written by reference to lists I to III of the 1961 Convention and lists II to IV of the 1971 Convention, for the products «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä», and this row is in neither.
Documentation: Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The locator a traveller or an official would be checking is Liite IV entry 43 of 543/2008, as that annex stands after 25.6.2026/651, and the entry printed there reads «5-MeO-DMT (5-metoksidimetyylitryptamiini, 2-(5-metoksi-1H-indol-3-yyli)-N,N-dimetyylietaaniamiini)». Because the row is outside the lists section 24 names, that section does not take a traveller's own medicine out of the Act's import and export provisions for this row, and nothing read here supplies a carriage allowance in its place. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, 5-MeO-DMT, a named entry of Liite IV of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 at printed position 43, that annex as amended by 25.6.2026/651 · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · Updated September 21, 2026

5-MeO-DMT (Bufo / Toad) in Finland, full detail →

6-APB

Legal status: Controlled. 6-APB is a narcotic in Finland by name. Section 1 of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 makes the substances, preparations and plants in annexes I to V narcotics, and this row's entry sits in Liite IV, a bare national list opening only with the words seuraavat aineet, which is Finland's own addition and rests on no convention schedule. The entry reads «6-(2-Aminopropyyli)bentsofuraani (6-APB) (1-(1-bentsofuran-6-yyli)propaani-2-amiini)». Section 5 subsection 1 of huumausainelaki 373/2008 then forbids production, manufacture, import into Finland, export from Finland, transport, transit, distribution, trade, handling, possession and use, and allows departure from that ban only for medical, research, supervisory and industrial purposes as separately provided. The same list closes by extending itself, in the words «sen suolat mukaan luettuna edellä mainittujen esterien, eetterien ja isomeerien suolat, jos sellaisten suolojen olemassaolo on mahdollista; sekä». That annex stands as amended by 25.6.2026/651.
Consequences if caught: Capital exposure: none. The ceiling anywhere in this regime is the ten year maximum that Criminal Code chapter 50 section 2 sets for an aggravated narcotics offence. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. This row sits in Liite IV among the substances of the decree, so those are the provisions its placement engages. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. They describe the offences that this row's placement brings into play. This row in particular. Its entry sits in Liite IV, the annex of substances and plants Finland controls nationally rather than by convention list, at printed position 4 of the 66 substance entries that follow the heading «Seuraavat aineet:», and the entry reads «6-(2-Aminopropyyli)bentsofuraani (6-APB) (1-(1-bentsofuran-6-yyli)propaani-2-amiini)». In the printed order of that list the entry above it is 5- and below it comes Adinatsolaami. The same list closes by extending itself beyond its named entries, in the words «tässä liitteessä mainittuja aineita sisältävät valmisteet.». The annex that carries this row stands as amended by 25.6.2026/651, which is the amendment that last touched this row's annex rather than the decree as a whole. Section 5 subsection 1 of huumausainelaki 373/2008 is the prohibition that placement engages, «Huumausaineen tuotanto, valmistus, tuonti Suomen alueelle, vienti Suomen alueelta, kuljetus, kauttakuljetus, jakelu, kauppa, käsittely, hallussapito ja käyttö on kielletty.», and chapter 50 section 5 subsection 1 of the Criminal Code makes the word huumausaine in those offences mean a narcotic under huumausainelaki, so the annex entry above is what puts this row inside them. Criminal Code chapter 50 section 2 a is the small quantity limb and it opens «Joka laittomasti käyttää taikka omaa käyttöä varten pitää hallussaan tai yrittää hankkia vähäisen määrän huumausainetta, on tuomittava», so the käyttörikos reaches this row on its own terms. No quantity figure is printed anywhere in chapter 50: whether a quantity is a suuri määrä, and whether the substance is an erittäin vaarallinen huumausaine under chapter 50 section 5 subsection 2, are findings of fact and the annex position does not settle either of them. No fine figure is printed either, because a Finnish fine is a day fine set on the offender's income.
If prescribed / medical: Section 24 of huumausainelaki 373/2008 writes its traveller carve out by reference to the convention lists, and this row is not placed in one of them, so the carve out does not describe it. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. This row is placed in Liite IV, which is a national annex and not a convention list, so section 24 of huumausainelaki 373/2008 has no list to match it against. The carve out is written by reference to lists I to III of the 1961 Convention and lists II to IV of the 1971 Convention, for the products «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä», and this row is in neither.
Documentation: Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The locator a traveller or an official would be checking is Liite IV entry 4 of 543/2008, as that annex stands after 25.6.2026/651, and the entry printed there reads «6-(2-Aminopropyyli)bentsofuraani (6-APB) (1-(1-bentsofuran-6-yyli)propaani-2-amiini)». Because the row is outside the lists section 24 names, that section does not take a traveller's own medicine out of the Act's import and export provisions for this row, and nothing read here supplies a carriage allowance in its place. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, 6-APB, a named entry of Liite IV of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 at printed position 4, that annex as amended by 25.6.2026/651 · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · Updated September 21, 2026

6-APB in Finland, full detail →

7-Hydroxymitragynine (7-OH)

Legal status: Controlled, though not as a narcotic. Section 1 of valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014 makes the substances in its annex psychoactive substances banned from the consumer market, and 7-hydroxymitragynine is named there. The entry reads «7-Hydroksimitragyniini (7-OH) (metyyli (E)-2-[(2S,3S,7aS,12bS)-3-etyyli-7a-hydroksi-8-metoksi-2,3,4,6,7,12b-heksahydro-1H-indolo[2,3-a]kvinolitsin-2-yyli]-3-metoksiprop-2-enoaatti)». That annex stands as substituted by 650/2026. Section 5 subsection 2 of huumausainelaki 373/2008 bans manufacture, import into Finland, storage, keeping for sale and transfer, and leaves research and industrial use to be permitted separately, so possession for one's own use and use itself are not among the banned acts. Section 3 subsection 3 of the same Act defines the category as substances used for intoxication that may be dangerous to health, notified for control, and that are neither medicines nor narcotics. It is not named in any annex of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, as those annexes stand after 651/2026, 1119/2025 and 650/2026.
Consequences if caught: Capital exposure: none. Criminal Code chapter 44 section 5 a carries the separate consumer market offence. It sets a fine or up to one year for manufacturing, importing, storing, keeping for sale or transferring a psychoactive substance banned from the consumer market, contrary to the Narcotics Act. Possession for one's own use and use itself are not among the acts it names. Section 33 a of huumausainelaki 373/2008 adds import and storage duties, and section 23 b allows a university, a research institute or a trader to import and store on prior notice to the Finnish Medicines Agency. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. This row is placed outside that regime, so they are recorded as Finland's published drug penalties and not as this substance's exposure. This row in particular. Its entry sits in the annex to valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, as that annex was substituted by 650/2026, at printed line 636 of the Finnish annex text Finlex serves, and it reads «7-Hydroksimitragyniini (7-OH)». In the printed order of that annex the line above it reads 4- and the line below it reads 8-metoksi-2,3,4,6,7,12b-heksahydro-1H-indolo[2,3-a]kvinolitsin-2-yyli]-3-metoksiprop-. Section 1 of that decree is one sentence and it does all of the work: «Kuluttajamarkkinoilta kiellettyjä psykoaktiivisia aineita ovat liitteessä mainitut aineet.». The penalty limb that placement engages is not chapter 50. It is Criminal Code chapter 44 section 5 a, which opens «Joka huumausainelain vastaisesti tahallaan tai törkeästä huolimattomuudesta valmistaa, tuo maahan, varastoi, pitää myynnissä tai luovuttaa kuluttajamarkkinoilta kiellettyä psykoaktiivista ainetta, on tuomittava» and sets a fine or up to one year, and only where no heavier penalty is provided elsewhere. Section 5 subsection 2 of huumausainelaki 373/2008 states the prohibition this row breaches, «Kuluttajamarkkinoilta kielletyn psykoaktiivisen aineen valmistus, tuonti Suomen alueelle, varastointi, myynnissä pitäminen ja luovuttaminen on kielletty.», and that list of acts does not include possession or use, so the huumausaineen käyttörikos in chapter 50 section 2 a does not reach this row. No quantity threshold and no fine figure is printed for this row in either the decree or chapter 44 section 5 a.
If prescribed / medical: A substance banned from the consumer market is by definition not a medicine, which is what section 3 subsection 3 of huumausainelaki 373/2008 says, so no prescription route follows from this listing. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. Section 24 of huumausainelaki 373/2008 writes its traveller carve out by reference to the convention lists and this row is in neither decree's convention annexes at all, so the carve out has nothing to attach to. The route in for this category is section 23 b instead, which reads «Elinkeinonharjoittaja saa tuoda maahan ja varastoida kuluttajamarkkinoilta kiellettyjä psykoaktiivisia aineita perustellusta syystä teollista toimintaansa varten, jos aineesta ja toiminnasta on tehty ennen maahantuontia ilmoitus Lääkealan turvallisuus- ja kehittämiskeskukselle.», and that is a research and industry route, not a prescription route.
Documentation: The traveller carve out in section 24 of huumausainelaki 373/2008 is written for medicinal products containing convention listed narcotics and does not describe this row. Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. What a traveller is carrying, if this row is in the bag, is a substance banned from the consumer market by name at printed line 636 of the annex to 1130/2014, reading «7-Hydroksimitragyniini (7-OH)», and import into Finland is one of the acts section 5 subsection 2 of huumausainelaki 373/2008 forbids. There is no traveller allowance to state for this row because the Act provides none for this category: the only import routes are the university and the industry notifications in section 23 b. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, 7-hydroxymitragynine, a named entry of the annex to valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014 at printed line 636 of the Finnish annex text, that annex as substituted by 650/2026 · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · Updated September 21, 2026

7-Hydroxymitragynine (7-OH) in Finland, full detail →

Adderall

Legal status: Controlled. Adderall is sold as a mixture of amphetamine salts and the decree names the salts and not the product. Section 1 of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 makes the substances, preparations and plants in annexes I to V narcotics, and this row's entry sits in Liite II, the annex headed as the substances and preparations in lists I to IV of the 1971 Convention on Psychotropic Substances, under list II, which the instrument itself heads as a schedule of the 1971 Convention on Psychotropic Substances, an attribution read off the annex heading and not checked against the INCB list in this pass. The entry reads «Deksamfetamiini ((+)- α -metyylifenetyyliamiini)». The instrument italicises part of that entry and the spacing around the italicised locants is as Finlex serves it. Section 5 subsection 1 of huumausainelaki 373/2008 then forbids production, manufacture, import into Finland, export from Finland, transport, transit, distribution, trade, handling, possession and use, and allows departure from that ban only for medical, research, supervisory and industrial purposes as separately provided. The same list closes by extending itself, in the words «tämän luettelon aineiden suolat, mukaan luettuna edellä mainittujen isomeerien suolat, jos sellaisten olemassaolo on mahdollista; sekä». That annex stands as amended by 4.12.2025/1119. The three entries read in this pass are amphetamine, dexamfetamine and levamfetamine, all in Liite II under list II of the 1971 Convention, and the closing salts clause of that list carries their salts. The three entries read verbatim as «Amfetamiini ((±)- α -metyylifenetyyliamiini)», «Deksamfetamiini ((+)- α -metyylifenetyyliamiini)» and «Levamfetamiini ((-)-(R)- α -metyylifenetyyliamiini)», with the spacing around the italicised locants as Finlex serves it.
Consequences if caught: Capital exposure: none. The ceiling anywhere in this regime is the ten year maximum that Criminal Code chapter 50 section 2 sets for an aggravated narcotics offence. Adderall is a mixture of amphetamine salts and no product name appears in the decree. Three constituent entries do. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. This row sits in Liite II under list II of the decree, so those are the provisions its placement engages. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. They describe the offences that this row's placement brings into play. This row in particular. The entry this row is reached through sits in Liite II, which the decree heads as the substances and preparations in the lists of the 1971 Convention on Psychotropic Substances, under list II of that annex, at printed position 23 of the 68 entries that list carries in the consolidated text read here, it reads «Deksamfetamiini ((+)-α-metyylifenetyyliamiini)», and it is that entry rather than this row's own name that the decree prints. In the printed order of that list the entry above it is CUMYL-PEGACLONE and below it comes Delta-9-tetrahydrokannabinoli. The same list closes by extending itself beyond its named entries, in the words «tässä luettelossa mainittuja aineita sisältävät valmisteet.». The annex that carries this row stands as amended by 4.12.2025/1119, which is the amendment that last touched this row's annex rather than the decree as a whole. Section 5 subsection 1 of huumausainelaki 373/2008 is the prohibition that placement engages, «Huumausaineen tuotanto, valmistus, tuonti Suomen alueelle, vienti Suomen alueelta, kuljetus, kauttakuljetus, jakelu, kauppa, käsittely, hallussapito ja käyttö on kielletty.», and chapter 50 section 5 subsection 1 of the Criminal Code makes the word huumausaine in those offences mean a narcotic under huumausainelaki, so the annex entry above is what puts this row inside them. Criminal Code chapter 50 section 2 a is the small quantity limb and it opens «Joka laittomasti käyttää taikka omaa käyttöä varten pitää hallussaan tai yrittää hankkia vähäisen määrän huumausainetta, on tuomittava», so the käyttörikos reaches this row on its own terms. No quantity figure is printed anywhere in chapter 50: whether a quantity is a suuri määrä, and whether the substance is an erittäin vaarallinen huumausaine under chapter 50 section 5 subsection 2, are findings of fact and the annex position does not settle either of them. No fine figure is printed either, because a Finnish fine is a day fine set on the offender's income.
If prescribed / medical: Section 24 of huumausainelaki 373/2008 disapplies the import and export rules for a medicinal product a traveller carries for personal medication where the substance is in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, and this row is inside that carve out. Section 19 of lääkelaki 395/1987 then governs. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. The entry this row is reached through sits in list II of the 1971 Convention annex, and section 24 of huumausainelaki 373/2008 reaches exactly that: it disapplies the import and export provisions of the Act for medicinal products containing a substance in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, the products being those «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä», and then hands the traveller to section 19 of lääkelaki 395/1987. That reading is about the entry, not about this row's own name, which the decree does not print. Whether a product containing this row falls inside the carve out follows from what the product contains, and this cell does not settle it.
Documentation: Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The locator a traveller or an official would be checking is Liite II list II entry 23 of 543/2008, as that annex stands after 4.12.2025/1119, and the entry printed there reads «Deksamfetamiini ((+)-α-metyylifenetyyliamiini)». Because the row is in that part of the convention annexes, section 24 of huumausainelaki 373/2008 takes a traveller's own prescribed medicine out of the Act's import and export provisions and leaves section 19 of lääkelaki 395/1987 to govern how much may be carried, which is the provision this cell did not read. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, Adderall, a named entry of Liite II list II of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 at printed position 23, that annex as amended by 4.12.2025/1119 · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · finlex.fi · Updated September 21, 2026

Adderall in Finland, full detail →

Alcohol

Legal status: Controlled by its own statute rather than by the narcotics schedule. Alkoholilaki 1102/2017 section 83 governs possession and it reads «Henkilö, joka on 20 vuotta nuorempi, ei saa pitää hallussa väkevää alkoholijuomaa. Henkilö, joka on 18 vuotta nuorempi, ei saa pitää hallussa mietoa alkoholijuomaa.» The same section forbids holding an alcoholic drink that was not lawfully made or imported. Section 5 makes the trade licensable and section 6 sets the exemptions. Ethanol is not named in any annex of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 and not named in the annex to valtioneuvoston asetus 1130/2014, as those annexes stand after 651/2026, 1119/2025 and 650/2026.
Consequences if caught: Capital exposure: none. Criminal Code chapter 50 a carries the alcohol offences. Section 1 sets a fine or up to two years for an alkoholirikos, section 2 sets four months to four years for an aggravated one, and section 3 sets a fine alone where the quantity and the circumstances make the act minor. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. This row is placed outside that regime, so they are recorded as Finland's published drug penalties and not as this substance's exposure. This row in particular. Alcohol is not carried by either drug decree, so neither the chapter 50 lane nor the chapter 44 section 5 a lane is the one that describes this row. The statute that does is alkoholilaki 1102/2017, and the bands stated above are the narcotics bands, reproduced because the live cell named chapter 50 and they are what that citation means, not because this row sits in them. It is not named in either decree and that is a measured absence, not an assumption. The Finnish forms put to both texts for this row were «Alkoholi», «Etanoli», «etyylialkoholi». Against the consolidated 543/2008, whose annexes carry 196 entries in Liite I, 192 in Liite II, 11 in Liite III, 70 in Liite IV and 1 in Liite V, and against the annex to 1130/2014 as substituted by 650/2026, no form returned an entry of its own. What the search did return is a near miss rather than a hit: in Liite II the longer entry «Katiini, (+)-norpseudoefedriini ((+)-(S)-α-[(S)-1-aminoetyyli]bentsyylialkoholi)»; and in Liite II the longer entry «Tsipeproli (α-(α-metoksibentsyyli)-4-(β-metoksifenetyyli)-1-piperatsiinietanoli)»; and in the 1130/2014 annex the longer entry «Difenyyliprolinoli (D2PM) (difenyyli[(2S)-pyrrolidin-2-yyli]metanoli)», which contains the searched form inside a different molecule's name and is not this row.
If prescribed / medical: Alcohol is not dispensed on prescription in this sense, so no prescription route is stated for this row. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. Neither decree names this row, so section 24 of huumausainelaki 373/2008 has no list to match it against: that section is written by reference to the convention lists and takes out of the Act's import and export provisions only medicinal products «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä» containing a substance in one of them. The medicines list 230/2025 was read for this row as well, in its Liite 1, Liite 1 A and Liite 2, and the Finnish forms recorded in the documentation field return no row of its own there either.
Documentation: No document is carried for alcohol itself. Age is the operative control and section 83 sets it at 20 for strong drink and 18 for mild drink. Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The search behind the absence stated for this row was run in Finnish and the forms were «Alkoholi», «Etanoli», «etyylialkoholi». Section 24 of huumausainelaki 373/2008, the provision that would otherwise carry a traveller's own medicine past the Act's import and export rules, reaches only products «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä» that contain a substance in one of the convention lists, and this row is in none of them. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, alcohol, not a named entry of either drug decree and governed by alkoholilaki 1102/2017 · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · finlex.fi · Updated September 21, 2026

Alcohol in Finland, full detail →

Amanita muscaria

Legal status: Not a narcotic in Finland. Amanita muscaria is not named in any annex of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 and is not named in the annex to valtioneuvoston asetus 1130/2014, as those annexes stand after 651/2026, 1119/2025 and 650/2026. It is a medicine question instead. The Finnish Medicines Agency decision on the medicines list, 230/2025, names it in annex 2, the list of rohdokset, where the Latin column of the row reads «Amanita muscaria». Annex 2 puts the Latin name first, and this row gives its Finnish name as Punainen kärpässieni and its English name as Fly agaric, Fly amanita. Section 3 of that decision supervises the annex 2 rohdokset as medicines when they are used in the way section 3 subsection 1 of lääkelaki 395/1987 describes. Section 1 of the decision states that the list is not exhaustive and that not every product containing a listed substance meets the medicine definition, so an individual product's status turns on its own classification. Section 3 opens «Lääkkeinä valvotaan lisäksi seuraavia aineita tai valmisteita silloin, kun niitä käytetään lääkelain 3 § 1 momentin mukaisesti:» and the live Finland cell's reading is kept, that this verifies the medicinal herb regime and does not turn every wild mushroom or non medicinal product into a narcotic.
Consequences if caught: Capital exposure: none. Criminal Code chapter 44 section 5 carries the medicines offence. It sets a fine or up to one year for manufacturing, importing, storing, keeping for sale or supplying medicines contrary to the Medicines Act or the European Union medicines regulations, unless a heavier penalty is provided elsewhere. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. This row is placed outside that regime, so they are recorded as Finland's published drug penalties and not as this substance's exposure. This row in particular. It is not named in either decree and that is a measured absence, not an assumption. The Finnish forms put to both texts for this row were «Amanita», «muscaria», «punakärpässieni», «Ibotenic», «ibotee», «muskimoli». Against the consolidated 543/2008, whose annexes carry 196 entries in Liite I, 192 in Liite II, 11 in Liite III, 70 in Liite IV and 1 in Liite V, and against the annex to 1130/2014 as substituted by 650/2026, no form returned an entry of its own. No near miss came back either: not one entry in either annex contains any of those forms as a substring, so there is no longer name to be mistaken for this one. The bands stated above are the narcotics bands and they are reproduced because the live cell named chapter 50. They describe the lane this row would fall into if it were listed, and on the text read here it is not.
If prescribed / medical: This row's whole answer is the prescription route, and whether an authorised product exists in a given form is a product by product question that this cell does not settle. Sections 3 and 6 of lääkelaki 395/1987 are the provisions the live Finland cell named for this route and they are kept. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. The list that does name this row is the medicines list, Finnish Medicines Agency decision 230/2025. Its Liite 2 carries the row at printed line 4077 of the annex text Finlex serves, and the printed row reads «Amanita muscaria Punainen kärpässieni Röflugsvamp Fly agaric, Fly amanita». In the printed order of that annex the line above it reads (Aloe barbadensis) aaloe Mediterranean aloes and the line below it reads Ammeos visnagae fructus Sirosudenporkkanan Tandpetarsilja frukt Toothpick-plant fruit.
Documentation: Section 24 of huumausainelaki 373/2008 is written for convention listed narcotics and does not describe this row, so the ordinary medicines rules are what apply. Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The search behind the absence stated for this row was run in Finnish and the forms were «Amanita», «muscaria», «punakärpässieni», «Ibotenic», «ibotee», «muskimoli». Section 24 of huumausainelaki 373/2008, the provision that would otherwise carry a traveller's own medicine past the Act's import and export rules, reaches only products «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä» that contain a substance in one of the convention lists, and this row is in none of them. The list that does name this row is the medicines list, Finnish Medicines Agency decision 230/2025. Its Liite 2 carries the row at printed line 4077 of the annex text Finlex serves, and the printed row reads «Amanita muscaria Punainen kärpässieni Röflugsvamp Fly agaric, Fly amanita». In the printed order of that annex the line above it reads (Aloe barbadensis) aaloe Mediterranean aloes and the line below it reads Ammeos visnagae fructus Sirosudenporkkanan Tandpetarsilja frukt Toothpick-plant fruit. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, Amanita muscaria, not a named entry of 543/2008 and not a named entry of the annex to 1130/2014, an absence measured by running the Finnish forms recorded in the documentation field against both texts · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · Lääkealan turvallisuus- ja kehittämiskeskuksen päätös lääkeluettelosta 230/2025 and its annexes, under lääkelaki 395/1987 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · finlex.fi · finlex.fi · Updated September 21, 2026

Amanita muscaria in Finland, full detail →

Amphetamine

Legal status: Controlled. Amphetamine is a narcotic in Finland by name. Section 1 of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 makes the substances, preparations and plants in annexes I to V narcotics, and this row's entry sits in Liite II, the annex headed as the substances and preparations in lists I to IV of the 1971 Convention on Psychotropic Substances, under list II, which the instrument itself heads as a schedule of the 1971 Convention on Psychotropic Substances, an attribution read off the annex heading and not checked against the INCB list in this pass. The entry reads «Amfetamiini ((±)- α -metyylifenetyyliamiini)». The instrument italicises part of that entry and the spacing around the italicised locants is as Finlex serves it. Section 5 subsection 1 of huumausainelaki 373/2008 then forbids production, manufacture, import into Finland, export from Finland, transport, transit, distribution, trade, handling, possession and use, and allows departure from that ban only for medical, research, supervisory and industrial purposes as separately provided. The same list closes by extending itself, in the words «tämän luettelon aineiden suolat, mukaan luettuna edellä mainittujen isomeerien suolat, jos sellaisten olemassaolo on mahdollista; sekä». That annex stands as amended by 4.12.2025/1119.
Consequences if caught: Capital exposure: none. The ceiling anywhere in this regime is the ten year maximum that Criminal Code chapter 50 section 2 sets for an aggravated narcotics offence. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. This row sits in Liite II under list II of the decree, so those are the provisions its placement engages. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. They describe the offences that this row's placement brings into play. This row in particular. Its entry sits in Liite II, which the decree heads as the substances and preparations in the lists of the 1971 Convention on Psychotropic Substances, under list II of that annex, at printed position 17 of the 68 entries that list carries in the consolidated text read here, and the entry reads «Amfetamiini ((±)-α-metyylifenetyyliamiini)». In the printed order of that list the entry above it is AM-2201 and below it comes Amineptiini. The same list closes by extending itself beyond its named entries, in the words «tässä luettelossa mainittuja aineita sisältävät valmisteet.». The annex that carries this row stands as amended by 4.12.2025/1119, which is the amendment that last touched this row's annex rather than the decree as a whole. Section 5 subsection 1 of huumausainelaki 373/2008 is the prohibition that placement engages, «Huumausaineen tuotanto, valmistus, tuonti Suomen alueelle, vienti Suomen alueelta, kuljetus, kauttakuljetus, jakelu, kauppa, käsittely, hallussapito ja käyttö on kielletty.», and chapter 50 section 5 subsection 1 of the Criminal Code makes the word huumausaine in those offences mean a narcotic under huumausainelaki, so the annex entry above is what puts this row inside them. Criminal Code chapter 50 section 2 a is the small quantity limb and it opens «Joka laittomasti käyttää taikka omaa käyttöä varten pitää hallussaan tai yrittää hankkia vähäisen määrän huumausainetta, on tuomittava», so the käyttörikos reaches this row on its own terms. No quantity figure is printed anywhere in chapter 50: whether a quantity is a suuri määrä, and whether the substance is an erittäin vaarallinen huumausaine under chapter 50 section 5 subsection 2, are findings of fact and the annex position does not settle either of them. No fine figure is printed either, because a Finnish fine is a day fine set on the offender's income.
If prescribed / medical: Section 24 of huumausainelaki 373/2008 disapplies the import and export rules for a medicinal product a traveller carries for personal medication where the substance is in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, and this row is inside that carve out. Section 19 of lääkelaki 395/1987 then governs. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. This row sits in list II of the 1971 Convention annex, and section 24 of huumausainelaki 373/2008 reaches exactly that: it disapplies the import and export provisions of the Act for medicinal products containing a substance in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, the products being those «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä», and then hands the traveller to section 19 of lääkelaki 395/1987.
Documentation: Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The locator a traveller or an official would be checking is Liite II list II entry 17 of 543/2008, as that annex stands after 4.12.2025/1119, and the entry printed there reads «Amfetamiini ((±)-α-metyylifenetyyliamiini)». Because the row is in that part of the convention annexes, section 24 of huumausainelaki 373/2008 takes a traveller's own prescribed medicine out of the Act's import and export provisions and leaves section 19 of lääkelaki 395/1987 to govern how much may be carried, which is the provision this cell did not read. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, amphetamine, a named entry of Liite II list II of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 at printed position 17, that annex as amended by 4.12.2025/1119 · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · Updated September 21, 2026

Amphetamine in Finland, full detail →

Amyl Nitrite

Legal status: Not a narcotic in Finland. Amyl nitrite is not named in any annex of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 and is not named in the annex to valtioneuvoston asetus 1130/2014, as those annexes stand after 651/2026, 1119/2025 and 650/2026. It is a medicine question instead. The Finnish Medicines Agency decision on the medicines list, 230/2025, names it in annex 1, where the Finnish column of the row reads «Amyylinitriitti». The row gives its Latin, Swedish and English columns as Amyli nitris, Amylnitrit, Amyl nitrite. Section 2 subsection 1 of that decision supervises the annex 1 substances, their salts and their esters as medicines under section 3 subsection 1 or 2 of lääkelaki 395/1987. Section 1 of the decision states that the list is not exhaustive and that not every product containing a listed substance meets the medicine definition, so an individual product's status turns on its own classification.
Consequences if caught: Capital exposure: none. Criminal Code chapter 44 section 5 carries the medicines offence. It sets a fine or up to one year for manufacturing, importing, storing, keeping for sale or supplying medicines contrary to the Medicines Act or the European Union medicines regulations, unless a heavier penalty is provided elsewhere. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. This row is placed outside that regime, so they are recorded as Finland's published drug penalties and not as this substance's exposure. This row in particular. It is not named in either decree and that is a measured absence, not an assumption. The Finnish forms put to both texts for this row were «Amyylinitriitti», «nitriitti», «Isopentyylinitriitti». Against the consolidated 543/2008, whose annexes carry 196 entries in Liite I, 192 in Liite II, 11 in Liite III, 70 in Liite IV and 1 in Liite V, and against the annex to 1130/2014 as substituted by 650/2026, no form returned an entry of its own. No near miss came back either: not one entry in either annex contains any of those forms as a substring, so there is no longer name to be mistaken for this one. The bands stated above are the narcotics bands and they are reproduced because the live cell named chapter 50. They describe the lane this row would fall into if it were listed, and on the text read here it is not.
If prescribed / medical: This row's whole answer is the prescription route, and whether an authorised product exists in a given form is a product by product question that this cell does not settle. Sections 3 and 6 of lääkelaki 395/1987 are the provisions the live Finland cell named for this route and they are kept. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. The list that does name this row is the medicines list, Finnish Medicines Agency decision 230/2025. Its Liite 1 carries the row at printed line 186 of the annex text Finlex serves, and the printed row reads «Amyylinitriitti Amyli nitris Amylnitrit Amyl nitrite». In the printed order of that annex the line above it reads Amyylimetakresoli Amylmetacresolum Amylmetakresol Amylmetacresol and the line below it reads Anagrelidi Anagrelidum Anagrelid Anagrelide.
Documentation: Section 24 of huumausainelaki 373/2008 is written for convention listed narcotics and does not describe this row, so the ordinary medicines rules are what apply. Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The search behind the absence stated for this row was run in Finnish and the forms were «Amyylinitriitti», «nitriitti», «Isopentyylinitriitti». Section 24 of huumausainelaki 373/2008, the provision that would otherwise carry a traveller's own medicine past the Act's import and export rules, reaches only products «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä» that contain a substance in one of the convention lists, and this row is in none of them. The list that does name this row is the medicines list, Finnish Medicines Agency decision 230/2025. Its Liite 1 carries the row at printed line 186 of the annex text Finlex serves, and the printed row reads «Amyylinitriitti Amyli nitris Amylnitrit Amyl nitrite». In the printed order of that annex the line above it reads Amyylimetakresoli Amylmetacresolum Amylmetakresol Amylmetacresol and the line below it reads Anagrelidi Anagrelidum Anagrelid Anagrelide. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, amyl nitrite, not a named entry of 543/2008 and not a named entry of the annex to 1130/2014, an absence measured by running the Finnish forms recorded in the documentation field against both texts · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · Lääkealan turvallisuus- ja kehittämiskeskuksen päätös lääkeluettelosta 230/2025 and its annexes, under lääkelaki 395/1987 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · finlex.fi · finlex.fi · Updated September 21, 2026

Amyl Nitrite in Finland, full detail →

Ayahuasca

Legal status: Controlled. Ayahuasca is a narcotic in Finland by name. Section 1 of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 makes the substances, preparations and plants in annexes I to V narcotics, and this row's entry sits in Liite IV, a bare national list of plants opening only with the words seuraavat kasvit, which is Finland's own addition and rests on no convention schedule. The entry reads «huumaantumistarkoituksessa käytettävät kasvijauheet, -rouheet ja -valmisteet, jotka sisältävät dimetyylitryptamiinia». Section 5 subsection 1 of huumausainelaki 373/2008 then forbids production, manufacture, import into Finland, export from Finland, transport, transit, distribution, trade, handling, possession and use, and allows departure from that ban only for medical, research, supervisory and industrial purposes as separately provided. Section 7 of huumausainelaki 373/2008 adds a cultivation ban, outright for the khat plant, Psilosybe mushrooms and the coca bush, and for the opium poppy, hemp and mescaline bearing cacti where the purpose is narcotic use or narcotic manufacture. Section 3 subsection 1 paragraph 5 sub-paragraph d of the same Act carries the same four plant items into the statutory definition of a narcotic. That annex stands as amended by 25.6.2026/651. The medicine route for the admixture plant is kept from the live Finland cell, which recorded Peganum harmala in annex 2 of the medicines list 230/2025 and noted that the brew name alone does not prove DMT content. That annex 2 row is carried forward and was not re-derived here. Section 3 subsection 1 paragraph 5 sub-paragraph d of huumausainelaki 373/2008 writes the same four plant items into the statutory definition in the partitive, as «kat-kasvia (Catha edulis), meskaliinia sisältäviä kaktuskasveja ja Psilosybe-sieniä sekä huumaantumistarkoituksessa käytettäviä kasvijauheita, -rouheita ja -valmisteita, jotka sisältävät dimetyylitryptamiinia», which is the form the live Finland cell quoted. The substance entry behind it, in Liite II under list I of the 1971 Convention, reads «Dimetyylitryptamiini (DMT) (3-[2-(dimetyyliamino)etyyli]indoli)».
Consequences if caught: Capital exposure: none. The ceiling anywhere in this regime is the ten year maximum that Criminal Code chapter 50 section 2 sets for an aggravated narcotics offence. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. This row sits in Liite IV among the plants of the decree, so those are the provisions its placement engages. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. They describe the offences that this row's placement brings into play. This row in particular. Its entry sits in Liite IV, the annex of substances and plants Finland controls nationally rather than by convention list, at printed position 4 of the four plant entries that follow the heading «Seuraavat kasvit:», and the entry reads «huumaantumistarkoituksessa käytettävät kasvijauheet, -rouheet ja -valmisteet, jotka sisältävät dimetyylitryptamiinia». It is the last entry printed in that list and above it comes Psilosybe-sienet. The same list closes by extending itself beyond its named entries, in the words «tässä liitteessä mainittuja aineita sisältävät valmisteet.». The annex that carries this row stands as amended by 25.6.2026/651, which is the amendment that last touched this row's annex rather than the decree as a whole. Section 5 subsection 1 of huumausainelaki 373/2008 is the prohibition that placement engages, «Huumausaineen tuotanto, valmistus, tuonti Suomen alueelle, vienti Suomen alueelta, kuljetus, kauttakuljetus, jakelu, kauppa, käsittely, hallussapito ja käyttö on kielletty.», and chapter 50 section 5 subsection 1 of the Criminal Code makes the word huumausaine in those offences mean a narcotic under huumausainelaki, so the annex entry above is what puts this row inside them. Criminal Code chapter 50 section 2 a is the small quantity limb and it opens «Joka laittomasti käyttää taikka omaa käyttöä varten pitää hallussaan tai yrittää hankkia vähäisen määrän huumausainetta, on tuomittava», so the käyttörikos reaches this row on its own terms. No quantity figure is printed anywhere in chapter 50: whether a quantity is a suuri määrä, and whether the substance is an erittäin vaarallinen huumausaine under chapter 50 section 5 subsection 2, are findings of fact and the annex position does not settle either of them. No fine figure is printed either, because a Finnish fine is a day fine set on the offender's income.
If prescribed / medical: Section 24 of huumausainelaki 373/2008 writes its traveller carve out by reference to the convention lists, and this row is not placed in one of them, so the carve out does not describe it. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. This row is placed in Liite IV, which is a national annex and not a convention list, so section 24 of huumausainelaki 373/2008 has no list to match it against. The carve out is written by reference to lists I to III of the 1961 Convention and lists II to IV of the 1971 Convention, for the products «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä», and this row is in neither.
Documentation: This row is a plant entry, so no medicine packaging answers it. Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The locator a traveller or an official would be checking is Liite IV entry 70 of 543/2008, as that annex stands after 25.6.2026/651, and the entry printed there reads «huumaantumistarkoituksessa käytettävät kasvijauheet, -rouheet ja -valmisteet, jotka sisältävät dimetyylitryptamiinia». Because the row is outside the lists section 24 names, that section does not take a traveller's own medicine out of the Act's import and export provisions for this row, and nothing read here supplies a carriage allowance in its place. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, ayahuasca, a named entry of Liite IV of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 at printed position 70, that annex as amended by 25.6.2026/651 · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · finlex.fi · Updated September 21, 2026

Ayahuasca in Finland, full detail →

Barbiturates

Legal status: Controlled through named members rather than as a class. The decree names no class term for this row. Section 1 of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 makes the substances, preparations and plants in annexes I to V narcotics, and this row's entry sits in Liite II, the annex headed as the substances and preparations in lists I to IV of the 1971 Convention on Psychotropic Substances, under list II, which the instrument itself heads as a schedule of the 1971 Convention on Psychotropic Substances, an attribution read off the annex heading and not checked against the INCB list in this pass. The entry reads «Sekobarbitaali (5-allyyli-5-(1-metyylibutyyli)barbituurihappo)». Section 5 subsection 1 of huumausainelaki 373/2008 then forbids production, manufacture, import into Finland, export from Finland, transport, transit, distribution, trade, handling, possession and use, and allows departure from that ban only for medical, research, supervisory and industrial purposes as separately provided. The same list closes by extending itself, in the words «tämän luettelon aineiden suolat, mukaan luettuna edellä mainittujen isomeerien suolat, jos sellaisten olemassaolo on mahdollista; sekä». That annex stands as amended by 4.12.2025/1119. The members read in this pass are secobarbital in list II, amobarbital, butalbital, pentobarbital and cyclobarbital in list III, and allobarbital, barbital, butobarbital, phenobarbital, methylphenobarbital, secbutabarbital and vinylbital in list IV, so the class spans three lists and no single answer covers it. The live Finland cell's wider reading is kept. It recorded eight further named medicinal members in annex 1 of the medicines list 230/2025, aprobarbital, brallobarbital, etallobarbital, hexobarbital, heptabarbital, narcobarbital, thiopental and vinbarbital, under lääkelaki 395/1987 sections 3 and 6, and it recorded that no finite intended membership was supplied for this class slug. The twelve entries read verbatim as «Sekobarbitaali», «Amobarbitaali», «Butalbitaali», «Pentobarbitaali», «Syklobarbitaali», «Allobarbitaali», «Barbitaali», «Butobarbitaali», «Fenobarbitaali», «Metyylifenobarbitaali», «Sekbutabarbitaali», «Vinyylibitaali», each followed in the instrument by its systematic name, and the further medicinal members the live Finland cell named read «Aprobarbitaali», «Brallobarbitaali», «Etallobarbitaali», «Heksobarbitaali», «Heptabarbitaali», «Narkobarbitaali», «Tiopentaali», «Vinbarbitaali».
Consequences if caught: Capital exposure: none. The ceiling anywhere in this regime is the ten year maximum that Criminal Code chapter 50 section 2 sets for an aggravated narcotics offence. No penalty is asserted for this entry as a class, because the classification itself is unresolved. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. This row sits in Liite II under list II of the decree, so those are the provisions its placement engages. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. They describe the offences that this row's placement brings into play. This row in particular. The entry this row is reached through sits in Liite II, which the decree heads as the substances and preparations in the lists of the 1971 Convention on Psychotropic Substances, under list II of that annex, at printed position 61 of the 68 entries that list carries in the consolidated text read here, it reads «Sekobarbitaali (5-allyyli-5-(1-metyylibutyyli)barbituurihappo)», and it is that entry rather than this row's own name that the decree prints. In the printed order of that list the entry above it is Pentedroni and below it comes Tsipeproli. The same list closes by extending itself beyond its named entries, in the words «tässä luettelossa mainittuja aineita sisältävät valmisteet.». The annex that carries this row stands as amended by 4.12.2025/1119, which is the amendment that last touched this row's annex rather than the decree as a whole. Section 5 subsection 1 of huumausainelaki 373/2008 is the prohibition that placement engages, «Huumausaineen tuotanto, valmistus, tuonti Suomen alueelle, vienti Suomen alueelta, kuljetus, kauttakuljetus, jakelu, kauppa, käsittely, hallussapito ja käyttö on kielletty.», and chapter 50 section 5 subsection 1 of the Criminal Code makes the word huumausaine in those offences mean a narcotic under huumausainelaki, so the annex entry above is what puts this row inside them. Criminal Code chapter 50 section 2 a is the small quantity limb and it opens «Joka laittomasti käyttää taikka omaa käyttöä varten pitää hallussaan tai yrittää hankkia vähäisen määrän huumausainetta, on tuomittava», so the käyttörikos reaches this row on its own terms. No quantity figure is printed anywhere in chapter 50: whether a quantity is a suuri määrä, and whether the substance is an erittäin vaarallinen huumausaine under chapter 50 section 5 subsection 2, are findings of fact and the annex position does not settle either of them. No fine figure is printed either, because a Finnish fine is a day fine set on the offender's income.
If prescribed / medical: Section 24 of huumausainelaki 373/2008 disapplies the import and export rules for a medicinal product a traveller carries for personal medication where the substance is in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, and this row is inside that carve out. Section 19 of lääkelaki 395/1987 then governs. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. The entry this row is reached through sits in list II of the 1971 Convention annex, and section 24 of huumausainelaki 373/2008 reaches exactly that: it disapplies the import and export provisions of the Act for medicinal products containing a substance in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, the products being those «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä», and then hands the traveller to section 19 of lääkelaki 395/1987. That reading is about the entry, not about this row's own name, which the decree does not print. Whether a product containing this row falls inside the carve out follows from what the product contains, and this cell does not settle it.
Documentation: Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The locator a traveller or an official would be checking is Liite II list II entry 61 of 543/2008, as that annex stands after 4.12.2025/1119, and the entry printed there reads «Sekobarbitaali (5-allyyli-5-(1-metyylibutyyli)barbituurihappo)». Because the row is in that part of the convention annexes, section 24 of huumausainelaki 373/2008 takes a traveller's own prescribed medicine out of the Act's import and export provisions and leaves section 19 of lääkelaki 395/1987 to govern how much may be carried, which is the provision this cell did not read. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, barbiturates, a named entry of Liite II list II of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 at printed position 61, that annex as amended by 4.12.2025/1119 · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · finlex.fi · finlex.fi · Updated September 21, 2026

Barbiturates in Finland, full detail →

Benzodiazepines

Legal status: Controlled through named members rather than as a class. The decree names no class term for this row. Section 1 of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 makes the substances, preparations and plants in annexes I to V narcotics, and this row's entry sits in Liite II, the annex headed as the substances and preparations in lists I to IV of the 1971 Convention on Psychotropic Substances, under list IV, which the instrument itself heads as a schedule of the 1971 Convention on Psychotropic Substances, an attribution read off the annex heading and not checked against the INCB list in this pass. The entry reads «Diatsepaami (7-kloori-1,3-dihydro-1-metyyli-5-fenyyli-2 H -1,4-bentsodiatsepin-2-oni)». The instrument italicises part of that entry and the spacing around the italicised locants is as Finlex serves it. Section 5 subsection 1 of huumausainelaki 373/2008 then forbids production, manufacture, import into Finland, export from Finland, transport, transit, distribution, trade, handling, possession and use, and allows departure from that ban only for medical, research, supervisory and industrial purposes as separately provided. The same list closes by extending itself, in the words «tämän luettelon aineiden suolat, mukaan luettuna edellä mainittujen isomeerien suolat, jos sellaisten olemassaolo on mahdollista; sekä». That annex stands as amended by 4.12.2025/1119. The members read in this pass and found in Liite II are alprazolam, diazepam, clonazepam, lorazepam, nimetazepam and etizolam in list IV, and flunitrazepam in list III, while a long tail of designer benzodiazepines sits instead in the annex to valtioneuvoston asetus 1130/2014. The live Finland cell's wider reading is kept. It recorded further named diazepine entries including flunitratsepaami, adinatsolaami, desalkyyligidatsepaami and klonipratsepaami, the annex to valtioneuvoston asetus 1130/2014, and named therapeutic ingredients and salts in annex 1 of the medicines list 230/2025 under lääkelaki 395/1987 sections 3 and 6, and it recorded that neither decree states that every present or future pharmacological benzodiazepine is controlled under a single class entry. The entries the live Finland cell quoted read «Flunitratsepaami», «Alpratsolaami», «Diatsepaami», «Adinatsolaami», «Desalkyyligidatsepaami», «Klonipratsepaami», and the last three of those are carried forward from that cell rather than re-derived here.
Consequences if caught: Capital exposure: none. The ceiling anywhere in this regime is the ten year maximum that Criminal Code chapter 50 section 2 sets for an aggravated narcotics offence. No penalty is asserted for this entry as a class, because the classification itself is unresolved. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. This row sits in Liite II under list IV of the decree, so those are the provisions its placement engages. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. They describe the offences that this row's placement brings into play. This row in particular. The entry this row is reached through sits in Liite II, which the decree heads as the substances and preparations in the lists of the 1971 Convention on Psychotropic Substances, under list IV of that annex, at printed position 11 of the 71 entries that list carries in the consolidated text read here, it reads «Diatsepaami (7-kloori-1,3-dihydro-1-metyyli-5-fenyyli-2H-1,4-bentsodiatsepin-2-oni)», and it is that entry rather than this row's own name that the decree prints. In the printed order of that list the entry above it is Deloratsepaami and below it comes Diklatsepaami. The same list closes by extending itself beyond its named entries, in the words «tässä luettelossa mainittuja aineita sisältävät valmisteet.». The annex that carries this row stands as amended by 4.12.2025/1119, which is the amendment that last touched this row's annex rather than the decree as a whole. Section 5 subsection 1 of huumausainelaki 373/2008 is the prohibition that placement engages, «Huumausaineen tuotanto, valmistus, tuonti Suomen alueelle, vienti Suomen alueelta, kuljetus, kauttakuljetus, jakelu, kauppa, käsittely, hallussapito ja käyttö on kielletty.», and chapter 50 section 5 subsection 1 of the Criminal Code makes the word huumausaine in those offences mean a narcotic under huumausainelaki, so the annex entry above is what puts this row inside them. Criminal Code chapter 50 section 2 a is the small quantity limb and it opens «Joka laittomasti käyttää taikka omaa käyttöä varten pitää hallussaan tai yrittää hankkia vähäisen määrän huumausainetta, on tuomittava», so the käyttörikos reaches this row on its own terms. No quantity figure is printed anywhere in chapter 50: whether a quantity is a suuri määrä, and whether the substance is an erittäin vaarallinen huumausaine under chapter 50 section 5 subsection 2, are findings of fact and the annex position does not settle either of them. No fine figure is printed either, because a Finnish fine is a day fine set on the offender's income.
If prescribed / medical: Section 24 of huumausainelaki 373/2008 disapplies the import and export rules for a medicinal product a traveller carries for personal medication where the substance is in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, and this row is inside that carve out. Section 19 of lääkelaki 395/1987 then governs. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. The entry this row is reached through sits in list IV of the 1971 Convention annex, and section 24 of huumausainelaki 373/2008 reaches exactly that: it disapplies the import and export provisions of the Act for medicinal products containing a substance in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, the products being those «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä», and then hands the traveller to section 19 of lääkelaki 395/1987. That reading is about the entry, not about this row's own name, which the decree does not print. Whether a product containing this row falls inside the carve out follows from what the product contains, and this cell does not settle it. Section 23 subsection 3 of the same Act is the neighbouring relief for this list: a combination preparation containing a psychotropic substance other than one in list I of the 1971 Convention needs no import or export licence where the narcotic content is small or hard to separate and the abuse risk is slight against the substance's wide medicinal use.
Documentation: Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The locator a traveller or an official would be checking is Liite II list IV entry 11 of 543/2008, as that annex stands after 4.12.2025/1119, and the entry printed there reads «Diatsepaami (7-kloori-1,3-dihydro-1-metyyli-5-fenyyli-2H-1,4-bentsodiatsepin-2-oni)». Because the row is in that part of the convention annexes, section 24 of huumausainelaki 373/2008 takes a traveller's own prescribed medicine out of the Act's import and export provisions and leaves section 19 of lääkelaki 395/1987 to govern how much may be carried, which is the provision this cell did not read. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, benzodiazepines, a named entry of Liite II list IV of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 at printed position 11, that annex as amended by 4.12.2025/1119 · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · finlex.fi · finlex.fi · Updated September 21, 2026

Benzodiazepines in Finland, full detail →

Buprenorphine

Legal status: Controlled. Buprenorphine is a narcotic in Finland by name. Section 1 of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 makes the substances, preparations and plants in annexes I to V narcotics, and this row's entry sits in Liite II, the annex headed as the substances and preparations in lists I to IV of the 1971 Convention on Psychotropic Substances, under list III, which the instrument itself heads as a schedule of the 1971 Convention on Psychotropic Substances, an attribution read off the annex heading and not checked against the INCB list in this pass. The entry reads «Buprenorfiini (21-syklopropyyli-7- α -[(S)-1-hydroksi-1,2,2-trimetyylipropyyli]-6,14- endo -etano-6,7,8,14-tetrahydro-oripaviini)». The instrument italicises part of that entry and the spacing around the italicised locants is as Finlex serves it. Section 5 subsection 1 of huumausainelaki 373/2008 then forbids production, manufacture, import into Finland, export from Finland, transport, transit, distribution, trade, handling, possession and use, and allows departure from that ban only for medical, research, supervisory and industrial purposes as separately provided. The same list closes by extending itself, in the words «tämän luettelon aineiden suolat, mukaan luettuna edellä mainittujen isomeerien suolat, jos sellaisten olemassaolo on mahdollista; sekä». That annex stands as amended by 4.12.2025/1119.
Consequences if caught: Capital exposure: none. The ceiling anywhere in this regime is the ten year maximum that Criminal Code chapter 50 section 2 sets for an aggravated narcotics offence. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. This row sits in Liite II under list III of the decree, so those are the provisions its placement engages. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. They describe the offences that this row's placement brings into play. This row in particular. Its entry sits in Liite II, which the decree heads as the substances and preparations in the lists of the 1971 Convention on Psychotropic Substances, under list III of that annex, at printed position 2 of the 12 entries that list carries in the consolidated text read here, and the entry reads «Buprenorfiini (21-syklopropyyli-7-α-[(S)-1-hydroksi-1,2,2-trimetyylipropyyli]-6,14-endo-etano-6,7,8,14-tetrahydro-oripaviini)». In the printed order of that list the entry above it is Amobarbitaali and below it comes Butalbitaali. The same list closes by extending itself beyond its named entries, in the words «tässä luettelossa mainittuja aineita sisältävät valmisteet.». The annex that carries this row stands as amended by 4.12.2025/1119, which is the amendment that last touched this row's annex rather than the decree as a whole. Section 5 subsection 1 of huumausainelaki 373/2008 is the prohibition that placement engages, «Huumausaineen tuotanto, valmistus, tuonti Suomen alueelle, vienti Suomen alueelta, kuljetus, kauttakuljetus, jakelu, kauppa, käsittely, hallussapito ja käyttö on kielletty.», and chapter 50 section 5 subsection 1 of the Criminal Code makes the word huumausaine in those offences mean a narcotic under huumausainelaki, so the annex entry above is what puts this row inside them. Criminal Code chapter 50 section 2 a is the small quantity limb and it opens «Joka laittomasti käyttää taikka omaa käyttöä varten pitää hallussaan tai yrittää hankkia vähäisen määrän huumausainetta, on tuomittava», so the käyttörikos reaches this row on its own terms. No quantity figure is printed anywhere in chapter 50: whether a quantity is a suuri määrä, and whether the substance is an erittäin vaarallinen huumausaine under chapter 50 section 5 subsection 2, are findings of fact and the annex position does not settle either of them. No fine figure is printed either, because a Finnish fine is a day fine set on the offender's income.
If prescribed / medical: Section 24 of huumausainelaki 373/2008 disapplies the import and export rules for a medicinal product a traveller carries for personal medication where the substance is in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, and this row is inside that carve out. Section 19 of lääkelaki 395/1987 then governs. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. This row sits in list III of the 1971 Convention annex, and section 24 of huumausainelaki 373/2008 reaches exactly that: it disapplies the import and export provisions of the Act for medicinal products containing a substance in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, the products being those «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä», and then hands the traveller to section 19 of lääkelaki 395/1987.
Documentation: Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The locator a traveller or an official would be checking is Liite II list III entry 2 of 543/2008, as that annex stands after 4.12.2025/1119, and the entry printed there reads «Buprenorfiini (21-syklopropyyli-7-α-[(S)-1-hydroksi-1,2,2-trimetyylipropyyli]-6,14-endo-etano-6,7,8,14-tetrahydro-oripaviini)». Because the row is in that part of the convention annexes, section 24 of huumausainelaki 373/2008 takes a traveller's own prescribed medicine out of the Act's import and export provisions and leaves section 19 of lääkelaki 395/1987 to govern how much may be carried, which is the provision this cell did not read. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, buprenorphine, a named entry of Liite II list III of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 at printed position 2, that annex as amended by 4.12.2025/1119 · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · Updated September 21, 2026

Buprenorphine in Finland, full detail →

Caffeine

Legal status: Not a narcotic in Finland. Caffeine is not named in any annex of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 and is not named in the annex to valtioneuvoston asetus 1130/2014, as those annexes stand after 651/2026, 1119/2025 and 650/2026. It is a medicine question instead. The Finnish Medicines Agency decision on the medicines list, 230/2025, names it in annex 1, where the Finnish column of the row reads «Kofeiini». The row gives its Latin, Swedish and English columns as Coffeinum, Koffein, Caffeine. Section 2 subsection 1 of that decision supervises the annex 1 substances, their salts and their esters as medicines under section 3 subsection 1 or 2 of lääkelaki 395/1987. Section 1 of the decision states that the list is not exhaustive and that not every product containing a listed substance meets the medicine definition, so an individual product's status turns on its own classification. A food route runs alongside the medicine route. Regulation (EU) No 1169/2011 annex III points 4.1 and 4.2 require the high caffeine content statement, which the live Finland cell recorded in Finnish as «Korkea kofeiinipitoisuus» and «Sisältää kofeiinia. Ei suositella lapsille eikä raskaana oleville», and that regulation is carried forward from the live cell rather than re-derived here.
Consequences if caught: Capital exposure: none. Criminal Code chapter 44 section 5 carries the medicines offence. It sets a fine or up to one year for manufacturing, importing, storing, keeping for sale or supplying medicines contrary to the Medicines Act or the European Union medicines regulations, unless a heavier penalty is provided elsewhere. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. This row is placed outside that regime, so they are recorded as Finland's published drug penalties and not as this substance's exposure. This row in particular. It is not named in either decree and that is a measured absence, not an assumption. The Finnish forms put to both texts for this row were «Kofeiini», «Coffea», «kahvi». Against the consolidated 543/2008, whose annexes carry 196 entries in Liite I, 192 in Liite II, 11 in Liite III, 70 in Liite IV and 1 in Liite V, and against the annex to 1130/2014 as substituted by 650/2026, no form returned an entry of its own. No near miss came back either: not one entry in either annex contains any of those forms as a substring, so there is no longer name to be mistaken for this one. The bands stated above are the narcotics bands and they are reproduced because the live cell named chapter 50. They describe the lane this row would fall into if it were listed, and on the text read here it is not.
If prescribed / medical: This row's whole answer is the prescription route, and whether an authorised product exists in a given form is a product by product question that this cell does not settle. Sections 3 and 6 of lääkelaki 395/1987 are the provisions the live Finland cell named for this route and they are kept. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. The list that does name this row is the medicines list, Finnish Medicines Agency decision 230/2025. Its Liite 1 carries the row at printed line 1917 of the annex text Finlex serves, and the printed row reads «Kofeiini Coffeinum Koffein Caffeine». In the printed order of that annex the line above it reads Kodergokriinimesilaatti Codergocrini mesilas Kodergokrinmesilat Codergocrine mesilate and the line below it reads Kokaiini Cocainum Kokain Cocaine.
Documentation: Section 24 of huumausainelaki 373/2008 is written for convention listed narcotics and does not describe this row, so the ordinary medicines rules are what apply. Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The search behind the absence stated for this row was run in Finnish and the forms were «Kofeiini», «Coffea», «kahvi». Section 24 of huumausainelaki 373/2008, the provision that would otherwise carry a traveller's own medicine past the Act's import and export rules, reaches only products «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä» that contain a substance in one of the convention lists, and this row is in none of them. The list that does name this row is the medicines list, Finnish Medicines Agency decision 230/2025. Its Liite 1 carries the row at printed line 1917 of the annex text Finlex serves, and the printed row reads «Kofeiini Coffeinum Koffein Caffeine». In the printed order of that annex the line above it reads Kodergokriinimesilaatti Codergocrini mesilas Kodergokrinmesilat Codergocrine mesilate and the line below it reads Kokaiini Cocainum Kokain Cocaine. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, caffeine, not a named entry of 543/2008 and not a named entry of the annex to 1130/2014, an absence measured by running the Finnish forms recorded in the documentation field against both texts · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · Lääkealan turvallisuus- ja kehittämiskeskuksen päätös lääkeluettelosta 230/2025 and its annexes, under lääkelaki 395/1987 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · finlex.fi · eur-lex.europa.eu · Updated September 21, 2026

Caffeine in Finland, full detail →

Cannabinol

Legal status: Controlled only as a constituent, and not on its own name. Cannabinol is not named in any annex of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, not named in the annex to valtioneuvoston asetus 1130/2014, and not named in annex 1, annex 1 A or annex 2 of the medicines list 230/2025, as those annexes stand after 651/2026, 1119/2025 and 650/2026. What is named, in Liite I under list I of the 1961 Single Convention, is «Kannabis, kannabishartsi sekä kannabisuutteet ja -tinktuurat», so a cannabis extract or tincture containing cannabinol is caught by that entry while isolated cannabinol is not reached by a name of its own. Section 1 of the medicines list decision states in terms «Lääkeaineluettelo ei ole tyhjentävä.», which the live Finland cell also quoted, so absence from annex 1 does not decide the medicine question either.
Consequences if caught: Capital exposure: none. No penalty is asserted for this entry as a class, because the classification itself is unresolved. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. Criminal Code chapter 44 section 5 a carries the separate consumer market offence. It sets a fine or up to one year for manufacturing, importing, storing, keeping for sale or transferring a psychoactive substance banned from the consumer market, contrary to the Narcotics Act. Possession for one's own use and use itself are not among the acts it names. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. Whether the offence reaches this row at all is exactly what was not established here. This row in particular. The entry this row is reached through sits in Liite I, which the decree heads as the substances and preparations in the lists of the 1961 Single Convention on Narcotic Drugs, under list I of that annex, at printed position 67 of the 145 entries that list carries in the consolidated text read here, it reads «Kannabis, kannabishartsi sekä kannabisuutteet ja -tinktuurat», and it is that entry rather than this row's own name that the decree prints. In the printed order of that list the entry above it is Isotonitatsepyyni and below it comes Karfentaniili. The same list closes by extending itself beyond its named entries, in the words «tässä luettelossa mainittuja aineita sisältävät valmisteet lukuun ottamatta luettelossa III mainittuja valmisteita.». The annex that carries this row stands as amended by 25.6.2026/651, which is the amendment that last touched this row's annex rather than the decree as a whole. Section 5 subsection 1 of huumausainelaki 373/2008 is the prohibition that placement engages, «Huumausaineen tuotanto, valmistus, tuonti Suomen alueelle, vienti Suomen alueelta, kuljetus, kauttakuljetus, jakelu, kauppa, käsittely, hallussapito ja käyttö on kielletty.», and chapter 50 section 5 subsection 1 of the Criminal Code makes the word huumausaine in those offences mean a narcotic under huumausainelaki, so the annex entry above is what puts this row inside them. Criminal Code chapter 50 section 2 a is the small quantity limb and it opens «Joka laittomasti käyttää taikka omaa käyttöä varten pitää hallussaan tai yrittää hankkia vähäisen määrän huumausainetta, on tuomittava», so the käyttörikos reaches this row on its own terms. No quantity figure is printed anywhere in chapter 50: whether a quantity is a suuri määrä, and whether the substance is an erittäin vaarallinen huumausaine under chapter 50 section 5 subsection 2, are findings of fact and the annex position does not settle either of them. No fine figure is printed either, because a Finnish fine is a day fine set on the offender's income.
If prescribed / medical: No authorised cannabinol medicine is identified for this row. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. The entry this row is reached through sits in list I of the 1961 Convention annex, and section 24 of huumausainelaki 373/2008 reaches exactly that: it disapplies the import and export provisions of the Act for medicinal products containing a substance in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, the products being those «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä», and then hands the traveller to section 19 of lääkelaki 395/1987. That reading is about the entry, not about this row's own name, which the decree does not print. Whether a product containing this row falls inside the carve out follows from what the product contains, and this cell does not settle it.
Documentation: Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The locator a traveller or an official would be checking is Liite I list I entry 67 of 543/2008, as that annex stands after 25.6.2026/651, and the entry printed there reads «Kannabis, kannabishartsi sekä kannabisuutteet ja -tinktuurat». Because the row is in that part of the convention annexes, section 24 of huumausainelaki 373/2008 takes a traveller's own prescribed medicine out of the Act's import and export provisions and leaves section 19 of lääkelaki 395/1987 to govern how much may be carried, which is the provision this cell did not read. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, cannabinol, a named entry of Liite I list I of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 at printed position 67, that annex as amended by 25.6.2026/651 · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · finlex.fi · finlex.fi · eur-lex.europa.eu · finlex.fi · Updated September 21, 2026

Cannabinol in Finland, full detail →

Cannabis / THC

Legal status: Controlled. Cannabis is a narcotic in Finland by name. Section 1 of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 makes the substances, preparations and plants in annexes I to V narcotics, and this row's entry sits in Liite I, the annex headed as the substances and preparations in lists I to IV of the 1961 Single Convention on Narcotic Drugs, under list I, which the instrument itself heads as a schedule of the 1961 Single Convention, an attribution read off the annex heading and not checked against the INCB list in this pass. The entry reads «Kannabis, kannabishartsi sekä kannabisuutteet ja -tinktuurat». Section 5 subsection 1 of huumausainelaki 373/2008 then forbids production, manufacture, import into Finland, export from Finland, transport, transit, distribution, trade, handling, possession and use, and allows departure from that ban only for medical, research, supervisory and industrial purposes as separately provided. The same list closes by extending itself, in the words «tämän luettelon aineiden suolat mukaan luettuna edellä mainittujen esterien, eetterien ja isomeerien suolat, jos sellaisten olemassaolo on mahdollista; sekä». That annex stands as amended by 25.6.2026/651.
Consequences if caught: Capital exposure: none. The ceiling anywhere in this regime is the ten year maximum that Criminal Code chapter 50 section 2 sets for an aggravated narcotics offence. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. This row sits in Liite I under list I of the decree, so those are the provisions its placement engages. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. They describe the offences that this row's placement brings into play. This row in particular. Its entry sits in Liite I, which the decree heads as the substances and preparations in the lists of the 1961 Single Convention on Narcotic Drugs, under list I of that annex, at printed position 67 of the 145 entries that list carries in the consolidated text read here, and the entry reads «Kannabis, kannabishartsi sekä kannabisuutteet ja -tinktuurat». In the printed order of that list the entry above it is Isotonitatsepyyni and below it comes Karfentaniili. The same list closes by extending itself beyond its named entries, in the words «tässä luettelossa mainittuja aineita sisältävät valmisteet lukuun ottamatta luettelossa III mainittuja valmisteita.». The annex that carries this row stands as amended by 25.6.2026/651, which is the amendment that last touched this row's annex rather than the decree as a whole. Section 5 subsection 1 of huumausainelaki 373/2008 is the prohibition that placement engages, «Huumausaineen tuotanto, valmistus, tuonti Suomen alueelle, vienti Suomen alueelta, kuljetus, kauttakuljetus, jakelu, kauppa, käsittely, hallussapito ja käyttö on kielletty.», and chapter 50 section 5 subsection 1 of the Criminal Code makes the word huumausaine in those offences mean a narcotic under huumausainelaki, so the annex entry above is what puts this row inside them. This row is reached by the purpose bound cultivation limb as well. Section 7 subsection 2 of huumausainelaki 373/2008 reads «Oopiumiunikon, hampun ja meskaliinia sisältävien kaktuskasvien viljely käytettäväksi huumausaineena taikka huumausaineen valmistuksessa tai tuotannossa on kielletty.», and Criminal Code chapter 50 section 1 carries the same limb as a paragraph of the offence, «viljelee tai yrittää viljellä oopiumiunikkoa, hamppua tai meskaliinia sisältäviä kaktuskasveja käytettäväksi huumausaineena tai sen raaka-aineena taikka käytettäväksi huumausaineen valmistuksessa tai tuotannossa,». Criminal Code chapter 50 section 2 a is the small quantity limb and it opens «Joka laittomasti käyttää taikka omaa käyttöä varten pitää hallussaan tai yrittää hankkia vähäisen määrän huumausainetta, on tuomittava», so the käyttörikos reaches this row on its own terms. No quantity figure is printed anywhere in chapter 50: whether a quantity is a suuri määrä, and whether the substance is an erittäin vaarallinen huumausaine under chapter 50 section 5 subsection 2, are findings of fact and the annex position does not settle either of them. No fine figure is printed either, because a Finnish fine is a day fine set on the offender's income.
If prescribed / medical: Section 24 of huumausainelaki 373/2008 disapplies the import and export rules for a medicinal product a traveller carries for personal medication where the substance is in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, and this row is inside that carve out. Section 19 of lääkelaki 395/1987 then governs. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. This row sits in list I of the 1961 Convention annex, and section 24 of huumausainelaki 373/2008 reaches exactly that: it disapplies the import and export provisions of the Act for medicinal products containing a substance in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, the products being those «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä», and then hands the traveller to section 19 of lääkelaki 395/1987.
Documentation: Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The locator a traveller or an official would be checking is Liite I list I entry 67 of 543/2008, as that annex stands after 25.6.2026/651, and the entry printed there reads «Kannabis, kannabishartsi sekä kannabisuutteet ja -tinktuurat». Because the row is in that part of the convention annexes, section 24 of huumausainelaki 373/2008 takes a traveller's own prescribed medicine out of the Act's import and export provisions and leaves section 19 of lääkelaki 395/1987 to govern how much may be carried, which is the provision this cell did not read. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, cannabis, a named entry of Liite I list I of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 at printed position 67, that annex as amended by 25.6.2026/651 · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · Lääkealan turvallisuus- ja kehittämiskeskuksen päätös lääkeluettelosta 230/2025 and its annexes, under lääkelaki 395/1987 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · Updated September 21, 2026

Cannabis / THC in Finland, full detail →

Cathinone

Legal status: Controlled. Cathinone is a narcotic in Finland by name. Section 1 of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 makes the substances, preparations and plants in annexes I to V narcotics, and this row's entry sits in Liite II, the annex headed as the substances and preparations in lists I to IV of the 1971 Convention on Psychotropic Substances, under list I, which the instrument itself heads as a schedule of the 1971 Convention on Psychotropic Substances, an attribution read off the annex heading and not checked against the INCB list in this pass. The entry reads «Katinoni ((-)-(S)-2-aminopropiofenoni)». Section 5 subsection 1 of huumausainelaki 373/2008 then forbids production, manufacture, import into Finland, export from Finland, transport, transit, distribution, trade, handling, possession and use, and allows departure from that ban only for medical, research, supervisory and industrial purposes as separately provided. The same list closes by extending itself, in the words «tämän luettelon aineiden suolat, jos sellaisen suolan muodostaminen on mahdollista; sekä». That annex stands as amended by 4.12.2025/1119.
Consequences if caught: Capital exposure: none. The ceiling anywhere in this regime is the ten year maximum that Criminal Code chapter 50 section 2 sets for an aggravated narcotics offence. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. This row sits in Liite II under list I of the decree, so those are the provisions its placement engages. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. They describe the offences that this row's placement brings into play. This row in particular. Its entry sits in Liite II, which the decree heads as the substances and preparations in the lists of the 1971 Convention on Psychotropic Substances, under list I of that annex, at printed position 13 of the 41 entries that list carries in the consolidated text read here, and the entry reads «Katinoni ((-)-(S)-2-aminopropiofenoni)». In the printed order of that list the entry above it is Etryptamiini and below it comes (+)-Lysergidi (LSD, LSD-25) (9,10-didehydro-N,N-dietyyli-6-metyyliergoliini-8β-karboksiamidi). The same list closes by extending itself beyond its named entries, in the words «tässä luettelossa mainittuja aineita sisältävät valmisteet.». The annex that carries this row stands as amended by 4.12.2025/1119, which is the amendment that last touched this row's annex rather than the decree as a whole. Section 5 subsection 1 of huumausainelaki 373/2008 is the prohibition that placement engages, «Huumausaineen tuotanto, valmistus, tuonti Suomen alueelle, vienti Suomen alueelta, kuljetus, kauttakuljetus, jakelu, kauppa, käsittely, hallussapito ja käyttö on kielletty.», and chapter 50 section 5 subsection 1 of the Criminal Code makes the word huumausaine in those offences mean a narcotic under huumausainelaki, so the annex entry above is what puts this row inside them. Criminal Code chapter 50 section 2 a is the small quantity limb and it opens «Joka laittomasti käyttää taikka omaa käyttöä varten pitää hallussaan tai yrittää hankkia vähäisen määrän huumausainetta, on tuomittava», so the käyttörikos reaches this row on its own terms. No quantity figure is printed anywhere in chapter 50: whether a quantity is a suuri määrä, and whether the substance is an erittäin vaarallinen huumausaine under chapter 50 section 5 subsection 2, are findings of fact and the annex position does not settle either of them. No fine figure is printed either, because a Finnish fine is a day fine set on the offender's income.
If prescribed / medical: Section 24 of huumausainelaki 373/2008 disapplies the import and export rules for a traveller's personal medication only where the substance is in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention. This row is in list I of the 1971 Convention, which that carve out does not reach. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. This row sits in list I of the 1971 Convention annex, which is the one list section 24 of huumausainelaki 373/2008 leaves out. The carve out covers lists I to III of the 1961 Convention and lists II to IV of the 1971 Convention, for the products «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä», and a list I entry of the 1971 Convention annex is outside it.
Documentation: Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The locator a traveller or an official would be checking is Liite II list I entry 13 of 543/2008, as that annex stands after 4.12.2025/1119, and the entry printed there reads «Katinoni ((-)-(S)-2-aminopropiofenoni)». Because the row is outside the lists section 24 names, that section does not take a traveller's own medicine out of the Act's import and export provisions for this row, and nothing read here supplies a carriage allowance in its place. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, cathinone, a named entry of Liite II list I of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 at printed position 13, that annex as amended by 4.12.2025/1119 · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · Updated September 21, 2026

Cathinone in Finland, full detail →

CBD

Legal status: Not a narcotic in Finland. Cannabidiol is not named in any annex of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 and is not named in the annex to valtioneuvoston asetus 1130/2014, as those annexes stand after 651/2026, 1119/2025 and 650/2026. It is a medicine question instead. The Finnish Medicines Agency decision on the medicines list, 230/2025, names it in annex 1, where the Finnish column of the row reads «Kannabidioli». The row gives its Latin, Swedish and English columns as Cannabidiolum, Cannabidiol, Cannabidiol. Section 2 subsection 1 of that decision supervises the annex 1 substances, their salts and their esters as medicines under section 3 subsection 1 or 2 of lääkelaki 395/1987. Section 1 of the decision states that the list is not exhaustive and that not every product containing a listed substance meets the medicine definition, so an individual product's status turns on its own classification. Cannabis itself is a narcotic in Liite I of the decree, so a cannabidiol product carrying cannabis extract is a different question from cannabidiol as a substance.
Consequences if caught: Capital exposure: none. Criminal Code chapter 44 section 5 carries the medicines offence. It sets a fine or up to one year for manufacturing, importing, storing, keeping for sale or supplying medicines contrary to the Medicines Act or the European Union medicines regulations, unless a heavier penalty is provided elsewhere. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. This row is placed outside that regime, so they are recorded as Finland's published drug penalties and not as this substance's exposure. This row in particular. It is not named in either decree and that is a measured absence, not an assumption. The Finnish forms put to both texts for this row were «Kannabidioli», «Cannabidiol», «CBD». Against the consolidated 543/2008, whose annexes carry 196 entries in Liite I, 192 in Liite II, 11 in Liite III, 70 in Liite IV and 1 in Liite V, and against the annex to 1130/2014 as substituted by 650/2026, no form returned an entry of its own. What the search did return is a near miss rather than a hit: in the 1130/2014 annex the longer entry «Tetrahydrokannabidioli (H4-CBD)», which contains the searched form inside a different molecule's name and is not this row. The bands stated above are the narcotics bands and they are reproduced because the live cell named chapter 50. They describe the lane this row would fall into if it were listed, and on the text read here it is not.
If prescribed / medical: This row's whole answer is the prescription route, and whether an authorised product exists in a given form is a product by product question that this cell does not settle. Sections 3 and 6 of lääkelaki 395/1987 are the provisions the live Finland cell named for this route and they are kept. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. The list that does name this row is the medicines list, Finnish Medicines Agency decision 230/2025. Its Liite 1 carries the row at printed line 1699 of the annex text Finlex serves, and the printed row reads «Kannabidioli Cannabidiolum Cannabidiol Cannabidiol». In the printed order of that annex the line above it reads Kangrelori Cangrelorum Kangrelor Cangrelor and the line below it reads Kantaksantiini Canthaxantinum Kantaxantin Canthaxantin.
Documentation: Section 24 of huumausainelaki 373/2008 is written for convention listed narcotics and does not describe this row, so the ordinary medicines rules are what apply. Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The search behind the absence stated for this row was run in Finnish and the forms were «Kannabidioli», «Cannabidiol», «CBD». Section 24 of huumausainelaki 373/2008, the provision that would otherwise carry a traveller's own medicine past the Act's import and export rules, reaches only products «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä» that contain a substance in one of the convention lists, and this row is in none of them. The list that does name this row is the medicines list, Finnish Medicines Agency decision 230/2025. Its Liite 1 carries the row at printed line 1699 of the annex text Finlex serves, and the printed row reads «Kannabidioli Cannabidiolum Cannabidiol Cannabidiol». In the printed order of that annex the line above it reads Kangrelori Cangrelorum Kangrelor Cangrelor and the line below it reads Kantaksantiini Canthaxantinum Kantaxantin Canthaxantin. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, cannabidiol, not a named entry of 543/2008 and not a named entry of the annex to 1130/2014, an absence measured by running the Finnish forms recorded in the documentation field against both texts · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · Lääkealan turvallisuus- ja kehittämiskeskuksen päätös lääkeluettelosta 230/2025 and its annexes, under lääkelaki 395/1987 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · finlex.fi · finlex.fi · Updated September 21, 2026

CBD in Finland, full detail →

Clonazepam

Legal status: Controlled. Clonazepam is a narcotic in Finland by name. Section 1 of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 makes the substances, preparations and plants in annexes I to V narcotics, and this row's entry sits in Liite II, the annex headed as the substances and preparations in lists I to IV of the 1971 Convention on Psychotropic Substances, under list IV, which the instrument itself heads as a schedule of the 1971 Convention on Psychotropic Substances, an attribution read off the annex heading and not checked against the INCB list in this pass. The entry reads «Klonatsepaami (5-(o -kloorifenyyli)-1,3-dihydro-7-nitro-2 H -1,4-bentsodiatsepin-2- oni)». The instrument italicises part of that entry and the spacing around the italicised locants is as Finlex serves it. Section 5 subsection 1 of huumausainelaki 373/2008 then forbids production, manufacture, import into Finland, export from Finland, transport, transit, distribution, trade, handling, possession and use, and allows departure from that ban only for medical, research, supervisory and industrial purposes as separately provided. The same list closes by extending itself, in the words «tämän luettelon aineiden suolat, mukaan luettuna edellä mainittujen isomeerien suolat, jos sellaisten olemassaolo on mahdollista; sekä». That annex stands as amended by 4.12.2025/1119.
Consequences if caught: Capital exposure: none. The ceiling anywhere in this regime is the ten year maximum that Criminal Code chapter 50 section 2 sets for an aggravated narcotics offence. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. This row sits in Liite II under list IV of the decree, so those are the provisions its placement engages. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. They describe the offences that this row's placement brings into play. This row in particular. Its entry sits in Liite II, which the decree heads as the substances and preparations in the lists of the 1971 Convention on Psychotropic Substances, under list IV of that annex, at printed position 36 of the 71 entries that list carries in the consolidated text read here, and the entry reads «Klonatsepaami (5-(o-kloorifenyyli)-1,3-dihydro-7-nitro-2H-1,4-bentsodiatsepin-2- oni)». In the printed order of that list the entry above it is Kloksatsolaami and below it comes Klonatsolaami. The same list closes by extending itself beyond its named entries, in the words «tässä luettelossa mainittuja aineita sisältävät valmisteet.». The annex that carries this row stands as amended by 4.12.2025/1119, which is the amendment that last touched this row's annex rather than the decree as a whole. Section 5 subsection 1 of huumausainelaki 373/2008 is the prohibition that placement engages, «Huumausaineen tuotanto, valmistus, tuonti Suomen alueelle, vienti Suomen alueelta, kuljetus, kauttakuljetus, jakelu, kauppa, käsittely, hallussapito ja käyttö on kielletty.», and chapter 50 section 5 subsection 1 of the Criminal Code makes the word huumausaine in those offences mean a narcotic under huumausainelaki, so the annex entry above is what puts this row inside them. Criminal Code chapter 50 section 2 a is the small quantity limb and it opens «Joka laittomasti käyttää taikka omaa käyttöä varten pitää hallussaan tai yrittää hankkia vähäisen määrän huumausainetta, on tuomittava», so the käyttörikos reaches this row on its own terms. No quantity figure is printed anywhere in chapter 50: whether a quantity is a suuri määrä, and whether the substance is an erittäin vaarallinen huumausaine under chapter 50 section 5 subsection 2, are findings of fact and the annex position does not settle either of them. No fine figure is printed either, because a Finnish fine is a day fine set on the offender's income.
If prescribed / medical: Section 24 of huumausainelaki 373/2008 disapplies the import and export rules for a medicinal product a traveller carries for personal medication where the substance is in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, and this row is inside that carve out. Section 19 of lääkelaki 395/1987 then governs. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. This row sits in list IV of the 1971 Convention annex, and section 24 of huumausainelaki 373/2008 reaches exactly that: it disapplies the import and export provisions of the Act for medicinal products containing a substance in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, the products being those «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä», and then hands the traveller to section 19 of lääkelaki 395/1987. Section 23 subsection 3 of the same Act is the neighbouring relief for this list: a combination preparation containing a psychotropic substance other than one in list I of the 1971 Convention needs no import or export licence where the narcotic content is small or hard to separate and the abuse risk is slight against the substance's wide medicinal use.
Documentation: Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The locator a traveller or an official would be checking is Liite II list IV entry 36 of 543/2008, as that annex stands after 4.12.2025/1119, and the entry printed there reads «Klonatsepaami (5-(o-kloorifenyyli)-1,3-dihydro-7-nitro-2H-1,4-bentsodiatsepin-2- oni)». Because the row is in that part of the convention annexes, section 24 of huumausainelaki 373/2008 takes a traveller's own prescribed medicine out of the Act's import and export provisions and leaves section 19 of lääkelaki 395/1987 to govern how much may be carried, which is the provision this cell did not read. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, clonazepam, a named entry of Liite II list IV of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 at printed position 36, that annex as amended by 4.12.2025/1119 · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · Updated September 21, 2026

Clonazepam in Finland, full detail →

Cocaine

Legal status: Controlled. Cocaine is a narcotic in Finland by name. Section 1 of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 makes the substances, preparations and plants in annexes I to V narcotics, and this row's entry sits in Liite I, the annex headed as the substances and preparations in lists I to IV of the 1961 Single Convention on Narcotic Drugs, under list I, which the instrument itself heads as a schedule of the 1961 Single Convention, an attribution read off the annex heading and not checked against the INCB list in this pass. The entry reads «Kokaiini (bentsoyyliekgoniinin metyyliesteri)». Section 5 subsection 1 of huumausainelaki 373/2008 then forbids production, manufacture, import into Finland, export from Finland, transport, transit, distribution, trade, handling, possession and use, and allows departure from that ban only for medical, research, supervisory and industrial purposes as separately provided. The same list closes by extending itself, in the words «tämän luettelon aineiden suolat mukaan luettuna edellä mainittujen esterien, eetterien ja isomeerien suolat, jos sellaisten olemassaolo on mahdollista; sekä». That annex stands as amended by 25.6.2026/651.
Consequences if caught: Capital exposure: none. The ceiling anywhere in this regime is the ten year maximum that Criminal Code chapter 50 section 2 sets for an aggravated narcotics offence. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. A quantity threshold applies to preparations. Item 2 of list III of the 1961 Convention annex takes out cocaine preparations of no more than 0.1 per cent cocaine calculated as base, and opium or morphine preparations of no more than 0.2 per cent morphine calculated as anhydrous base, where they are compounded so the narcotic cannot readily be recovered. No fine figure is stated anywhere in chapter 50, which sets the day fine by the general rules of chapter 2 a rather than by a sum. This row sits in Liite I under list I of the decree, so those are the provisions its placement engages. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. They describe the offences that this row's placement brings into play. This row in particular. Its entry sits in Liite I, which the decree heads as the substances and preparations in the lists of the 1961 Single Convention on Narcotic Drugs, under list I of that annex, at printed position 72 of the 145 entries that list carries in the consolidated text read here, and the entry reads «Kokaiini (bentsoyyliekgoniinin metyyliesteri)». In the printed order of that list the entry above it is Kodoksiimi and below it comes Kokanlehti. The same list closes by extending itself beyond its named entries, in the words «tässä luettelossa mainittuja aineita sisältävät valmisteet lukuun ottamatta luettelossa III mainittuja valmisteita.». The annex that carries this row stands as amended by 25.6.2026/651, which is the amendment that last touched this row's annex rather than the decree as a whole. Section 5 subsection 1 of huumausainelaki 373/2008 is the prohibition that placement engages, «Huumausaineen tuotanto, valmistus, tuonti Suomen alueelle, vienti Suomen alueelta, kuljetus, kauttakuljetus, jakelu, kauppa, käsittely, hallussapito ja käyttö on kielletty.», and chapter 50 section 5 subsection 1 of the Criminal Code makes the word huumausaine in those offences mean a narcotic under huumausainelaki, so the annex entry above is what puts this row inside them. This row is reached by the cultivation limb as well. Section 7 subsection 1 of huumausainelaki 373/2008 reads «Kat-kasvin (Catha edulis), Psilosybe-sienien ja kokapensaan viljely on kielletty.», and Criminal Code chapter 50 section 1 carries the same limb as a paragraph of the offence, «viljelee tai yrittää viljellä kokapensasta, kat-kasvia (Catha edulis) tai Psilosybe-sieniä,». Criminal Code chapter 50 section 2 a is the small quantity limb and it opens «Joka laittomasti käyttää taikka omaa käyttöä varten pitää hallussaan tai yrittää hankkia vähäisen määrän huumausainetta, on tuomittava», so the käyttörikos reaches this row on its own terms. No quantity figure is printed anywhere in chapter 50: whether a quantity is a suuri määrä, and whether the substance is an erittäin vaarallinen huumausaine under chapter 50 section 5 subsection 2, are findings of fact and the annex position does not settle either of them. No fine figure is printed either, because a Finnish fine is a day fine set on the offender's income.
If prescribed / medical: Section 24 of huumausainelaki 373/2008 disapplies the import and export rules for a medicinal product a traveller carries for personal medication where the substance is in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, and this row is inside that carve out. Section 19 of lääkelaki 395/1987 then governs. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. This row sits in list I of the 1961 Convention annex, and section 24 of huumausainelaki 373/2008 reaches exactly that: it disapplies the import and export provisions of the Act for medicinal products containing a substance in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, the products being those «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä», and then hands the traveller to section 19 of lääkelaki 395/1987.
Documentation: Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The locator a traveller or an official would be checking is Liite I list I entry 72 of 543/2008, as that annex stands after 25.6.2026/651, and the entry printed there reads «Kokaiini (bentsoyyliekgoniinin metyyliesteri)». Because the row is in that part of the convention annexes, section 24 of huumausainelaki 373/2008 takes a traveller's own prescribed medicine out of the Act's import and export provisions and leaves section 19 of lääkelaki 395/1987 to govern how much may be carried, which is the provision this cell did not read. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, cocaine, a named entry of Liite I list I of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 at printed position 72, that annex as amended by 25.6.2026/651 · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · Updated September 21, 2026

Cocaine in Finland, full detail →

Codeine

Legal status: Controlled. Codeine is a narcotic in Finland by name. Section 1 of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 makes the substances, preparations and plants in annexes I to V narcotics, and this row's entry sits in Liite I, the annex headed as the substances and preparations in lists I to IV of the 1961 Single Convention on Narcotic Drugs, under list II, which the instrument itself heads as a schedule of the 1961 Single Convention, an attribution read off the annex heading and not checked against the INCB list in this pass. The entry reads «Kodeiini (3-metyylimorfiini)». Section 5 subsection 1 of huumausainelaki 373/2008 then forbids production, manufacture, import into Finland, export from Finland, transport, transit, distribution, trade, handling, possession and use, and allows departure from that ban only for medical, research, supervisory and industrial purposes as separately provided. The same list closes by extending itself, in the words «tämän luettelon aineiden suolat, mukaan luettuna edellä mainittujen isomeerien suolat, jos sellaisten olemassaolo on mahdollista; sekä». That annex stands as amended by 25.6.2026/651. The preparation clause that carries low dose mixtures into list III reads «eivätkä sisällä enempää kuin 100 milligrammaa huumausainetta annostusyksikköä kohti eikä niiden pitoisuus ole enempää kuin 2,5 prosenttia jakelematonta valmistetta kohti.» The live Finland cell held the same figures and the same clause.
Consequences if caught: Capital exposure: none. The ceiling anywhere in this regime is the ten year maximum that Criminal Code chapter 50 section 2 sets for an aggravated narcotics offence. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. A quantity threshold applies to preparations. List III of the 1961 Convention annex carries codeine preparations out of the narcotic entries where the preparation contains no more than 100 milligrams of the narcotic per dosage unit and no more than 2.5 per cent in an undivided preparation. No fine figure is stated anywhere in chapter 50, which sets the day fine by the general rules of chapter 2 a rather than by a sum. This row sits in Liite I under list II of the decree, so those are the provisions its placement engages. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. They describe the offences that this row's placement brings into play. This row in particular. Its entry sits in Liite I, which the decree heads as the substances and preparations in the lists of the 1961 Single Convention on Narcotic Drugs, under list II of that annex, at printed position 6 of the 13 entries that list carries in the consolidated text read here, and the entry reads «Kodeiini (3-metyylimorfiini)». In the printed order of that list the entry above it is Folkodiini and below it comes Nikodikodiini. The same list closes by extending itself beyond its named entries, in the words «tässä luettelossa mainittuja aineita sisältävät valmisteet lukuun ottamatta luettelossa III mainittuja valmisteita.». The annex that carries this row stands as amended by 25.6.2026/651, which is the amendment that last touched this row's annex rather than the decree as a whole. Section 5 subsection 1 of huumausainelaki 373/2008 is the prohibition that placement engages, «Huumausaineen tuotanto, valmistus, tuonti Suomen alueelle, vienti Suomen alueelta, kuljetus, kauttakuljetus, jakelu, kauppa, käsittely, hallussapito ja käyttö on kielletty.», and chapter 50 section 5 subsection 1 of the Criminal Code makes the word huumausaine in those offences mean a narcotic under huumausainelaki, so the annex entry above is what puts this row inside them. Criminal Code chapter 50 section 2 a is the small quantity limb and it opens «Joka laittomasti käyttää taikka omaa käyttöä varten pitää hallussaan tai yrittää hankkia vähäisen määrän huumausainetta, on tuomittava», so the käyttörikos reaches this row on its own terms. No quantity figure is printed anywhere in chapter 50: whether a quantity is a suuri määrä, and whether the substance is an erittäin vaarallinen huumausaine under chapter 50 section 5 subsection 2, are findings of fact and the annex position does not settle either of them. No fine figure is printed either, because a Finnish fine is a day fine set on the offender's income.
If prescribed / medical: Section 24 of huumausainelaki 373/2008 disapplies the import and export rules for a medicinal product a traveller carries for personal medication where the substance is in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, and this row is inside that carve out. Section 19 of lääkelaki 395/1987 then governs. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. This row sits in list II of the 1961 Convention annex, and section 24 of huumausainelaki 373/2008 reaches exactly that: it disapplies the import and export provisions of the Act for medicinal products containing a substance in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, the products being those «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä», and then hands the traveller to section 19 of lääkelaki 395/1987.
Documentation: Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The locator a traveller or an official would be checking is Liite I list II entry 6 of 543/2008, as that annex stands after 25.6.2026/651, and the entry printed there reads «Kodeiini (3-metyylimorfiini)». Because the row is in that part of the convention annexes, section 24 of huumausainelaki 373/2008 takes a traveller's own prescribed medicine out of the Act's import and export provisions and leaves section 19 of lääkelaki 395/1987 to govern how much may be carried, which is the provision this cell did not read. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, codeine, a named entry of Liite I list II of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 at printed position 6, that annex as amended by 25.6.2026/651 · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · Updated September 21, 2026

Codeine in Finland, full detail →

Crack Cocaine

Legal status: Controlled. Crack is cocaine in base form and the decree names cocaine. Section 1 of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 makes the substances, preparations and plants in annexes I to V narcotics, and this row's entry sits in Liite I, the annex headed as the substances and preparations in lists I to IV of the 1961 Single Convention on Narcotic Drugs, under list I, which the instrument itself heads as a schedule of the 1961 Single Convention, an attribution read off the annex heading and not checked against the INCB list in this pass. The entry reads «Kokaiini (bentsoyyliekgoniinin metyyliesteri)». Section 5 subsection 1 of huumausainelaki 373/2008 then forbids production, manufacture, import into Finland, export from Finland, transport, transit, distribution, trade, handling, possession and use, and allows departure from that ban only for medical, research, supervisory and industrial purposes as separately provided. The same list closes by extending itself, in the words «tämän luettelon aineiden suolat mukaan luettuna edellä mainittujen esterien, eetterien ja isomeerien suolat, jos sellaisten olemassaolo on mahdollista; sekä». That annex stands as amended by 25.6.2026/651.
Consequences if caught: Capital exposure: none. The ceiling anywhere in this regime is the ten year maximum that Criminal Code chapter 50 section 2 sets for an aggravated narcotics offence. Crack is cocaine in base form and the decree names no separate base entry, so the cocaine entry is what reaches it. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. A quantity threshold applies to preparations. Item 2 of list III of the 1961 Convention annex takes out cocaine preparations of no more than 0.1 per cent cocaine calculated as base, and opium or morphine preparations of no more than 0.2 per cent morphine calculated as anhydrous base, where they are compounded so the narcotic cannot readily be recovered. No fine figure is stated anywhere in chapter 50, which sets the day fine by the general rules of chapter 2 a rather than by a sum. This row sits in Liite I under list I of the decree, so those are the provisions its placement engages. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. They describe the offences that this row's placement brings into play. This row in particular. The entry this row is reached through sits in Liite I, which the decree heads as the substances and preparations in the lists of the 1961 Single Convention on Narcotic Drugs, under list I of that annex, at printed position 72 of the 145 entries that list carries in the consolidated text read here, it reads «Kokaiini (bentsoyyliekgoniinin metyyliesteri)», and it is that entry rather than this row's own name that the decree prints. In the printed order of that list the entry above it is Kodoksiimi and below it comes Kokanlehti. The same list closes by extending itself beyond its named entries, in the words «tässä luettelossa mainittuja aineita sisältävät valmisteet lukuun ottamatta luettelossa III mainittuja valmisteita.». The annex that carries this row stands as amended by 25.6.2026/651, which is the amendment that last touched this row's annex rather than the decree as a whole. Section 5 subsection 1 of huumausainelaki 373/2008 is the prohibition that placement engages, «Huumausaineen tuotanto, valmistus, tuonti Suomen alueelle, vienti Suomen alueelta, kuljetus, kauttakuljetus, jakelu, kauppa, käsittely, hallussapito ja käyttö on kielletty.», and chapter 50 section 5 subsection 1 of the Criminal Code makes the word huumausaine in those offences mean a narcotic under huumausainelaki, so the annex entry above is what puts this row inside them. This row is reached by the cultivation limb as well. Section 7 subsection 1 of huumausainelaki 373/2008 reads «Kat-kasvin (Catha edulis), Psilosybe-sienien ja kokapensaan viljely on kielletty.», and Criminal Code chapter 50 section 1 carries the same limb as a paragraph of the offence, «viljelee tai yrittää viljellä kokapensasta, kat-kasvia (Catha edulis) tai Psilosybe-sieniä,». Criminal Code chapter 50 section 2 a is the small quantity limb and it opens «Joka laittomasti käyttää taikka omaa käyttöä varten pitää hallussaan tai yrittää hankkia vähäisen määrän huumausainetta, on tuomittava», so the käyttörikos reaches this row on its own terms. No quantity figure is printed anywhere in chapter 50: whether a quantity is a suuri määrä, and whether the substance is an erittäin vaarallinen huumausaine under chapter 50 section 5 subsection 2, are findings of fact and the annex position does not settle either of them. No fine figure is printed either, because a Finnish fine is a day fine set on the offender's income.
If prescribed / medical: Section 24 of huumausainelaki 373/2008 disapplies the import and export rules for a medicinal product a traveller carries for personal medication where the substance is in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, and this row is inside that carve out. Section 19 of lääkelaki 395/1987 then governs. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. The entry this row is reached through sits in list I of the 1961 Convention annex, and section 24 of huumausainelaki 373/2008 reaches exactly that: it disapplies the import and export provisions of the Act for medicinal products containing a substance in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, the products being those «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä», and then hands the traveller to section 19 of lääkelaki 395/1987. That reading is about the entry, not about this row's own name, which the decree does not print. Whether a product containing this row falls inside the carve out follows from what the product contains, and this cell does not settle it.
Documentation: Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The locator a traveller or an official would be checking is Liite I list I entry 72 of 543/2008, as that annex stands after 25.6.2026/651, and the entry printed there reads «Kokaiini (bentsoyyliekgoniinin metyyliesteri)». Because the row is in that part of the convention annexes, section 24 of huumausainelaki 373/2008 takes a traveller's own prescribed medicine out of the Act's import and export provisions and leaves section 19 of lääkelaki 395/1987 to govern how much may be carried, which is the provision this cell did not read. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, crack cocaine, a named entry of Liite I list I of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 at printed position 72, that annex as amended by 25.6.2026/651 · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · Updated September 21, 2026

Crack Cocaine in Finland, full detail →

Delta-8-THC

Legal status: Controlled. Delta 8 tetrahydrocannabinol is a narcotic in Finland by name. Section 1 of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 makes the substances, preparations and plants in annexes I to V narcotics, and this row's entry sits in Liite II, the annex headed as the substances and preparations in lists I to IV of the 1971 Convention on Psychotropic Substances, under list I, which the instrument itself heads as a schedule of the 1971 Convention on Psychotropic Substances, an attribution read off the annex heading and not checked against the INCB list in this pass. The entry reads «(6a R,10a R)-6a,7,10,10a-tetrahydro-6,6,9-trimetyyli-3-pentyyli-6 H -dibentso[ b, d ]pyran-1-oli (delta -8-THC)». The instrument italicises part of that entry and the spacing around the italicised locants is as Finlex serves it. Section 5 subsection 1 of huumausainelaki 373/2008 then forbids production, manufacture, import into Finland, export from Finland, transport, transit, distribution, trade, handling, possession and use, and allows departure from that ban only for medical, research, supervisory and industrial purposes as separately provided. The same list closes by extending itself, in the words «tämän luettelon aineiden suolat, jos sellaisen suolan muodostaminen on mahdollista; sekä». That annex stands as amended by 4.12.2025/1119. The entry sits under a heading that governs it, and the heading reads «Tetrahydrokannabinoli, seuraavat isomeerit ja niiden stereokemialliset muunnokset:» so delta 8 is one of six expressly listed isomers and not an inference from the delta 9 entry, which is the live Finland cell's reading and is kept. The live Finland cell quoted the same entry without the italic spacing, as «(6aR,10aR)-6a,7,10,10a-tetrahydro-6,6,9-trimetyyli-3-pentyyli-6H-dibentso[b,d]pyran-1-oli (delta-8-THC)».
Consequences if caught: Capital exposure: none. The ceiling anywhere in this regime is the ten year maximum that Criminal Code chapter 50 section 2 sets for an aggravated narcotics offence. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. This row sits in Liite II under list I of the decree, so those are the provisions its placement engages. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. They describe the offences that this row's placement brings into play. This row in particular. Its entry sits in Liite II, which the decree heads as the substances and preparations in the lists of the 1971 Convention on Psychotropic Substances, under list I of that annex, at printed position 35 of the 41 entries that list carries in the consolidated text read here, and the entry reads «(6aR,10aR)-6a,7,10,10a-tetrahydro-6,6,9-trimetyyli-3-pentyyli-6H-dibentso[b,d]pyran-1-oli (delta-8-THC)». In the printed order of that list the entry above it is (6aR,9R,10aR)-6a,9,10,10a-tetrahydro-6,6,9-trimetyyli-3-pentyyli-6H-dibentso[b,d]pyran-1-oli (delta-7-THC) and below it comes 6a,7,8,9-tetrahydro-6,6,9-trimetyyli-3-pentyyli-6H-dibentso[b,d]pyran-1-oli. The same list closes by extending itself beyond its named entries, in the words «tässä luettelossa mainittuja aineita sisältävät valmisteet.». The annex that carries this row stands as amended by 4.12.2025/1119, which is the amendment that last touched this row's annex rather than the decree as a whole. Section 5 subsection 1 of huumausainelaki 373/2008 is the prohibition that placement engages, «Huumausaineen tuotanto, valmistus, tuonti Suomen alueelle, vienti Suomen alueelta, kuljetus, kauttakuljetus, jakelu, kauppa, käsittely, hallussapito ja käyttö on kielletty.», and chapter 50 section 5 subsection 1 of the Criminal Code makes the word huumausaine in those offences mean a narcotic under huumausainelaki, so the annex entry above is what puts this row inside them. Criminal Code chapter 50 section 2 a is the small quantity limb and it opens «Joka laittomasti käyttää taikka omaa käyttöä varten pitää hallussaan tai yrittää hankkia vähäisen määrän huumausainetta, on tuomittava», so the käyttörikos reaches this row on its own terms. No quantity figure is printed anywhere in chapter 50: whether a quantity is a suuri määrä, and whether the substance is an erittäin vaarallinen huumausaine under chapter 50 section 5 subsection 2, are findings of fact and the annex position does not settle either of them. No fine figure is printed either, because a Finnish fine is a day fine set on the offender's income.
If prescribed / medical: Section 24 of huumausainelaki 373/2008 disapplies the import and export rules for a traveller's personal medication only where the substance is in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention. This row is in list I of the 1971 Convention, which that carve out does not reach. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. This row sits in list I of the 1971 Convention annex, which is the one list section 24 of huumausainelaki 373/2008 leaves out. The carve out covers lists I to III of the 1961 Convention and lists II to IV of the 1971 Convention, for the products «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä», and a list I entry of the 1971 Convention annex is outside it.
Documentation: Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The locator a traveller or an official would be checking is Liite II list I entry 35 of 543/2008, as that annex stands after 4.12.2025/1119, and the entry printed there reads «(6aR,10aR)-6a,7,10,10a-tetrahydro-6,6,9-trimetyyli-3-pentyyli-6H-dibentso[b,d]pyran-1-oli (delta-8-THC)». Because the row is outside the lists section 24 names, that section does not take a traveller's own medicine out of the Act's import and export provisions for this row, and nothing read here supplies a carriage allowance in its place. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, delta 8 tetrahydrocannabinol, a named entry of Liite II list I of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 at printed position 35, that annex as amended by 4.12.2025/1119 · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · Updated September 21, 2026

Delta-8-THC in Finland, full detail →

Diazepam

Legal status: Controlled. Diazepam is a narcotic in Finland by name. Section 1 of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 makes the substances, preparations and plants in annexes I to V narcotics, and this row's entry sits in Liite II, the annex headed as the substances and preparations in lists I to IV of the 1971 Convention on Psychotropic Substances, under list IV, which the instrument itself heads as a schedule of the 1971 Convention on Psychotropic Substances, an attribution read off the annex heading and not checked against the INCB list in this pass. The entry reads «Diatsepaami (7-kloori-1,3-dihydro-1-metyyli-5-fenyyli-2 H -1,4-bentsodiatsepin-2-oni)». The instrument italicises part of that entry and the spacing around the italicised locants is as Finlex serves it. Section 5 subsection 1 of huumausainelaki 373/2008 then forbids production, manufacture, import into Finland, export from Finland, transport, transit, distribution, trade, handling, possession and use, and allows departure from that ban only for medical, research, supervisory and industrial purposes as separately provided. The same list closes by extending itself, in the words «tämän luettelon aineiden suolat, mukaan luettuna edellä mainittujen isomeerien suolat, jos sellaisten olemassaolo on mahdollista; sekä». That annex stands as amended by 4.12.2025/1119.
Consequences if caught: Capital exposure: none. The ceiling anywhere in this regime is the ten year maximum that Criminal Code chapter 50 section 2 sets for an aggravated narcotics offence. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. This row sits in Liite II under list IV of the decree, so those are the provisions its placement engages. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. They describe the offences that this row's placement brings into play. This row in particular. Its entry sits in Liite II, which the decree heads as the substances and preparations in the lists of the 1971 Convention on Psychotropic Substances, under list IV of that annex, at printed position 11 of the 71 entries that list carries in the consolidated text read here, and the entry reads «Diatsepaami (7-kloori-1,3-dihydro-1-metyyli-5-fenyyli-2H-1,4-bentsodiatsepin-2-oni)». In the printed order of that list the entry above it is Deloratsepaami and below it comes Diklatsepaami. The same list closes by extending itself beyond its named entries, in the words «tässä luettelossa mainittuja aineita sisältävät valmisteet.». The annex that carries this row stands as amended by 4.12.2025/1119, which is the amendment that last touched this row's annex rather than the decree as a whole. Section 5 subsection 1 of huumausainelaki 373/2008 is the prohibition that placement engages, «Huumausaineen tuotanto, valmistus, tuonti Suomen alueelle, vienti Suomen alueelta, kuljetus, kauttakuljetus, jakelu, kauppa, käsittely, hallussapito ja käyttö on kielletty.», and chapter 50 section 5 subsection 1 of the Criminal Code makes the word huumausaine in those offences mean a narcotic under huumausainelaki, so the annex entry above is what puts this row inside them. Criminal Code chapter 50 section 2 a is the small quantity limb and it opens «Joka laittomasti käyttää taikka omaa käyttöä varten pitää hallussaan tai yrittää hankkia vähäisen määrän huumausainetta, on tuomittava», so the käyttörikos reaches this row on its own terms. No quantity figure is printed anywhere in chapter 50: whether a quantity is a suuri määrä, and whether the substance is an erittäin vaarallinen huumausaine under chapter 50 section 5 subsection 2, are findings of fact and the annex position does not settle either of them. No fine figure is printed either, because a Finnish fine is a day fine set on the offender's income.
If prescribed / medical: Section 24 of huumausainelaki 373/2008 disapplies the import and export rules for a medicinal product a traveller carries for personal medication where the substance is in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, and this row is inside that carve out. Section 19 of lääkelaki 395/1987 then governs. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. This row sits in list IV of the 1971 Convention annex, and section 24 of huumausainelaki 373/2008 reaches exactly that: it disapplies the import and export provisions of the Act for medicinal products containing a substance in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, the products being those «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä», and then hands the traveller to section 19 of lääkelaki 395/1987. Section 23 subsection 3 of the same Act is the neighbouring relief for this list: a combination preparation containing a psychotropic substance other than one in list I of the 1971 Convention needs no import or export licence where the narcotic content is small or hard to separate and the abuse risk is slight against the substance's wide medicinal use.
Documentation: Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The locator a traveller or an official would be checking is Liite II list IV entry 11 of 543/2008, as that annex stands after 4.12.2025/1119, and the entry printed there reads «Diatsepaami (7-kloori-1,3-dihydro-1-metyyli-5-fenyyli-2H-1,4-bentsodiatsepin-2-oni)». Because the row is in that part of the convention annexes, section 24 of huumausainelaki 373/2008 takes a traveller's own prescribed medicine out of the Act's import and export provisions and leaves section 19 of lääkelaki 395/1987 to govern how much may be carried, which is the provision this cell did not read. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, diazepam, a named entry of Liite II list IV of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 at printed position 11, that annex as amended by 4.12.2025/1119 · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · Updated September 21, 2026

Diazepam in Finland, full detail →

DMT

Legal status: Controlled. DMT is a narcotic in Finland by name. Section 1 of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 makes the substances, preparations and plants in annexes I to V narcotics, and this row's entry sits in Liite II, the annex headed as the substances and preparations in lists I to IV of the 1971 Convention on Psychotropic Substances, under list I, which the instrument itself heads as a schedule of the 1971 Convention on Psychotropic Substances, an attribution read off the annex heading and not checked against the INCB list in this pass. The entry reads «Dimetyylitryptamiini (DMT) (3-[2-(dimetyyliamino)etyyli]indoli)». Section 5 subsection 1 of huumausainelaki 373/2008 then forbids production, manufacture, import into Finland, export from Finland, transport, transit, distribution, trade, handling, possession and use, and allows departure from that ban only for medical, research, supervisory and industrial purposes as separately provided. The same list closes by extending itself, in the words «tämän luettelon aineiden suolat, jos sellaisen suolan muodostaminen on mahdollista; sekä». That annex stands as amended by 4.12.2025/1119.
Consequences if caught: Capital exposure: none. The ceiling anywhere in this regime is the ten year maximum that Criminal Code chapter 50 section 2 sets for an aggravated narcotics offence. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. This row sits in Liite II under list I of the decree, so those are the provisions its placement engages. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. They describe the offences that this row's placement brings into play. This row in particular. Its entry sits in Liite II, which the decree heads as the substances and preparations in the lists of the 1971 Convention on Psychotropic Substances, under list I of that annex, at printed position 9 of the 41 entries that list carries in the consolidated text read here, and the entry reads «Dimetyylitryptamiini (DMT) (3-[2-(dimetyyliamino)etyyli]indoli)». In the printed order of that list the entry above it is DMHP and below it comes DOC. The same list closes by extending itself beyond its named entries, in the words «tässä luettelossa mainittuja aineita sisältävät valmisteet.». The annex that carries this row stands as amended by 4.12.2025/1119, which is the amendment that last touched this row's annex rather than the decree as a whole. Section 5 subsection 1 of huumausainelaki 373/2008 is the prohibition that placement engages, «Huumausaineen tuotanto, valmistus, tuonti Suomen alueelle, vienti Suomen alueelta, kuljetus, kauttakuljetus, jakelu, kauppa, käsittely, hallussapito ja käyttö on kielletty.», and chapter 50 section 5 subsection 1 of the Criminal Code makes the word huumausaine in those offences mean a narcotic under huumausainelaki, so the annex entry above is what puts this row inside them. Criminal Code chapter 50 section 2 a is the small quantity limb and it opens «Joka laittomasti käyttää taikka omaa käyttöä varten pitää hallussaan tai yrittää hankkia vähäisen määrän huumausainetta, on tuomittava», so the käyttörikos reaches this row on its own terms. No quantity figure is printed anywhere in chapter 50: whether a quantity is a suuri määrä, and whether the substance is an erittäin vaarallinen huumausaine under chapter 50 section 5 subsection 2, are findings of fact and the annex position does not settle either of them. No fine figure is printed either, because a Finnish fine is a day fine set on the offender's income.
If prescribed / medical: Section 24 of huumausainelaki 373/2008 disapplies the import and export rules for a traveller's personal medication only where the substance is in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention. This row is in list I of the 1971 Convention, which that carve out does not reach. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. This row sits in list I of the 1971 Convention annex, which is the one list section 24 of huumausainelaki 373/2008 leaves out. The carve out covers lists I to III of the 1961 Convention and lists II to IV of the 1971 Convention, for the products «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä», and a list I entry of the 1971 Convention annex is outside it.
Documentation: Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The locator a traveller or an official would be checking is Liite II list I entry 9 of 543/2008, as that annex stands after 4.12.2025/1119, and the entry printed there reads «Dimetyylitryptamiini (DMT) (3-[2-(dimetyyliamino)etyyli]indoli)». Because the row is outside the lists section 24 names, that section does not take a traveller's own medicine out of the Act's import and export provisions for this row, and nothing read here supplies a carriage allowance in its place. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, DMT, a named entry of Liite II list I of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 at printed position 9, that annex as amended by 4.12.2025/1119 · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · Updated September 21, 2026

DMT in Finland, full detail →

DOM

Legal status: Controlled. DOM is a narcotic in Finland by name. Section 1 of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 makes the substances, preparations and plants in annexes I to V narcotics, and this row's entry sits in Liite II, the annex headed as the substances and preparations in lists I to IV of the 1971 Convention on Psychotropic Substances, under list I, which the instrument itself heads as a schedule of the 1971 Convention on Psychotropic Substances, an attribution read off the annex heading and not checked against the INCB list in this pass. The entry reads «STP, DOM (2,5-dimetoksi- α,4-dimetyylifenetyyliamiini)». The instrument italicises part of that entry and the spacing around the italicised locants is as Finlex serves it. Section 5 subsection 1 of huumausainelaki 373/2008 then forbids production, manufacture, import into Finland, export from Finland, transport, transit, distribution, trade, handling, possession and use, and allows departure from that ban only for medical, research, supervisory and industrial purposes as separately provided. The same list closes by extending itself, in the words «tämän luettelon aineiden suolat, jos sellaisen suolan muodostaminen on mahdollista; sekä». That annex stands as amended by 4.12.2025/1119.
Consequences if caught: Capital exposure: none. The ceiling anywhere in this regime is the ten year maximum that Criminal Code chapter 50 section 2 sets for an aggravated narcotics offence. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. This row sits in Liite II under list I of the decree, so those are the provisions its placement engages. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. They describe the offences that this row's placement brings into play. This row in particular. Its entry sits in Liite II, which the decree heads as the substances and preparations in the lists of the 1971 Convention on Psychotropic Substances, under list I of that annex, at printed position 29 of the 41 entries that list carries in the consolidated text read here, and the entry reads «STP, DOM (2,5-dimetoksi-α,4-dimetyylifenetyyliamiini)». In the printed order of that list the entry above it is Rolisyklidiini and below it comes Tenamfetamiini, metyleenidioksiamfetamiini. The same list closes by extending itself beyond its named entries, in the words «tässä luettelossa mainittuja aineita sisältävät valmisteet.». The annex that carries this row stands as amended by 4.12.2025/1119, which is the amendment that last touched this row's annex rather than the decree as a whole. Section 5 subsection 1 of huumausainelaki 373/2008 is the prohibition that placement engages, «Huumausaineen tuotanto, valmistus, tuonti Suomen alueelle, vienti Suomen alueelta, kuljetus, kauttakuljetus, jakelu, kauppa, käsittely, hallussapito ja käyttö on kielletty.», and chapter 50 section 5 subsection 1 of the Criminal Code makes the word huumausaine in those offences mean a narcotic under huumausainelaki, so the annex entry above is what puts this row inside them. Criminal Code chapter 50 section 2 a is the small quantity limb and it opens «Joka laittomasti käyttää taikka omaa käyttöä varten pitää hallussaan tai yrittää hankkia vähäisen määrän huumausainetta, on tuomittava», so the käyttörikos reaches this row on its own terms. No quantity figure is printed anywhere in chapter 50: whether a quantity is a suuri määrä, and whether the substance is an erittäin vaarallinen huumausaine under chapter 50 section 5 subsection 2, are findings of fact and the annex position does not settle either of them. No fine figure is printed either, because a Finnish fine is a day fine set on the offender's income.
If prescribed / medical: Section 24 of huumausainelaki 373/2008 disapplies the import and export rules for a traveller's personal medication only where the substance is in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention. This row is in list I of the 1971 Convention, which that carve out does not reach. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. This row sits in list I of the 1971 Convention annex, which is the one list section 24 of huumausainelaki 373/2008 leaves out. The carve out covers lists I to III of the 1961 Convention and lists II to IV of the 1971 Convention, for the products «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä», and a list I entry of the 1971 Convention annex is outside it.
Documentation: Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The locator a traveller or an official would be checking is Liite II list I entry 29 of 543/2008, as that annex stands after 4.12.2025/1119, and the entry printed there reads «STP, DOM (2,5-dimetoksi-α,4-dimetyylifenetyyliamiini)». Because the row is outside the lists section 24 names, that section does not take a traveller's own medicine out of the Act's import and export provisions for this row, and nothing read here supplies a carriage allowance in its place. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, DOM, a named entry of Liite II list I of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 at printed position 29, that annex as amended by 4.12.2025/1119 · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · Updated September 21, 2026

DOM in Finland, full detail →

DXM

Legal status: Not a narcotic in Finland, and expressly excluded rather than merely unlisted. Dextromethorphan is not named as an entry in any annex of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 and is not named in the annex to valtioneuvoston asetus 1130/2014, as those annexes stand after 651/2026, 1119/2025 and 650/2026. It is named once, in the footnote that closes Liite I under list I of the 1961 Single Convention, which reads «* Isomeerit Dekstrometorfaani ((+)-3-metoksi- N -metyylimorfinaani) ja dekstrorfaani ((+)-3-hydroksi- N -metyylimorfinaani) on erityisesti jätetty pois tästä luettelosta.». The instrument italicises part of that entry and the spacing around the italicised locants is as Finlex serves it. That footnote takes dextromethorphan and dextrorphan out of the isomer clause of that list, so the clause extending the list to isomers does not reach them. It is a medicine instead: annex 1 of the medicines list 230/2025 carries it, and the Finnish column of the row reads «Dekstrometorfaani». The row gives its other columns as Dextromethorphanum, Dextrometorfan, Dextromethorphan.
Consequences if caught: Capital exposure: none. Criminal Code chapter 44 section 5 carries the medicines offence. It sets a fine or up to one year for manufacturing, importing, storing, keeping for sale or supplying medicines contrary to the Medicines Act or the European Union medicines regulations, unless a heavier penalty is provided elsewhere. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. This row is placed outside that regime, so they are recorded as Finland's published drug penalties and not as this substance's exposure. This row in particular. The text this row turns on is not a listing at all. It is the footnote printed at position 145 of list I of the 1961 Convention annex in Liite I, which expressly takes dextromethorphan and dextrorphan out of that list, and it reads «* Isomeerit Dekstrometorfaani ((+)-3-metoksi-N-metyylimorfinaani) ja dekstrorfaani ((+)-3-hydroksi-N-metyylimorfinaani) on erityisesti jätetty pois tästä luettelosta.». It is the last entry printed in that list and above it comes the extension clause that closes the list. The same list closes by extending itself beyond its named entries, in the words «tässä luettelossa mainittuja aineita sisältävät valmisteet lukuun ottamatta luettelossa III mainittuja valmisteita.». The annex that carries this row stands as amended by 25.6.2026/651, which is the amendment that last touched this row's annex rather than the decree as a whole. Section 5 subsection 1 of huumausainelaki 373/2008 is the prohibition that placement engages, «Huumausaineen tuotanto, valmistus, tuonti Suomen alueelle, vienti Suomen alueelta, kuljetus, kauttakuljetus, jakelu, kauppa, käsittely, hallussapito ja käyttö on kielletty.», and chapter 50 section 5 subsection 1 of the Criminal Code makes the word huumausaine in those offences mean a narcotic under huumausainelaki, so the annex entry above is what puts this row inside them. Criminal Code chapter 50 section 2 a is the small quantity limb and it opens «Joka laittomasti käyttää taikka omaa käyttöä varten pitää hallussaan tai yrittää hankkia vähäisen määrän huumausainetta, on tuomittava», so the käyttörikos reaches this row on its own terms. No quantity figure is printed anywhere in chapter 50: whether a quantity is a suuri määrä, and whether the substance is an erittäin vaarallinen huumausaine under chapter 50 section 5 subsection 2, are findings of fact and the annex position does not settle either of them. No fine figure is printed either, because a Finnish fine is a day fine set on the offender's income.
If prescribed / medical: This row's whole answer is the medicine route. Sections 3 and 6 of lääkelaki 395/1987 are the provisions the live Finland cell named for this route and they are kept. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. The entry this row is reached through sits in list I of the 1961 Convention annex, and section 24 of huumausainelaki 373/2008 reaches exactly that: it disapplies the import and export provisions of the Act for medicinal products containing a substance in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, the products being those «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä», and then hands the traveller to section 19 of lääkelaki 395/1987. That reading is about the entry, not about this row's own name, which the decree does not print. Whether a product containing this row falls inside the carve out follows from what the product contains, and this cell does not settle it.
Documentation: Section 24 of huumausainelaki 373/2008 is written for convention listed narcotics and does not describe this row, so the ordinary medicines rules are what apply. Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The locator a traveller or an official would be checking is Liite I list I entry 145 of 543/2008, as that annex stands after 25.6.2026/651, and the entry printed there reads «* Isomeerit Dekstrometorfaani ((+)-3-metoksi-N-metyylimorfinaani) ja dekstrorfaani ((+)-3-hydroksi-N-metyylimorfinaani) on erityisesti jätetty pois tästä luettelosta.». Because the row is in that part of the convention annexes, section 24 of huumausainelaki 373/2008 takes a traveller's own prescribed medicine out of the Act's import and export provisions and leaves section 19 of lääkelaki 395/1987 to govern how much may be carried, which is the provision this cell did not read. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, dextromethorphan, a named entry of Liite I list I of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 at printed position 145, that annex as amended by 25.6.2026/651 · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · Lääkealan turvallisuus- ja kehittämiskeskuksen päätös lääkeluettelosta 230/2025 and its annexes, under lääkelaki 395/1987 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · finlex.fi · finlex.fi · Updated September 21, 2026

DXM in Finland, full detail →

Ephedrine

Legal status: Not a narcotic in Finland. Ephedrine is not named in any annex of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 and is not named in the annex to valtioneuvoston asetus 1130/2014, as those annexes stand after 651/2026, 1119/2025 and 650/2026. It is a medicine question instead. The Finnish Medicines Agency decision on the medicines list, 230/2025, names it in annex 1, where the Finnish column of the row reads «Efedriini». The row gives its Latin, Swedish and English columns as Ephedrinum, Efedrin, Ephedrine. Section 2 subsection 1 of that decision supervises the annex 1 substances, their salts and their esters as medicines under section 3 subsection 1 or 2 of lääkelaki 395/1987. Section 1 of the decision states that the list is not exhaustive and that not every product containing a listed substance meets the medicine definition, so an individual product's status turns on its own classification. Ephedrine is also a scheduled drug precursor under Regulation (EC) No 273/2004 and Regulation (EC) No 111/2005, which huumausainelaki 373/2008 section 3 subsection 1 paragraphs 2 and 3 defines and section 33 applies, a route carried forward from the live Finland cell and not re-derived here. The precursor route is more specific than a bare citation. Regulation (EC) No 273/2004 annex I category 1 and article 3 cover ephedrine, and Regulation (EC) No 111/2005 covers it in annex categories 1 and 4 for external trade. The live Finland cell recorded the category 1 salts clause in Finnish as «Tässä luokassa lueteltujen aineiden (ei kuitenkaan katiinin) suolat, mikäli kyseisenlainen suola voi olla olemassa.» and both regulations and that clause are carried forward from it rather than re-derived here.
Consequences if caught: Capital exposure: none. Criminal Code chapter 44 section 5 carries the medicines offence. It sets a fine or up to one year for manufacturing, importing, storing, keeping for sale or supplying medicines contrary to the Medicines Act or the European Union medicines regulations, unless a heavier penalty is provided elsewhere. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. This row is placed outside that regime, so they are recorded as Finland's published drug penalties and not as this substance's exposure. This row in particular. It is not named in either decree and that is a measured absence, not an assumption. The Finnish forms put to both texts for this row were «Efedriini», «Ephedra», «efedra». Against the consolidated 543/2008, whose annexes carry 196 entries in Liite I, 192 in Liite II, 11 in Liite III, 70 in Liite IV and 1 in Liite V, and against the annex to 1130/2014 as substituted by 650/2026, no form returned an entry of its own. What the search did return is a near miss rather than a hit: in Liite II the longer entry «Katiini, (+)-norpseudoefedriini ((+)-(S)-α-[(S)-1-aminoetyyli]bentsyylialkoholi)», which contains the searched form inside a different molecule's name and is not this row. The bands stated above are the narcotics bands and they are reproduced because the live cell named chapter 50. They describe the lane this row would fall into if it were listed, and on the text read here it is not.
If prescribed / medical: This row's whole answer is the prescription route, and whether an authorised product exists in a given form is a product by product question that this cell does not settle. Sections 3 and 6 of lääkelaki 395/1987 are the provisions the live Finland cell named for this route and they are kept. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. The list that does name this row is the medicines list, Finnish Medicines Agency decision 230/2025. Its Liite 1 carries the row at printed line 848 of the annex text Finlex serves, and the printed row reads «Efedriini Ephedrinum Efedrin Ephedrine». In the printed order of that annex the line above it reads alfa and the line below it reads Efgartigimodi alfa Efgartigimodum alfa Efgartigimod alfa Efgartigimod alfa. A second row for this substance sits in Liite 2 of the same list at printed line 4415, reading «Ephedra sp. Efedrat Efedra Ephedra, Joint-firs».
Documentation: Section 24 of huumausainelaki 373/2008 is written for convention listed narcotics and does not describe this row, so the ordinary medicines rules are what apply. Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The search behind the absence stated for this row was run in Finnish and the forms were «Efedriini», «Ephedra», «efedra». Section 24 of huumausainelaki 373/2008, the provision that would otherwise carry a traveller's own medicine past the Act's import and export rules, reaches only products «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä» that contain a substance in one of the convention lists, and this row is in none of them. The list that does name this row is the medicines list, Finnish Medicines Agency decision 230/2025. Its Liite 1 carries the row at printed line 848 of the annex text Finlex serves, and the printed row reads «Efedriini Ephedrinum Efedrin Ephedrine». In the printed order of that annex the line above it reads alfa and the line below it reads Efgartigimodi alfa Efgartigimodum alfa Efgartigimod alfa Efgartigimod alfa. A second row for this substance sits in Liite 2 of the same list at printed line 4415, reading «Ephedra sp. Efedrat Efedra Ephedra, Joint-firs». Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, ephedrine, not a named entry of 543/2008 and not a named entry of the annex to 1130/2014, an absence measured by running the Finnish forms recorded in the documentation field against both texts · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · Lääkealan turvallisuus- ja kehittämiskeskuksen päätös lääkeluettelosta 230/2025 and its annexes, under lääkelaki 395/1987 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · finlex.fi · eur-lex.europa.eu · eur-lex.europa.eu · Updated September 21, 2026

Ephedrine in Finland, full detail →

Etizolam

Legal status: Controlled. Etizolam is a narcotic in Finland by name. Section 1 of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 makes the substances, preparations and plants in annexes I to V narcotics, and this row's entry sits in Liite II, the annex headed as the substances and preparations in lists I to IV of the 1971 Convention on Psychotropic Substances, under list IV, which the instrument itself heads as a schedule of the 1971 Convention on Psychotropic Substances, an attribution read off the annex heading and not checked against the INCB list in this pass. The entry reads «Etitsolaami (4-(2-klorofenyyli)-2-etyyli-9-metyyli-6 H -tieno[3,2-f][1,2,4]triatsolo[4,3-a][1,4]diatsepiini)». The instrument italicises part of that entry and the spacing around the italicised locants is as Finlex serves it. Section 5 subsection 1 of huumausainelaki 373/2008 then forbids production, manufacture, import into Finland, export from Finland, transport, transit, distribution, trade, handling, possession and use, and allows departure from that ban only for medical, research, supervisory and industrial purposes as separately provided. The same list closes by extending itself, in the words «tämän luettelon aineiden suolat, mukaan luettuna edellä mainittujen isomeerien suolat, jos sellaisten olemassaolo on mahdollista; sekä». That annex stands as amended by 4.12.2025/1119.
Consequences if caught: Capital exposure: none. The ceiling anywhere in this regime is the ten year maximum that Criminal Code chapter 50 section 2 sets for an aggravated narcotics offence. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. This row sits in Liite II under list IV of the decree, so those are the provisions its placement engages. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. They describe the offences that this row's placement brings into play. This row in particular. Its entry sits in Liite II, which the decree heads as the substances and preparations in the lists of the 1971 Convention on Psychotropic Substances, under list IV of that annex, at printed position 16 of the 71 entries that list carries in the consolidated text read here, and the entry reads «Etitsolaami (4-(2-klorofenyyli)-2-etyyli-9-metyyli-6H-tieno[3,2-f][1,2,4]triatsolo[4,3-a][1,4]diatsepiini)». In the printed order of that list the entry above it is Etinamaatti and below it comes Etklorvynoli. The same list closes by extending itself beyond its named entries, in the words «tässä luettelossa mainittuja aineita sisältävät valmisteet.». The annex that carries this row stands as amended by 4.12.2025/1119, which is the amendment that last touched this row's annex rather than the decree as a whole. Section 5 subsection 1 of huumausainelaki 373/2008 is the prohibition that placement engages, «Huumausaineen tuotanto, valmistus, tuonti Suomen alueelle, vienti Suomen alueelta, kuljetus, kauttakuljetus, jakelu, kauppa, käsittely, hallussapito ja käyttö on kielletty.», and chapter 50 section 5 subsection 1 of the Criminal Code makes the word huumausaine in those offences mean a narcotic under huumausainelaki, so the annex entry above is what puts this row inside them. Criminal Code chapter 50 section 2 a is the small quantity limb and it opens «Joka laittomasti käyttää taikka omaa käyttöä varten pitää hallussaan tai yrittää hankkia vähäisen määrän huumausainetta, on tuomittava», so the käyttörikos reaches this row on its own terms. No quantity figure is printed anywhere in chapter 50: whether a quantity is a suuri määrä, and whether the substance is an erittäin vaarallinen huumausaine under chapter 50 section 5 subsection 2, are findings of fact and the annex position does not settle either of them. No fine figure is printed either, because a Finnish fine is a day fine set on the offender's income.
If prescribed / medical: Section 24 of huumausainelaki 373/2008 disapplies the import and export rules for a medicinal product a traveller carries for personal medication where the substance is in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, and this row is inside that carve out. Section 19 of lääkelaki 395/1987 then governs. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. This row sits in list IV of the 1971 Convention annex, and section 24 of huumausainelaki 373/2008 reaches exactly that: it disapplies the import and export provisions of the Act for medicinal products containing a substance in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, the products being those «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä», and then hands the traveller to section 19 of lääkelaki 395/1987. Section 23 subsection 3 of the same Act is the neighbouring relief for this list: a combination preparation containing a psychotropic substance other than one in list I of the 1971 Convention needs no import or export licence where the narcotic content is small or hard to separate and the abuse risk is slight against the substance's wide medicinal use.
Documentation: Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The locator a traveller or an official would be checking is Liite II list IV entry 16 of 543/2008, as that annex stands after 4.12.2025/1119, and the entry printed there reads «Etitsolaami (4-(2-klorofenyyli)-2-etyyli-9-metyyli-6H-tieno[3,2-f][1,2,4]triatsolo[4,3-a][1,4]diatsepiini)». Because the row is in that part of the convention annexes, section 24 of huumausainelaki 373/2008 takes a traveller's own prescribed medicine out of the Act's import and export provisions and leaves section 19 of lääkelaki 395/1987 to govern how much may be carried, which is the provision this cell did not read. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, etizolam, a named entry of Liite II list IV of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 at printed position 16, that annex as amended by 4.12.2025/1119 · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · Updated September 21, 2026

Etizolam in Finland, full detail →

Fentanyl

Legal status: Controlled. Fentanyl is a narcotic in Finland by name. Section 1 of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 makes the substances, preparations and plants in annexes I to V narcotics, and this row's entry sits in Liite I, the annex headed as the substances and preparations in lists I to IV of the 1961 Single Convention on Narcotic Drugs, under list I, which the instrument itself heads as a schedule of the 1961 Single Convention, an attribution read off the annex heading and not checked against the INCB list in this pass. The entry reads «Fentanyyli (1-fenetyyli-4- N -propionyylianilinopiperidiini)». The instrument italicises part of that entry and the spacing around the italicised locants is as Finlex serves it. Section 5 subsection 1 of huumausainelaki 373/2008 then forbids production, manufacture, import into Finland, export from Finland, transport, transit, distribution, trade, handling, possession and use, and allows departure from that ban only for medical, research, supervisory and industrial purposes as separately provided. The same list closes by extending itself, in the words «tämän luettelon aineiden suolat mukaan luettuna edellä mainittujen esterien, eetterien ja isomeerien suolat, jos sellaisten olemassaolo on mahdollista; sekä». That annex stands as amended by 25.6.2026/651.
Consequences if caught: Capital exposure: none. The ceiling anywhere in this regime is the ten year maximum that Criminal Code chapter 50 section 2 sets for an aggravated narcotics offence. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. This row sits in Liite I under list I of the decree, so those are the provisions its placement engages. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. They describe the offences that this row's placement brings into play. This row in particular. Its entry sits in Liite I, which the decree heads as the substances and preparations in the lists of the 1961 Single Convention on Narcotic Drugs, under list I of that annex, at printed position 55 of the 145 entries that list carries in the consolidated text read here, and the entry reads «Fentanyyli (1-fenetyyli-4-N-propionyylianilinopiperidiini)». In the printed order of that list the entry above it is Fenoperidiini and below it comes 4-Fluori-isobutyyrifentanyyli. The same list closes by extending itself beyond its named entries, in the words «tässä luettelossa mainittuja aineita sisältävät valmisteet lukuun ottamatta luettelossa III mainittuja valmisteita.». The annex that carries this row stands as amended by 25.6.2026/651, which is the amendment that last touched this row's annex rather than the decree as a whole. Section 5 subsection 1 of huumausainelaki 373/2008 is the prohibition that placement engages, «Huumausaineen tuotanto, valmistus, tuonti Suomen alueelle, vienti Suomen alueelta, kuljetus, kauttakuljetus, jakelu, kauppa, käsittely, hallussapito ja käyttö on kielletty.», and chapter 50 section 5 subsection 1 of the Criminal Code makes the word huumausaine in those offences mean a narcotic under huumausainelaki, so the annex entry above is what puts this row inside them. Criminal Code chapter 50 section 2 a is the small quantity limb and it opens «Joka laittomasti käyttää taikka omaa käyttöä varten pitää hallussaan tai yrittää hankkia vähäisen määrän huumausainetta, on tuomittava», so the käyttörikos reaches this row on its own terms. No quantity figure is printed anywhere in chapter 50: whether a quantity is a suuri määrä, and whether the substance is an erittäin vaarallinen huumausaine under chapter 50 section 5 subsection 2, are findings of fact and the annex position does not settle either of them. No fine figure is printed either, because a Finnish fine is a day fine set on the offender's income.
If prescribed / medical: Section 24 of huumausainelaki 373/2008 disapplies the import and export rules for a medicinal product a traveller carries for personal medication where the substance is in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, and this row is inside that carve out. Section 19 of lääkelaki 395/1987 then governs. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. This row sits in list I of the 1961 Convention annex, and section 24 of huumausainelaki 373/2008 reaches exactly that: it disapplies the import and export provisions of the Act for medicinal products containing a substance in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, the products being those «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä», and then hands the traveller to section 19 of lääkelaki 395/1987.
Documentation: Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The locator a traveller or an official would be checking is Liite I list I entry 55 of 543/2008, as that annex stands after 25.6.2026/651, and the entry printed there reads «Fentanyyli (1-fenetyyli-4-N-propionyylianilinopiperidiini)». Because the row is in that part of the convention annexes, section 24 of huumausainelaki 373/2008 takes a traveller's own prescribed medicine out of the Act's import and export provisions and leaves section 19 of lääkelaki 395/1987 to govern how much may be carried, which is the provision this cell did not read. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, fentanyl, a named entry of Liite I list I of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 at printed position 55, that annex as amended by 25.6.2026/651 · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · Updated September 21, 2026

Fentanyl in Finland, full detail →

Gabapentin

Legal status: Not a narcotic in Finland. Gabapentin is not named in any annex of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 and is not named in the annex to valtioneuvoston asetus 1130/2014, as those annexes stand after 651/2026, 1119/2025 and 650/2026. It is a medicine question instead. The Finnish Medicines Agency decision on the medicines list, 230/2025, names it in annex 1, where the Finnish column of the row reads «Gabapentiini». The row gives its Latin, Swedish and English columns as Gabapentinum, Gabapentin, Gabapentin. Section 2 subsection 1 of that decision supervises the annex 1 substances, their salts and their esters as medicines under section 3 subsection 1 or 2 of lääkelaki 395/1987. Section 1 of the decision states that the list is not exhaustive and that not every product containing a listed substance meets the medicine definition, so an individual product's status turns on its own classification.
Consequences if caught: Capital exposure: none. Criminal Code chapter 44 section 5 carries the medicines offence. It sets a fine or up to one year for manufacturing, importing, storing, keeping for sale or supplying medicines contrary to the Medicines Act or the European Union medicines regulations, unless a heavier penalty is provided elsewhere. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. This row is placed outside that regime, so they are recorded as Finland's published drug penalties and not as this substance's exposure. This row in particular. It is not named in either decree and that is a measured absence, not an assumption. The Finnish forms put to both texts for this row were «Gabapentiini», «Gabapentin». Against the consolidated 543/2008, whose annexes carry 196 entries in Liite I, 192 in Liite II, 11 in Liite III, 70 in Liite IV and 1 in Liite V, and against the annex to 1130/2014 as substituted by 650/2026, no form returned an entry of its own. No near miss came back either: not one entry in either annex contains any of those forms as a substring, so there is no longer name to be mistaken for this one. The bands stated above are the narcotics bands and they are reproduced because the live cell named chapter 50. They describe the lane this row would fall into if it were listed, and on the text read here it is not.
If prescribed / medical: This row's whole answer is the prescription route, and whether an authorised product exists in a given form is a product by product question that this cell does not settle. Sections 3 and 6 of lääkelaki 395/1987 are the provisions the live Finland cell named for this route and they are kept. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. The list that does name this row is the medicines list, Finnish Medicines Agency decision 230/2025. Its Liite 1 carries the row at printed line 1288 of the annex text Finlex serves, and the printed row reads «Gabapentiini Gabapentinum Gabapentin Gabapentin». In the printed order of that annex the line above it reads Fytomenadioni Phytomenadionum Fytomenadion Phytomenadione and the line below it reads Gadobutroli Gadobutrolum Gadobutrol Gadobutrol.
Documentation: Section 24 of huumausainelaki 373/2008 is written for convention listed narcotics and does not describe this row, so the ordinary medicines rules are what apply. Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The search behind the absence stated for this row was run in Finnish and the forms were «Gabapentiini», «Gabapentin». Section 24 of huumausainelaki 373/2008, the provision that would otherwise carry a traveller's own medicine past the Act's import and export rules, reaches only products «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä» that contain a substance in one of the convention lists, and this row is in none of them. The list that does name this row is the medicines list, Finnish Medicines Agency decision 230/2025. Its Liite 1 carries the row at printed line 1288 of the annex text Finlex serves, and the printed row reads «Gabapentiini Gabapentinum Gabapentin Gabapentin». In the printed order of that annex the line above it reads Fytomenadioni Phytomenadionum Fytomenadion Phytomenadione and the line below it reads Gadobutroli Gadobutrolum Gadobutrol Gadobutrol. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, gabapentin, not a named entry of 543/2008 and not a named entry of the annex to 1130/2014, an absence measured by running the Finnish forms recorded in the documentation field against both texts · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · Lääkealan turvallisuus- ja kehittämiskeskuksen päätös lääkeluettelosta 230/2025 and its annexes, under lääkelaki 395/1987 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · finlex.fi · finlex.fi · Updated September 21, 2026

Gabapentin in Finland, full detail →

GBL

Legal status: Controlled, though not as a narcotic. Section 1 of valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014 makes the substances in its annex psychoactive substances banned from the consumer market, and GBL is named there. The entry reads «Gammabutyrolaktoni (GBL) (dihydrofuran-2(3H)-oni)». That annex stands as substituted by 650/2026. Section 5 subsection 2 of huumausainelaki 373/2008 bans manufacture, import into Finland, storage, keeping for sale and transfer, and leaves research and industrial use to be permitted separately, so possession for one's own use and use itself are not among the banned acts. Section 3 subsection 3 of the same Act defines the category as substances used for intoxication that may be dangerous to health, notified for control, and that are neither medicines nor narcotics. It is not named in any annex of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, as those annexes stand after 651/2026, 1119/2025 and 650/2026.
Consequences if caught: Capital exposure: none. Criminal Code chapter 44 section 5 a carries the separate consumer market offence. It sets a fine or up to one year for manufacturing, importing, storing, keeping for sale or transferring a psychoactive substance banned from the consumer market, contrary to the Narcotics Act. Possession for one's own use and use itself are not among the acts it names. Section 33 a of huumausainelaki 373/2008 adds import and storage duties, and section 23 b allows a university, a research institute or a trader to import and store on prior notice to the Finnish Medicines Agency. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. This row is placed outside that regime, so they are recorded as Finland's published drug penalties and not as this substance's exposure. This row in particular. Its entry sits in the annex to valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, as that annex was substituted by 650/2026, at printed line 582 of the Finnish annex text Finlex serves, and it reads «Gammabutyrolaktoni (GBL) (dihydrofuran-2(3H)-oni)». In the printed order of that annex the line above it reads G-130 and the line below it reads Harmiini. Section 1 of that decree is one sentence and it does all of the work: «Kuluttajamarkkinoilta kiellettyjä psykoaktiivisia aineita ovat liitteessä mainitut aineet.». The penalty limb that placement engages is not chapter 50. It is Criminal Code chapter 44 section 5 a, which opens «Joka huumausainelain vastaisesti tahallaan tai törkeästä huolimattomuudesta valmistaa, tuo maahan, varastoi, pitää myynnissä tai luovuttaa kuluttajamarkkinoilta kiellettyä psykoaktiivista ainetta, on tuomittava» and sets a fine or up to one year, and only where no heavier penalty is provided elsewhere. Section 5 subsection 2 of huumausainelaki 373/2008 states the prohibition this row breaches, «Kuluttajamarkkinoilta kielletyn psykoaktiivisen aineen valmistus, tuonti Suomen alueelle, varastointi, myynnissä pitäminen ja luovuttaminen on kielletty.», and that list of acts does not include possession or use, so the huumausaineen käyttörikos in chapter 50 section 2 a does not reach this row. No quantity threshold and no fine figure is printed for this row in either the decree or chapter 44 section 5 a.
If prescribed / medical: A substance banned from the consumer market is by definition not a medicine, which is what section 3 subsection 3 of huumausainelaki 373/2008 says, so no prescription route follows from this listing. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. Section 24 of huumausainelaki 373/2008 writes its traveller carve out by reference to the convention lists and this row is in neither decree's convention annexes at all, so the carve out has nothing to attach to. The route in for this category is section 23 b instead, which reads «Elinkeinonharjoittaja saa tuoda maahan ja varastoida kuluttajamarkkinoilta kiellettyjä psykoaktiivisia aineita perustellusta syystä teollista toimintaansa varten, jos aineesta ja toiminnasta on tehty ennen maahantuontia ilmoitus Lääkealan turvallisuus- ja kehittämiskeskukselle.», and that is a research and industry route, not a prescription route.
Documentation: The traveller carve out in section 24 of huumausainelaki 373/2008 is written for medicinal products containing convention listed narcotics and does not describe this row. Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. What a traveller is carrying, if this row is in the bag, is a substance banned from the consumer market by name at printed line 582 of the annex to 1130/2014, reading «Gammabutyrolaktoni (GBL) (dihydrofuran-2(3H)-oni)», and import into Finland is one of the acts section 5 subsection 2 of huumausainelaki 373/2008 forbids. There is no traveller allowance to state for this row because the Act provides none for this category: the only import routes are the university and the industry notifications in section 23 b. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, GBL, a named entry of the annex to valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014 at printed line 582 of the Finnish annex text, that annex as substituted by 650/2026 · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · Updated September 21, 2026

GBL in Finland, full detail →

GHB

Legal status: Controlled. GHB is a narcotic in Finland by name. Section 1 of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 makes the substances, preparations and plants in annexes I to V narcotics, and this row's entry sits in Liite II, the annex headed as the substances and preparations in lists I to IV of the 1971 Convention on Psychotropic Substances, under list II, which the instrument itself heads as a schedule of the 1971 Convention on Psychotropic Substances, an attribution read off the annex heading and not checked against the INCB list in this pass. The entry reads «GHB (γ-hydroksivoihappo)». Section 5 subsection 1 of huumausainelaki 373/2008 then forbids production, manufacture, import into Finland, export from Finland, transport, transit, distribution, trade, handling, possession and use, and allows departure from that ban only for medical, research, supervisory and industrial purposes as separately provided. The same list closes by extending itself, in the words «tämän luettelon aineiden suolat, mukaan luettuna edellä mainittujen isomeerien suolat, jos sellaisten olemassaolo on mahdollista; sekä». That annex stands as amended by 4.12.2025/1119.
Consequences if caught: Capital exposure: none. The ceiling anywhere in this regime is the ten year maximum that Criminal Code chapter 50 section 2 sets for an aggravated narcotics offence. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. This row sits in Liite II under list II of the decree, so those are the provisions its placement engages. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. They describe the offences that this row's placement brings into play. This row in particular. Its entry sits in Liite II, which the decree heads as the substances and preparations in the lists of the 1971 Convention on Psychotropic Substances, under list II of that annex, at printed position 36 of the 68 entries that list carries in the consolidated text read here, and the entry reads «GHB (γ-hydroksivoihappo)». In the printed order of that list the entry above it is FUB-AMB and below it comes Heksahydrokannabinoli. The same list closes by extending itself beyond its named entries, in the words «tässä luettelossa mainittuja aineita sisältävät valmisteet.». The annex that carries this row stands as amended by 4.12.2025/1119, which is the amendment that last touched this row's annex rather than the decree as a whole. Section 5 subsection 1 of huumausainelaki 373/2008 is the prohibition that placement engages, «Huumausaineen tuotanto, valmistus, tuonti Suomen alueelle, vienti Suomen alueelta, kuljetus, kauttakuljetus, jakelu, kauppa, käsittely, hallussapito ja käyttö on kielletty.», and chapter 50 section 5 subsection 1 of the Criminal Code makes the word huumausaine in those offences mean a narcotic under huumausainelaki, so the annex entry above is what puts this row inside them. Criminal Code chapter 50 section 2 a is the small quantity limb and it opens «Joka laittomasti käyttää taikka omaa käyttöä varten pitää hallussaan tai yrittää hankkia vähäisen määrän huumausainetta, on tuomittava», so the käyttörikos reaches this row on its own terms. No quantity figure is printed anywhere in chapter 50: whether a quantity is a suuri määrä, and whether the substance is an erittäin vaarallinen huumausaine under chapter 50 section 5 subsection 2, are findings of fact and the annex position does not settle either of them. No fine figure is printed either, because a Finnish fine is a day fine set on the offender's income.
If prescribed / medical: Section 24 of huumausainelaki 373/2008 disapplies the import and export rules for a medicinal product a traveller carries for personal medication where the substance is in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, and this row is inside that carve out. Section 19 of lääkelaki 395/1987 then governs. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. This row sits in list II of the 1971 Convention annex, and section 24 of huumausainelaki 373/2008 reaches exactly that: it disapplies the import and export provisions of the Act for medicinal products containing a substance in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, the products being those «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä», and then hands the traveller to section 19 of lääkelaki 395/1987.
Documentation: Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The locator a traveller or an official would be checking is Liite II list II entry 36 of 543/2008, as that annex stands after 4.12.2025/1119, and the entry printed there reads «GHB (γ-hydroksivoihappo)». Because the row is in that part of the convention annexes, section 24 of huumausainelaki 373/2008 takes a traveller's own prescribed medicine out of the Act's import and export provisions and leaves section 19 of lääkelaki 395/1987 to govern how much may be carried, which is the provision this cell did not read. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, GHB, a named entry of Liite II list II of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 at printed position 36, that annex as amended by 4.12.2025/1119 · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · Updated September 21, 2026

GHB in Finland, full detail →

Heroin

Legal status: Controlled. Heroin is a narcotic in Finland by name. Section 1 of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 makes the substances, preparations and plants in annexes I to V narcotics, and this row's entry sits in Liite I, the annex headed as the substances and preparations in lists I to IV of the 1961 Single Convention on Narcotic Drugs, under list I, which the instrument itself heads as a schedule of the 1961 Single Convention, an attribution read off the annex heading and not checked against the INCB list in this pass. The entry reads «Heroiini (diasetyylimorfiini)». Section 5 subsection 1 of huumausainelaki 373/2008 then forbids production, manufacture, import into Finland, export from Finland, transport, transit, distribution, trade, handling, possession and use, and allows departure from that ban only for medical, research, supervisory and industrial purposes as separately provided. The same list closes by extending itself, in the words «tämän luettelon aineiden suolat mukaan luettuna edellä mainittujen esterien, eetterien ja isomeerien suolat, jos sellaisten olemassaolo on mahdollista; sekä». That annex stands as amended by 25.6.2026/651.
Consequences if caught: Capital exposure: none. The ceiling anywhere in this regime is the ten year maximum that Criminal Code chapter 50 section 2 sets for an aggravated narcotics offence. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. This row sits in Liite I under list I of the decree, so those are the provisions its placement engages. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. They describe the offences that this row's placement brings into play. This row in particular. Its entry sits in Liite I, which the decree heads as the substances and preparations in the lists of the 1961 Single Convention on Narcotic Drugs, under list I of that annex, at printed position 59 of the 145 entries that list carries in the consolidated text read here, and the entry reads «Heroiini (diasetyylimorfiini)». In the printed order of that list the entry above it is Furetidiini and below it comes Hydrokodoni. The same list closes by extending itself beyond its named entries, in the words «tässä luettelossa mainittuja aineita sisältävät valmisteet lukuun ottamatta luettelossa III mainittuja valmisteita.». The annex that carries this row stands as amended by 25.6.2026/651, which is the amendment that last touched this row's annex rather than the decree as a whole. Section 5 subsection 1 of huumausainelaki 373/2008 is the prohibition that placement engages, «Huumausaineen tuotanto, valmistus, tuonti Suomen alueelle, vienti Suomen alueelta, kuljetus, kauttakuljetus, jakelu, kauppa, käsittely, hallussapito ja käyttö on kielletty.», and chapter 50 section 5 subsection 1 of the Criminal Code makes the word huumausaine in those offences mean a narcotic under huumausainelaki, so the annex entry above is what puts this row inside them. Criminal Code chapter 50 section 2 a is the small quantity limb and it opens «Joka laittomasti käyttää taikka omaa käyttöä varten pitää hallussaan tai yrittää hankkia vähäisen määrän huumausainetta, on tuomittava», so the käyttörikos reaches this row on its own terms. No quantity figure is printed anywhere in chapter 50: whether a quantity is a suuri määrä, and whether the substance is an erittäin vaarallinen huumausaine under chapter 50 section 5 subsection 2, are findings of fact and the annex position does not settle either of them. No fine figure is printed either, because a Finnish fine is a day fine set on the offender's income.
If prescribed / medical: Section 24 of huumausainelaki 373/2008 disapplies the import and export rules for a medicinal product a traveller carries for personal medication where the substance is in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, and this row is inside that carve out. Section 19 of lääkelaki 395/1987 then governs. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. This row sits in list I of the 1961 Convention annex, and section 24 of huumausainelaki 373/2008 reaches exactly that: it disapplies the import and export provisions of the Act for medicinal products containing a substance in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, the products being those «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä», and then hands the traveller to section 19 of lääkelaki 395/1987.
Documentation: Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The locator a traveller or an official would be checking is Liite I list I entry 59 of 543/2008, as that annex stands after 25.6.2026/651, and the entry printed there reads «Heroiini (diasetyylimorfiini)». Because the row is in that part of the convention annexes, section 24 of huumausainelaki 373/2008 takes a traveller's own prescribed medicine out of the Act's import and export provisions and leaves section 19 of lääkelaki 395/1987 to govern how much may be carried, which is the provision this cell did not read. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, heroin, a named entry of Liite I list I of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 at printed position 59, that annex as amended by 25.6.2026/651 · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · Updated September 21, 2026

Heroin in Finland, full detail →

HHC

Legal status: Controlled. HHC is a narcotic in Finland by name. Section 1 of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 makes the substances, preparations and plants in annexes I to V narcotics, and this row's entry sits in Liite II, the annex headed as the substances and preparations in lists I to IV of the 1971 Convention on Psychotropic Substances, under list II, which the instrument itself heads as a schedule of the 1971 Convention on Psychotropic Substances, an attribution read off the annex heading and not checked against the INCB list in this pass. The entry reads «Heksahydrokannabinoli (HHC) (6a,7,8,9,10,10a-heksahydro-6,6,9-trimetyyli-3-pentyyli-6 H -dibentso[b,d]pyran-1-oli)». The instrument italicises part of that entry and the spacing around the italicised locants is as Finlex serves it. Section 5 subsection 1 of huumausainelaki 373/2008 then forbids production, manufacture, import into Finland, export from Finland, transport, transit, distribution, trade, handling, possession and use, and allows departure from that ban only for medical, research, supervisory and industrial purposes as separately provided. The same list closes by extending itself, in the words «tämän luettelon aineiden suolat, mukaan luettuna edellä mainittujen isomeerien suolat, jos sellaisten olemassaolo on mahdollista; sekä». That annex stands as amended by 4.12.2025/1119.
Consequences if caught: Capital exposure: none. The ceiling anywhere in this regime is the ten year maximum that Criminal Code chapter 50 section 2 sets for an aggravated narcotics offence. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. This row sits in Liite II under list II of the decree, so those are the provisions its placement engages. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. They describe the offences that this row's placement brings into play. This row in particular. Its entry sits in Liite II, which the decree heads as the substances and preparations in the lists of the 1971 Convention on Psychotropic Substances, under list II of that annex, at printed position 37 of the 68 entries that list carries in the consolidated text read here, and the entry reads «Heksahydrokannabinoli (HHC) (6a,7,8,9,10,10a-heksahydro-6,6,9-trimetyyli-3-pentyyli-6H-dibentso[b,d]pyran-1-oli)». In the printed order of that list the entry above it is GHB and below it comes JWH-018. The same list closes by extending itself beyond its named entries, in the words «tässä luettelossa mainittuja aineita sisältävät valmisteet.». The annex that carries this row stands as amended by 4.12.2025/1119, which is the amendment that last touched this row's annex rather than the decree as a whole. Section 5 subsection 1 of huumausainelaki 373/2008 is the prohibition that placement engages, «Huumausaineen tuotanto, valmistus, tuonti Suomen alueelle, vienti Suomen alueelta, kuljetus, kauttakuljetus, jakelu, kauppa, käsittely, hallussapito ja käyttö on kielletty.», and chapter 50 section 5 subsection 1 of the Criminal Code makes the word huumausaine in those offences mean a narcotic under huumausainelaki, so the annex entry above is what puts this row inside them. Criminal Code chapter 50 section 2 a is the small quantity limb and it opens «Joka laittomasti käyttää taikka omaa käyttöä varten pitää hallussaan tai yrittää hankkia vähäisen määrän huumausainetta, on tuomittava», so the käyttörikos reaches this row on its own terms. No quantity figure is printed anywhere in chapter 50: whether a quantity is a suuri määrä, and whether the substance is an erittäin vaarallinen huumausaine under chapter 50 section 5 subsection 2, are findings of fact and the annex position does not settle either of them. No fine figure is printed either, because a Finnish fine is a day fine set on the offender's income.
If prescribed / medical: Section 24 of huumausainelaki 373/2008 disapplies the import and export rules for a medicinal product a traveller carries for personal medication where the substance is in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, and this row is inside that carve out. Section 19 of lääkelaki 395/1987 then governs. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. This row sits in list II of the 1971 Convention annex, and section 24 of huumausainelaki 373/2008 reaches exactly that: it disapplies the import and export provisions of the Act for medicinal products containing a substance in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, the products being those «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä», and then hands the traveller to section 19 of lääkelaki 395/1987.
Documentation: Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The locator a traveller or an official would be checking is Liite II list II entry 37 of 543/2008, as that annex stands after 4.12.2025/1119, and the entry printed there reads «Heksahydrokannabinoli (HHC) (6a,7,8,9,10,10a-heksahydro-6,6,9-trimetyyli-3-pentyyli-6H-dibentso[b,d]pyran-1-oli)». Because the row is in that part of the convention annexes, section 24 of huumausainelaki 373/2008 takes a traveller's own prescribed medicine out of the Act's import and export provisions and leaves section 19 of lääkelaki 395/1987 to govern how much may be carried, which is the provision this cell did not read. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, HHC, a named entry of Liite II list II of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 at printed position 37, that annex as amended by 4.12.2025/1119 · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · Updated September 21, 2026

HHC in Finland, full detail →

Hydrocodone

Legal status: Controlled. Hydrocodone is a narcotic in Finland by name. Section 1 of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 makes the substances, preparations and plants in annexes I to V narcotics, and this row's entry sits in Liite I, the annex headed as the substances and preparations in lists I to IV of the 1961 Single Convention on Narcotic Drugs, under list I, which the instrument itself heads as a schedule of the 1961 Single Convention, an attribution read off the annex heading and not checked against the INCB list in this pass. The entry reads «Hydrokodoni (dihydrokodeinoni)». Section 5 subsection 1 of huumausainelaki 373/2008 then forbids production, manufacture, import into Finland, export from Finland, transport, transit, distribution, trade, handling, possession and use, and allows departure from that ban only for medical, research, supervisory and industrial purposes as separately provided. The same list closes by extending itself, in the words «tämän luettelon aineiden suolat mukaan luettuna edellä mainittujen esterien, eetterien ja isomeerien suolat, jos sellaisten olemassaolo on mahdollista; sekä». That annex stands as amended by 25.6.2026/651.
Consequences if caught: Capital exposure: none. The ceiling anywhere in this regime is the ten year maximum that Criminal Code chapter 50 section 2 sets for an aggravated narcotics offence. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. This row sits in Liite I under list I of the decree, so those are the provisions its placement engages. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. They describe the offences that this row's placement brings into play. This row in particular. Its entry sits in Liite I, which the decree heads as the substances and preparations in the lists of the 1961 Single Convention on Narcotic Drugs, under list I of that annex, at printed position 60 of the 145 entries that list carries in the consolidated text read here, and the entry reads «Hydrokodoni (dihydrokodeinoni)». In the printed order of that list the entry above it is Heroiini and below it comes Hydroksipetidiini. The same list closes by extending itself beyond its named entries, in the words «tässä luettelossa mainittuja aineita sisältävät valmisteet lukuun ottamatta luettelossa III mainittuja valmisteita.». The annex that carries this row stands as amended by 25.6.2026/651, which is the amendment that last touched this row's annex rather than the decree as a whole. Section 5 subsection 1 of huumausainelaki 373/2008 is the prohibition that placement engages, «Huumausaineen tuotanto, valmistus, tuonti Suomen alueelle, vienti Suomen alueelta, kuljetus, kauttakuljetus, jakelu, kauppa, käsittely, hallussapito ja käyttö on kielletty.», and chapter 50 section 5 subsection 1 of the Criminal Code makes the word huumausaine in those offences mean a narcotic under huumausainelaki, so the annex entry above is what puts this row inside them. Criminal Code chapter 50 section 2 a is the small quantity limb and it opens «Joka laittomasti käyttää taikka omaa käyttöä varten pitää hallussaan tai yrittää hankkia vähäisen määrän huumausainetta, on tuomittava», so the käyttörikos reaches this row on its own terms. No quantity figure is printed anywhere in chapter 50: whether a quantity is a suuri määrä, and whether the substance is an erittäin vaarallinen huumausaine under chapter 50 section 5 subsection 2, are findings of fact and the annex position does not settle either of them. No fine figure is printed either, because a Finnish fine is a day fine set on the offender's income.
If prescribed / medical: Section 24 of huumausainelaki 373/2008 disapplies the import and export rules for a medicinal product a traveller carries for personal medication where the substance is in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, and this row is inside that carve out. Section 19 of lääkelaki 395/1987 then governs. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. This row sits in list I of the 1961 Convention annex, and section 24 of huumausainelaki 373/2008 reaches exactly that: it disapplies the import and export provisions of the Act for medicinal products containing a substance in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, the products being those «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä», and then hands the traveller to section 19 of lääkelaki 395/1987.
Documentation: Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The locator a traveller or an official would be checking is Liite I list I entry 60 of 543/2008, as that annex stands after 25.6.2026/651, and the entry printed there reads «Hydrokodoni (dihydrokodeinoni)». Because the row is in that part of the convention annexes, section 24 of huumausainelaki 373/2008 takes a traveller's own prescribed medicine out of the Act's import and export provisions and leaves section 19 of lääkelaki 395/1987 to govern how much may be carried, which is the provision this cell did not read. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, hydrocodone, a named entry of Liite I list I of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 at printed position 60, that annex as amended by 25.6.2026/651 · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · Updated September 21, 2026

Hydrocodone in Finland, full detail →

Ketamine

Legal status: Not a narcotic in Finland. Ketamine is not named in any annex of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 and is not named in the annex to valtioneuvoston asetus 1130/2014, as those annexes stand after 651/2026, 1119/2025 and 650/2026. It is a medicine question instead. The Finnish Medicines Agency decision on the medicines list, 230/2025, names it in annex 1, where the Finnish column of the row reads «Ketamiini». The row gives its Latin, Swedish and English columns as Ketaminum, Ketamin, Ketamine. Section 2 subsection 1 of that decision supervises the annex 1 substances, their salts and their esters as medicines under section 3 subsection 1 or 2 of lääkelaki 395/1987. Section 1 of the decision states that the list is not exhaustive and that not every product containing a listed substance meets the medicine definition, so an individual product's status turns on its own classification.
Consequences if caught: Capital exposure: none. Criminal Code chapter 44 section 5 carries the medicines offence. It sets a fine or up to one year for manufacturing, importing, storing, keeping for sale or supplying medicines contrary to the Medicines Act or the European Union medicines regulations, unless a heavier penalty is provided elsewhere. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. This row is placed outside that regime, so they are recorded as Finland's published drug penalties and not as this substance's exposure. This row in particular. It is not named in either decree and that is a measured absence, not an assumption. The Finnish forms put to both texts for this row were «Ketamiini», «Ketamine». Against the consolidated 543/2008, whose annexes carry 196 entries in Liite I, 192 in Liite II, 11 in Liite III, 70 in Liite IV and 1 in Liite V, and against the annex to 1130/2014 as substituted by 650/2026, no form returned an entry of its own. What the search did return is a near miss rather than a hit: in Liite II the longer entry «2-Fluoridesklooriketamiini (2-FDCK) (2-(2-fluorifenyyli)-2-(metyyliamino)sykloheksan-1-oni)»; and in the 1130/2014 annex the longer entry «Desklooriketamiini (2-(metyyliamino)-2-fenyylisykloheksanoni)»; and in the 1130/2014 annex the longer entry «Deskloori-N-etyyliketamiini (O-PCE) (2-(etyyliamino)-2-fenyylisykloheksan-1-oni)», which contains the searched form inside a different molecule's name and is not this row. The bands stated above are the narcotics bands and they are reproduced because the live cell named chapter 50. They describe the lane this row would fall into if it were listed, and on the text read here it is not.
If prescribed / medical: This row's whole answer is the prescription route, and whether an authorised product exists in a given form is a product by product question that this cell does not settle. Sections 3 and 6 of lääkelaki 395/1987 are the provisions the live Finland cell named for this route and they are kept. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. The list that does name this row is the medicines list, Finnish Medicines Agency decision 230/2025. Its Liite 1 carries the row at printed line 1801 of the annex text Finlex serves, and the printed row reads «Ketamiini Ketaminum Ketamin Ketamine». In the printed order of that annex the line above it reads chenodeoxycholicum and the line below it reads Ketanseriini Ketanserinum Ketanserin Ketanserin.
Documentation: Section 24 of huumausainelaki 373/2008 is written for convention listed narcotics and does not describe this row, so the ordinary medicines rules are what apply. Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The search behind the absence stated for this row was run in Finnish and the forms were «Ketamiini», «Ketamine». Section 24 of huumausainelaki 373/2008, the provision that would otherwise carry a traveller's own medicine past the Act's import and export rules, reaches only products «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä» that contain a substance in one of the convention lists, and this row is in none of them. The list that does name this row is the medicines list, Finnish Medicines Agency decision 230/2025. Its Liite 1 carries the row at printed line 1801 of the annex text Finlex serves, and the printed row reads «Ketamiini Ketaminum Ketamin Ketamine». In the printed order of that annex the line above it reads chenodeoxycholicum and the line below it reads Ketanseriini Ketanserinum Ketanserin Ketanserin. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, ketamine, not a named entry of 543/2008 and not a named entry of the annex to 1130/2014, an absence measured by running the Finnish forms recorded in the documentation field against both texts · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · Lääkealan turvallisuus- ja kehittämiskeskuksen päätös lääkeluettelosta 230/2025 and its annexes, under lääkelaki 395/1987 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · finlex.fi · finlex.fi · Updated September 21, 2026

Ketamine in Finland, full detail →

Khat

Legal status: Controlled. Khat is a narcotic in Finland by name. Section 1 of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 makes the substances, preparations and plants in annexes I to V narcotics, and this row's entry sits in Liite IV, a bare national list of plants opening only with the words seuraavat kasvit, which is Finland's own addition and rests on no convention schedule. The entry reads «kat-kasvi (Catha edulis)». The instrument italicises part of that entry and the spacing around the italicised locants is as Finlex serves it. Section 5 subsection 1 of huumausainelaki 373/2008 then forbids production, manufacture, import into Finland, export from Finland, transport, transit, distribution, trade, handling, possession and use, and allows departure from that ban only for medical, research, supervisory and industrial purposes as separately provided. Section 7 of huumausainelaki 373/2008 adds a cultivation ban, outright for the khat plant, Psilosybe mushrooms and the coca bush, and for the opium poppy, hemp and mescaline bearing cacti where the purpose is narcotic use or narcotic manufacture. Section 3 subsection 1 paragraph 5 sub-paragraph d of the same Act carries the same four plant items into the statutory definition of a narcotic. That annex stands as amended by 25.6.2026/651. Section 7 subsection 1 reads «Kat-kasvin (Catha edulis), Psilosybe-sienien ja kokapensaan viljely on kielletty.» Section 3 subsection 1 paragraph 5 sub-paragraph d of huumausainelaki 373/2008 writes the same four plant items into the statutory definition in the partitive, as «kat-kasvia (Catha edulis), meskaliinia sisältäviä kaktuskasveja ja Psilosybe-sieniä sekä huumaantumistarkoituksessa käytettäviä kasvijauheita, -rouheita ja -valmisteita, jotka sisältävät dimetyylitryptamiinia», which is the form the live Finland cell quoted.
Consequences if caught: Capital exposure: none. The ceiling anywhere in this regime is the ten year maximum that Criminal Code chapter 50 section 2 sets for an aggravated narcotics offence. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. This row sits in Liite IV among the plants of the decree, so those are the provisions its placement engages. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. They describe the offences that this row's placement brings into play. This row in particular. Its entry sits in Liite IV, the annex of substances and plants Finland controls nationally rather than by convention list, at printed position 1 of the four plant entries that follow the heading «Seuraavat kasvit:», and the entry reads «kat-kasvi (Catha edulis)». In the printed order of that list the entry above it is the extension clause that closes the list and below it comes meskaliinia sisältävät kaktuskasvit. The same list closes by extending itself beyond its named entries, in the words «tässä liitteessä mainittuja aineita sisältävät valmisteet.». The annex that carries this row stands as amended by 25.6.2026/651, which is the amendment that last touched this row's annex rather than the decree as a whole. Section 5 subsection 1 of huumausainelaki 373/2008 is the prohibition that placement engages, «Huumausaineen tuotanto, valmistus, tuonti Suomen alueelle, vienti Suomen alueelta, kuljetus, kauttakuljetus, jakelu, kauppa, käsittely, hallussapito ja käyttö on kielletty.», and chapter 50 section 5 subsection 1 of the Criminal Code makes the word huumausaine in those offences mean a narcotic under huumausainelaki, so the annex entry above is what puts this row inside them. This row is reached by the cultivation limb as well. Section 7 subsection 1 of huumausainelaki 373/2008 reads «Kat-kasvin (Catha edulis), Psilosybe-sienien ja kokapensaan viljely on kielletty.», and Criminal Code chapter 50 section 1 carries the same limb as a paragraph of the offence, «viljelee tai yrittää viljellä kokapensasta, kat-kasvia (Catha edulis) tai Psilosybe-sieniä,». Criminal Code chapter 50 section 2 a is the small quantity limb and it opens «Joka laittomasti käyttää taikka omaa käyttöä varten pitää hallussaan tai yrittää hankkia vähäisen määrän huumausainetta, on tuomittava», so the käyttörikos reaches this row on its own terms. No quantity figure is printed anywhere in chapter 50: whether a quantity is a suuri määrä, and whether the substance is an erittäin vaarallinen huumausaine under chapter 50 section 5 subsection 2, are findings of fact and the annex position does not settle either of them. No fine figure is printed either, because a Finnish fine is a day fine set on the offender's income.
If prescribed / medical: Section 24 of huumausainelaki 373/2008 writes its traveller carve out by reference to the convention lists, and this row is not placed in one of them, so the carve out does not describe it. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. This row is placed in Liite IV, which is a national annex and not a convention list, so section 24 of huumausainelaki 373/2008 has no list to match it against. The carve out is written by reference to lists I to III of the 1961 Convention and lists II to IV of the 1971 Convention, for the products «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä», and this row is in neither.
Documentation: This row is a plant entry, so no medicine packaging answers it. Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The locator a traveller or an official would be checking is Liite IV entry 67 of 543/2008, as that annex stands after 25.6.2026/651, and the entry printed there reads «kat-kasvi (Catha edulis)». Because the row is outside the lists section 24 names, that section does not take a traveller's own medicine out of the Act's import and export provisions for this row, and nothing read here supplies a carriage allowance in its place. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, khat, a named entry of Liite IV of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 at printed position 67, that annex as amended by 25.6.2026/651 · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · Updated September 21, 2026

Khat in Finland, full detail →

Kratom

Legal status: Controlled, though not as a narcotic. Section 1 of valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014 makes the substances in its annex psychoactive substances banned from the consumer market, and Kratom is named there. The entry reads «Kratom (Mitragyna Speciosa)». That annex stands as substituted by 650/2026. Section 5 subsection 2 of huumausainelaki 373/2008 bans manufacture, import into Finland, storage, keeping for sale and transfer, and leaves research and industrial use to be permitted separately, so possession for one's own use and use itself are not among the banned acts. Section 3 subsection 3 of the same Act defines the category as substances used for intoxication that may be dangerous to health, notified for control, and that are neither medicines nor narcotics. It is not named in any annex of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, as those annexes stand after 651/2026, 1119/2025 and 650/2026.
Consequences if caught: Capital exposure: none. Criminal Code chapter 44 section 5 a carries the separate consumer market offence. It sets a fine or up to one year for manufacturing, importing, storing, keeping for sale or transferring a psychoactive substance banned from the consumer market, contrary to the Narcotics Act. Possession for one's own use and use itself are not among the acts it names. Section 33 a of huumausainelaki 373/2008 adds import and storage duties, and section 23 b allows a university, a research institute or a trader to import and store on prior notice to the Finnish Medicines Agency. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. This row is placed outside that regime, so they are recorded as Finland's published drug penalties and not as this substance's exposure. This row in particular. Its entry sits in the annex to valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, as that annex was substituted by 650/2026, at printed line 723 of the Finnish annex text Finlex serves, and it reads «Kratom (Mitragyna Speciosa)». In the printed order of that annex the line above it reads 4-Klooripentedroni and the line below it reads LTI-701. Section 1 of that decree is one sentence and it does all of the work: «Kuluttajamarkkinoilta kiellettyjä psykoaktiivisia aineita ovat liitteessä mainitut aineet.». The penalty limb that placement engages is not chapter 50. It is Criminal Code chapter 44 section 5 a, which opens «Joka huumausainelain vastaisesti tahallaan tai törkeästä huolimattomuudesta valmistaa, tuo maahan, varastoi, pitää myynnissä tai luovuttaa kuluttajamarkkinoilta kiellettyä psykoaktiivista ainetta, on tuomittava» and sets a fine or up to one year, and only where no heavier penalty is provided elsewhere. Section 5 subsection 2 of huumausainelaki 373/2008 states the prohibition this row breaches, «Kuluttajamarkkinoilta kielletyn psykoaktiivisen aineen valmistus, tuonti Suomen alueelle, varastointi, myynnissä pitäminen ja luovuttaminen on kielletty.», and that list of acts does not include possession or use, so the huumausaineen käyttörikos in chapter 50 section 2 a does not reach this row. No quantity threshold and no fine figure is printed for this row in either the decree or chapter 44 section 5 a.
If prescribed / medical: A substance banned from the consumer market is by definition not a medicine, which is what section 3 subsection 3 of huumausainelaki 373/2008 says, so no prescription route follows from this listing. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. Section 24 of huumausainelaki 373/2008 writes its traveller carve out by reference to the convention lists and this row is in neither decree's convention annexes at all, so the carve out has nothing to attach to. The route in for this category is section 23 b instead, which reads «Elinkeinonharjoittaja saa tuoda maahan ja varastoida kuluttajamarkkinoilta kiellettyjä psykoaktiivisia aineita perustellusta syystä teollista toimintaansa varten, jos aineesta ja toiminnasta on tehty ennen maahantuontia ilmoitus Lääkealan turvallisuus- ja kehittämiskeskukselle.», and that is a research and industry route, not a prescription route.
Documentation: The traveller carve out in section 24 of huumausainelaki 373/2008 is written for medicinal products containing convention listed narcotics and does not describe this row. Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. What a traveller is carrying, if this row is in the bag, is a substance banned from the consumer market by name at printed line 723 of the annex to 1130/2014, reading «Kratom (Mitragyna Speciosa)», and import into Finland is one of the acts section 5 subsection 2 of huumausainelaki 373/2008 forbids. There is no traveller allowance to state for this row because the Act provides none for this category: the only import routes are the university and the industry notifications in section 23 b. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, kratom, a named entry of the annex to valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014 at printed line 723 of the Finnish annex text, that annex as substituted by 650/2026 · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · Updated September 21, 2026

Kratom in Finland, full detail →

Lorazepam

Legal status: Controlled. Lorazepam is a narcotic in Finland by name. Section 1 of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 makes the substances, preparations and plants in annexes I to V narcotics, and this row's entry sits in Liite II, the annex headed as the substances and preparations in lists I to IV of the 1971 Convention on Psychotropic Substances, under list IV, which the instrument itself heads as a schedule of the 1971 Convention on Psychotropic Substances, an attribution read off the annex heading and not checked against the INCB list in this pass. The entry reads «Loratsepaami (7-kloori-5-(o -kloorifenyyli)-1,3-dihydro-3-hydroksi-2 H -1,4-bentsodiatsepin-2-oni)». The instrument italicises part of that entry and the spacing around the italicised locants is as Finlex serves it. Section 5 subsection 1 of huumausainelaki 373/2008 then forbids production, manufacture, import into Finland, export from Finland, transport, transit, distribution, trade, handling, possession and use, and allows departure from that ban only for medical, research, supervisory and industrial purposes as separately provided. The same list closes by extending itself, in the words «tämän luettelon aineiden suolat, mukaan luettuna edellä mainittujen isomeerien suolat, jos sellaisten olemassaolo on mahdollista; sekä». That annex stands as amended by 4.12.2025/1119.
Consequences if caught: Capital exposure: none. The ceiling anywhere in this regime is the ten year maximum that Criminal Code chapter 50 section 2 sets for an aggravated narcotics offence. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. This row sits in Liite II under list IV of the decree, so those are the provisions its placement engages. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. They describe the offences that this row's placement brings into play. This row in particular. Its entry sits in Liite II, which the decree heads as the substances and preparations in the lists of the 1971 Convention on Psychotropic Substances, under list IV of that annex, at printed position 43 of the 71 entries that list carries in the consolidated text read here, and the entry reads «Loratsepaami (7-kloori-5-(o-kloorifenyyli)-1,3-dihydro-3-hydroksi-2H-1,4-bentsodiatsepin-2-oni)». In the printed order of that list the entry above it is Lopratsolaami and below it comes Lormetatsepaami. The same list closes by extending itself beyond its named entries, in the words «tässä luettelossa mainittuja aineita sisältävät valmisteet.». The annex that carries this row stands as amended by 4.12.2025/1119, which is the amendment that last touched this row's annex rather than the decree as a whole. Section 5 subsection 1 of huumausainelaki 373/2008 is the prohibition that placement engages, «Huumausaineen tuotanto, valmistus, tuonti Suomen alueelle, vienti Suomen alueelta, kuljetus, kauttakuljetus, jakelu, kauppa, käsittely, hallussapito ja käyttö on kielletty.», and chapter 50 section 5 subsection 1 of the Criminal Code makes the word huumausaine in those offences mean a narcotic under huumausainelaki, so the annex entry above is what puts this row inside them. Criminal Code chapter 50 section 2 a is the small quantity limb and it opens «Joka laittomasti käyttää taikka omaa käyttöä varten pitää hallussaan tai yrittää hankkia vähäisen määrän huumausainetta, on tuomittava», so the käyttörikos reaches this row on its own terms. No quantity figure is printed anywhere in chapter 50: whether a quantity is a suuri määrä, and whether the substance is an erittäin vaarallinen huumausaine under chapter 50 section 5 subsection 2, are findings of fact and the annex position does not settle either of them. No fine figure is printed either, because a Finnish fine is a day fine set on the offender's income.
If prescribed / medical: Section 24 of huumausainelaki 373/2008 disapplies the import and export rules for a medicinal product a traveller carries for personal medication where the substance is in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, and this row is inside that carve out. Section 19 of lääkelaki 395/1987 then governs. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. This row sits in list IV of the 1971 Convention annex, and section 24 of huumausainelaki 373/2008 reaches exactly that: it disapplies the import and export provisions of the Act for medicinal products containing a substance in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, the products being those «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä», and then hands the traveller to section 19 of lääkelaki 395/1987. Section 23 subsection 3 of the same Act is the neighbouring relief for this list: a combination preparation containing a psychotropic substance other than one in list I of the 1971 Convention needs no import or export licence where the narcotic content is small or hard to separate and the abuse risk is slight against the substance's wide medicinal use.
Documentation: Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The locator a traveller or an official would be checking is Liite II list IV entry 43 of 543/2008, as that annex stands after 4.12.2025/1119, and the entry printed there reads «Loratsepaami (7-kloori-5-(o-kloorifenyyli)-1,3-dihydro-3-hydroksi-2H-1,4-bentsodiatsepin-2-oni)». Because the row is in that part of the convention annexes, section 24 of huumausainelaki 373/2008 takes a traveller's own prescribed medicine out of the Act's import and export provisions and leaves section 19 of lääkelaki 395/1987 to govern how much may be carried, which is the provision this cell did not read. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, lorazepam, a named entry of Liite II list IV of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 at printed position 43, that annex as amended by 4.12.2025/1119 · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · Updated September 21, 2026

Lorazepam in Finland, full detail →

LSA (Morning Glory)

Legal status: Not a narcotic in Finland, and not named anywhere as a substance. Lysergic acid amide is not named in any annex of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, is not named in the annex to valtioneuvoston asetus 1130/2014, and is not named in annex 1 or annex 1 A of the medicines list 230/2025, as those annexes stand after 651/2026, 1119/2025 and 650/2026. What the medicines list does name, in annex 2 among the rohdokset, are the plants that carry it, and the row for the Hawaiian baby woodrose opens its Latin column «Argyreia nervosa». Annex 2 puts the Latin name first, and this row gives its Finnish name as Havaijilainen puuruusu and its English name as Hawaiian baby woodrose. Rivea corymbosa and several Ipomoea species have their own rows in the same annex. Section 3 of that decision supervises the annex 2 rohdokset as medicines when they are used in the way section 3 subsection 1 of lääkelaki 395/1987 describes. The live Finland cell's own unresolved reasoning is kept. It recorded that the express wording «Lysergihapon amidi» was located in the superseded 1993 decision 1709/1993 with no current carry forward identified, that lysergic acid is a category 1 precursor under Regulation (EC) No 273/2004 annex I whose salts clause does not establish the distinct amide, and that failed Finlex positive controls prevented reliance on a zero search result. Those three points are carried forward and were not re-derived here. The live Finland cell also quoted «(+)-Lysergidi (LSD, LSD-25)», «Lysergihappo» and «Ipomoea sp.» and those three are kept.
Consequences if caught: Capital exposure: none. No penalty is asserted for this entry as a class, because the classification itself is unresolved. Criminal Code chapter 44 section 5 carries the medicines offence. It sets a fine or up to one year for manufacturing, importing, storing, keeping for sale or supplying medicines contrary to the Medicines Act or the European Union medicines regulations, unless a heavier penalty is provided elsewhere. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. Whether the offence reaches this row at all is exactly what was not established here. This row in particular. It is not named in either decree and that is a measured absence, not an assumption. The Finnish forms put to both texts for this row were «Lysergihapon amidi», «Lysergiamidi», «Argyreia», «Ipomoea», «Rivea», «LSA». Against the consolidated 543/2008, whose annexes carry 196 entries in Liite I, 192 in Liite II, 11 in Liite III, 70 in Liite IV and 1 in Liite V, and against the annex to 1130/2014 as substituted by 650/2026, no form returned an entry of its own. No near miss came back either: not one entry in either annex contains any of those forms as a substring, so there is no longer name to be mistaken for this one. The bands stated above are the narcotics bands and they are reproduced because the live cell named chapter 50. They describe the lane this row would fall into if it were listed, and on the text read here it is not.
If prescribed / medical: This row's whole answer is the prescription route, and whether an authorised product exists in a given form is a product by product question that this cell does not settle. Sections 3 and 6 of lääkelaki 395/1987 are the provisions the live Finland cell named for this route and they are kept. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. The list that does name this row is the medicines list, Finnish Medicines Agency decision 230/2025. Its Liite 2 carries the row at printed line 4116 of the annex text Finlex serves, and the printed row reads «Argyreia nervosa Havaijilainen puuruusu, Elefantvinda Hawaiian baby woodrose,». In the printed order of that annex the line above it reads (Carex arenaria) and the line below it reads ruusunorsukierto Elephant creeper. A second row for this substance sits in Liite 2 of the same list at printed line 4535, reading «Ipomoea sp. Elämänlangat Ipomoea Ipomoea».
Documentation: Section 24 of huumausainelaki 373/2008 is written for convention listed narcotics and does not describe this row, so the ordinary medicines rules are what apply. Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The search behind the absence stated for this row was run in Finnish and the forms were «Lysergihapon amidi», «Lysergiamidi», «Argyreia», «Ipomoea», «Rivea», «LSA». Section 24 of huumausainelaki 373/2008, the provision that would otherwise carry a traveller's own medicine past the Act's import and export rules, reaches only products «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä» that contain a substance in one of the convention lists, and this row is in none of them. The list that does name this row is the medicines list, Finnish Medicines Agency decision 230/2025. Its Liite 2 carries the row at printed line 4116 of the annex text Finlex serves, and the printed row reads «Argyreia nervosa Havaijilainen puuruusu, Elefantvinda Hawaiian baby woodrose,». In the printed order of that annex the line above it reads (Carex arenaria) and the line below it reads ruusunorsukierto Elephant creeper. A second row for this substance sits in Liite 2 of the same list at printed line 4535, reading «Ipomoea sp. Elämänlangat Ipomoea Ipomoea». Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, lysergic acid amide, not a named entry of 543/2008 and not a named entry of the annex to 1130/2014, an absence measured by running the Finnish forms recorded in the documentation field against both texts · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · Lääkealan turvallisuus- ja kehittämiskeskuksen päätös lääkeluettelosta 230/2025 and its annexes, under lääkelaki 395/1987 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · finlex.fi · eur-lex.europa.eu · finlex.fi · finlex.fi · Updated September 21, 2026

LSA (Morning Glory) in Finland, full detail →

LSD

Legal status: Controlled. LSD is a narcotic in Finland by name. Section 1 of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 makes the substances, preparations and plants in annexes I to V narcotics, and this row's entry sits in Liite II, the annex headed as the substances and preparations in lists I to IV of the 1971 Convention on Psychotropic Substances, under list I, which the instrument itself heads as a schedule of the 1971 Convention on Psychotropic Substances, an attribution read off the annex heading and not checked against the INCB list in this pass. The entry reads «(+)-Lysergidi (LSD, LSD-25) (9,10-didehydro- N, N -dietyyli-6-metyyliergoliini-8 β -karboksiamidi)». The instrument italicises part of that entry and the spacing around the italicised locants is as Finlex serves it. Section 5 subsection 1 of huumausainelaki 373/2008 then forbids production, manufacture, import into Finland, export from Finland, transport, transit, distribution, trade, handling, possession and use, and allows departure from that ban only for medical, research, supervisory and industrial purposes as separately provided. The same list closes by extending itself, in the words «tämän luettelon aineiden suolat, jos sellaisen suolan muodostaminen on mahdollista; sekä». That annex stands as amended by 4.12.2025/1119.
Consequences if caught: Capital exposure: none. The ceiling anywhere in this regime is the ten year maximum that Criminal Code chapter 50 section 2 sets for an aggravated narcotics offence. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. This row sits in Liite II under list I of the decree, so those are the provisions its placement engages. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. They describe the offences that this row's placement brings into play. This row in particular. Its entry sits in Liite II, which the decree heads as the substances and preparations in the lists of the 1971 Convention on Psychotropic Substances, under list I of that annex, at printed position 14 of the 41 entries that list carries in the consolidated text read here, and the entry reads «(+)-Lysergidi (LSD, LSD-25) (9,10-didehydro-N,N-dietyyli-6-metyyliergoliini-8β-karboksiamidi)». In the printed order of that list the entry above it is Katinoni and below it comes MDE,N-etyyli MDA. The same list closes by extending itself beyond its named entries, in the words «tässä luettelossa mainittuja aineita sisältävät valmisteet.». The annex that carries this row stands as amended by 4.12.2025/1119, which is the amendment that last touched this row's annex rather than the decree as a whole. Section 5 subsection 1 of huumausainelaki 373/2008 is the prohibition that placement engages, «Huumausaineen tuotanto, valmistus, tuonti Suomen alueelle, vienti Suomen alueelta, kuljetus, kauttakuljetus, jakelu, kauppa, käsittely, hallussapito ja käyttö on kielletty.», and chapter 50 section 5 subsection 1 of the Criminal Code makes the word huumausaine in those offences mean a narcotic under huumausainelaki, so the annex entry above is what puts this row inside them. Criminal Code chapter 50 section 2 a is the small quantity limb and it opens «Joka laittomasti käyttää taikka omaa käyttöä varten pitää hallussaan tai yrittää hankkia vähäisen määrän huumausainetta, on tuomittava», so the käyttörikos reaches this row on its own terms. No quantity figure is printed anywhere in chapter 50: whether a quantity is a suuri määrä, and whether the substance is an erittäin vaarallinen huumausaine under chapter 50 section 5 subsection 2, are findings of fact and the annex position does not settle either of them. No fine figure is printed either, because a Finnish fine is a day fine set on the offender's income.
If prescribed / medical: Section 24 of huumausainelaki 373/2008 disapplies the import and export rules for a traveller's personal medication only where the substance is in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention. This row is in list I of the 1971 Convention, which that carve out does not reach. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. This row sits in list I of the 1971 Convention annex, which is the one list section 24 of huumausainelaki 373/2008 leaves out. The carve out covers lists I to III of the 1961 Convention and lists II to IV of the 1971 Convention, for the products «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä», and a list I entry of the 1971 Convention annex is outside it.
Documentation: Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The locator a traveller or an official would be checking is Liite II list I entry 14 of 543/2008, as that annex stands after 4.12.2025/1119, and the entry printed there reads «(+)-Lysergidi (LSD, LSD-25) (9,10-didehydro-N,N-dietyyli-6-metyyliergoliini-8β-karboksiamidi)». Because the row is outside the lists section 24 names, that section does not take a traveller's own medicine out of the Act's import and export provisions for this row, and nothing read here supplies a carriage allowance in its place. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, LSD, a named entry of Liite II list I of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 at printed position 14, that annex as amended by 4.12.2025/1119 · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · Updated September 21, 2026

LSD in Finland, full detail →

MDA

Legal status: Controlled. MDA is a narcotic in Finland by name. Section 1 of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 makes the substances, preparations and plants in annexes I to V narcotics, and this row's entry sits in Liite II, the annex headed as the substances and preparations in lists I to IV of the 1971 Convention on Psychotropic Substances, under list I, which the instrument itself heads as a schedule of the 1971 Convention on Psychotropic Substances, an attribution read off the annex heading and not checked against the INCB list in this pass. The entry reads «Tenamfetamiini, metyleenidioksiamfetamiini (MDA) (α -metyyli-3,4-metyleenidioksifenetyyliamiini)». The instrument italicises part of that entry and the spacing around the italicised locants is as Finlex serves it. Section 5 subsection 1 of huumausainelaki 373/2008 then forbids production, manufacture, import into Finland, export from Finland, transport, transit, distribution, trade, handling, possession and use, and allows departure from that ban only for medical, research, supervisory and industrial purposes as separately provided. The same list closes by extending itself, in the words «tämän luettelon aineiden suolat, jos sellaisen suolan muodostaminen on mahdollista; sekä». That annex stands as amended by 4.12.2025/1119.
Consequences if caught: Capital exposure: none. The ceiling anywhere in this regime is the ten year maximum that Criminal Code chapter 50 section 2 sets for an aggravated narcotics offence. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. This row sits in Liite II under list I of the decree, so those are the provisions its placement engages. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. They describe the offences that this row's placement brings into play. This row in particular. Its entry sits in Liite II, which the decree heads as the substances and preparations in the lists of the 1971 Convention on Psychotropic Substances, under list I of that annex, at printed position 30 of the 41 entries that list carries in the consolidated text read here, and the entry reads «Tenamfetamiini, metyleenidioksiamfetamiini (MDA) (α-metyyli-3,4-metyleenidioksifenetyyliamiini)». In the printed order of that list the entry above it is STP, DOM and below it comes Tenosyklidiini. The same list closes by extending itself beyond its named entries, in the words «tässä luettelossa mainittuja aineita sisältävät valmisteet.». The annex that carries this row stands as amended by 4.12.2025/1119, which is the amendment that last touched this row's annex rather than the decree as a whole. Section 5 subsection 1 of huumausainelaki 373/2008 is the prohibition that placement engages, «Huumausaineen tuotanto, valmistus, tuonti Suomen alueelle, vienti Suomen alueelta, kuljetus, kauttakuljetus, jakelu, kauppa, käsittely, hallussapito ja käyttö on kielletty.», and chapter 50 section 5 subsection 1 of the Criminal Code makes the word huumausaine in those offences mean a narcotic under huumausainelaki, so the annex entry above is what puts this row inside them. Criminal Code chapter 50 section 2 a is the small quantity limb and it opens «Joka laittomasti käyttää taikka omaa käyttöä varten pitää hallussaan tai yrittää hankkia vähäisen määrän huumausainetta, on tuomittava», so the käyttörikos reaches this row on its own terms. No quantity figure is printed anywhere in chapter 50: whether a quantity is a suuri määrä, and whether the substance is an erittäin vaarallinen huumausaine under chapter 50 section 5 subsection 2, are findings of fact and the annex position does not settle either of them. No fine figure is printed either, because a Finnish fine is a day fine set on the offender's income.
If prescribed / medical: Section 24 of huumausainelaki 373/2008 disapplies the import and export rules for a traveller's personal medication only where the substance is in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention. This row is in list I of the 1971 Convention, which that carve out does not reach. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. This row sits in list I of the 1971 Convention annex, which is the one list section 24 of huumausainelaki 373/2008 leaves out. The carve out covers lists I to III of the 1961 Convention and lists II to IV of the 1971 Convention, for the products «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä», and a list I entry of the 1971 Convention annex is outside it.
Documentation: Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The locator a traveller or an official would be checking is Liite II list I entry 30 of 543/2008, as that annex stands after 4.12.2025/1119, and the entry printed there reads «Tenamfetamiini, metyleenidioksiamfetamiini (MDA) (α-metyyli-3,4-metyleenidioksifenetyyliamiini)». Because the row is outside the lists section 24 names, that section does not take a traveller's own medicine out of the Act's import and export provisions for this row, and nothing read here supplies a carriage allowance in its place. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, MDA, a named entry of Liite II list I of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 at printed position 30, that annex as amended by 4.12.2025/1119 · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · Updated September 21, 2026

MDA in Finland, full detail →

MDMA

Legal status: Controlled. MDMA is a narcotic in Finland by name. Section 1 of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 makes the substances, preparations and plants in annexes I to V narcotics, and this row's entry sits in Liite II, the annex headed as the substances and preparations in lists I to IV of the 1971 Convention on Psychotropic Substances, under list I, which the instrument itself heads as a schedule of the 1971 Convention on Psychotropic Substances, an attribution read off the annex heading and not checked against the INCB list in this pass. The entry reads «Metyleenidioksimetamfetamiini (MDMA) ((±)- N, α -dimetyyli-3,4-metyleenidioksifenetyyliamiini)». The instrument italicises part of that entry and the spacing around the italicised locants is as Finlex serves it. Section 5 subsection 1 of huumausainelaki 373/2008 then forbids production, manufacture, import into Finland, export from Finland, transport, transit, distribution, trade, handling, possession and use, and allows departure from that ban only for medical, research, supervisory and industrial purposes as separately provided. The same list closes by extending itself, in the words «tämän luettelon aineiden suolat, jos sellaisen suolan muodostaminen on mahdollista; sekä». That annex stands as amended by 4.12.2025/1119.
Consequences if caught: Capital exposure: none. The ceiling anywhere in this regime is the ten year maximum that Criminal Code chapter 50 section 2 sets for an aggravated narcotics offence. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. This row sits in Liite II under list I of the decree, so those are the provisions its placement engages. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. They describe the offences that this row's placement brings into play. This row in particular. Its entry sits in Liite II, which the decree heads as the substances and preparations in the lists of the 1971 Convention on Psychotropic Substances, under list I of that annex, at printed position 19 of the 41 entries that list carries in the consolidated text read here, and the entry reads «Metyleenidioksimetamfetamiini (MDMA) ((±)-N,α-dimetyyli-3,4-metyleenidioksifenetyyliamiini)». In the printed order of that list the entry above it is Metoksimetyleenidioksiamfetamiini and below it comes 4-Metyyliaminoreksi. The same list closes by extending itself beyond its named entries, in the words «tässä luettelossa mainittuja aineita sisältävät valmisteet.». The annex that carries this row stands as amended by 4.12.2025/1119, which is the amendment that last touched this row's annex rather than the decree as a whole. Section 5 subsection 1 of huumausainelaki 373/2008 is the prohibition that placement engages, «Huumausaineen tuotanto, valmistus, tuonti Suomen alueelle, vienti Suomen alueelta, kuljetus, kauttakuljetus, jakelu, kauppa, käsittely, hallussapito ja käyttö on kielletty.», and chapter 50 section 5 subsection 1 of the Criminal Code makes the word huumausaine in those offences mean a narcotic under huumausainelaki, so the annex entry above is what puts this row inside them. Criminal Code chapter 50 section 2 a is the small quantity limb and it opens «Joka laittomasti käyttää taikka omaa käyttöä varten pitää hallussaan tai yrittää hankkia vähäisen määrän huumausainetta, on tuomittava», so the käyttörikos reaches this row on its own terms. No quantity figure is printed anywhere in chapter 50: whether a quantity is a suuri määrä, and whether the substance is an erittäin vaarallinen huumausaine under chapter 50 section 5 subsection 2, are findings of fact and the annex position does not settle either of them. No fine figure is printed either, because a Finnish fine is a day fine set on the offender's income.
If prescribed / medical: Section 24 of huumausainelaki 373/2008 disapplies the import and export rules for a traveller's personal medication only where the substance is in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention. This row is in list I of the 1971 Convention, which that carve out does not reach. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. This row sits in list I of the 1971 Convention annex, which is the one list section 24 of huumausainelaki 373/2008 leaves out. The carve out covers lists I to III of the 1961 Convention and lists II to IV of the 1971 Convention, for the products «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä», and a list I entry of the 1971 Convention annex is outside it.
Documentation: Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The locator a traveller or an official would be checking is Liite II list I entry 19 of 543/2008, as that annex stands after 4.12.2025/1119, and the entry printed there reads «Metyleenidioksimetamfetamiini (MDMA) ((±)-N,α-dimetyyli-3,4-metyleenidioksifenetyyliamiini)». Because the row is outside the lists section 24 names, that section does not take a traveller's own medicine out of the Act's import and export provisions for this row, and nothing read here supplies a carriage allowance in its place. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, MDMA, a named entry of Liite II list I of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 at printed position 19, that annex as amended by 4.12.2025/1119 · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · Updated September 21, 2026

MDMA in Finland, full detail →

MDPV

Legal status: Controlled. MDPV is a narcotic in Finland by name. Section 1 of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 makes the substances, preparations and plants in annexes I to V narcotics, and this row's entry sits in Liite II, the annex headed as the substances and preparations in lists I to IV of the 1971 Convention on Psychotropic Substances, under list II, which the instrument itself heads as a schedule of the 1971 Convention on Psychotropic Substances, an attribution read off the annex heading and not checked against the INCB list in this pass. The entry reads «Metyleenidioksipyrovaleroni (MDPV) (1-(3,4-metyleenidioksifenyyli)-2-pyrrolidinyylipentan-1-oni)». Section 5 subsection 1 of huumausainelaki 373/2008 then forbids production, manufacture, import into Finland, export from Finland, transport, transit, distribution, trade, handling, possession and use, and allows departure from that ban only for medical, research, supervisory and industrial purposes as separately provided. The same list closes by extending itself, in the words «tämän luettelon aineiden suolat, mukaan luettuna edellä mainittujen isomeerien suolat, jos sellaisten olemassaolo on mahdollista; sekä». That annex stands as amended by 4.12.2025/1119.
Consequences if caught: Capital exposure: none. The ceiling anywhere in this regime is the ten year maximum that Criminal Code chapter 50 section 2 sets for an aggravated narcotics offence. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. This row sits in Liite II under list II of the decree, so those are the provisions its placement engages. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. They describe the offences that this row's placement brings into play. This row in particular. Its entry sits in Liite II, which the decree heads as the substances and preparations in the lists of the 1971 Convention on Psychotropic Substances, under list II of that annex, at printed position 51 of the 68 entries that list carries in the consolidated text read here, and the entry reads «Metyleenidioksipyrovaleroni (MDPV) (1-(3,4-metyleenidioksifenyyli)-2-pyrrolidinyylipentan-1-oni)». In the printed order of that list the entry above it is 3-Metoksifensyklidiini and below it comes Metyloni. The same list closes by extending itself beyond its named entries, in the words «tässä luettelossa mainittuja aineita sisältävät valmisteet.». The annex that carries this row stands as amended by 4.12.2025/1119, which is the amendment that last touched this row's annex rather than the decree as a whole. Section 5 subsection 1 of huumausainelaki 373/2008 is the prohibition that placement engages, «Huumausaineen tuotanto, valmistus, tuonti Suomen alueelle, vienti Suomen alueelta, kuljetus, kauttakuljetus, jakelu, kauppa, käsittely, hallussapito ja käyttö on kielletty.», and chapter 50 section 5 subsection 1 of the Criminal Code makes the word huumausaine in those offences mean a narcotic under huumausainelaki, so the annex entry above is what puts this row inside them. Criminal Code chapter 50 section 2 a is the small quantity limb and it opens «Joka laittomasti käyttää taikka omaa käyttöä varten pitää hallussaan tai yrittää hankkia vähäisen määrän huumausainetta, on tuomittava», so the käyttörikos reaches this row on its own terms. No quantity figure is printed anywhere in chapter 50: whether a quantity is a suuri määrä, and whether the substance is an erittäin vaarallinen huumausaine under chapter 50 section 5 subsection 2, are findings of fact and the annex position does not settle either of them. No fine figure is printed either, because a Finnish fine is a day fine set on the offender's income.
If prescribed / medical: Section 24 of huumausainelaki 373/2008 disapplies the import and export rules for a medicinal product a traveller carries for personal medication where the substance is in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, and this row is inside that carve out. Section 19 of lääkelaki 395/1987 then governs. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. This row sits in list II of the 1971 Convention annex, and section 24 of huumausainelaki 373/2008 reaches exactly that: it disapplies the import and export provisions of the Act for medicinal products containing a substance in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, the products being those «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä», and then hands the traveller to section 19 of lääkelaki 395/1987.
Documentation: Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The locator a traveller or an official would be checking is Liite II list II entry 51 of 543/2008, as that annex stands after 4.12.2025/1119, and the entry printed there reads «Metyleenidioksipyrovaleroni (MDPV) (1-(3,4-metyleenidioksifenyyli)-2-pyrrolidinyylipentan-1-oni)». Because the row is in that part of the convention annexes, section 24 of huumausainelaki 373/2008 takes a traveller's own prescribed medicine out of the Act's import and export provisions and leaves section 19 of lääkelaki 395/1987 to govern how much may be carried, which is the provision this cell did not read. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, MDPV, a named entry of Liite II list II of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 at printed position 51, that annex as amended by 4.12.2025/1119 · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · Updated September 21, 2026

MDPV in Finland, full detail →

Memantine

Legal status: Not a narcotic in Finland. Memantine is not named in any annex of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 and is not named in the annex to valtioneuvoston asetus 1130/2014, as those annexes stand after 651/2026, 1119/2025 and 650/2026. It is a medicine question instead. The Finnish Medicines Agency decision on the medicines list, 230/2025, names it in annex 1, where the Finnish column of the row reads «Memantiini». The row gives its Latin, Swedish and English columns as Memantinum, Memantin, Memantine. Section 2 subsection 1 of that decision supervises the annex 1 substances, their salts and their esters as medicines under section 3 subsection 1 or 2 of lääkelaki 395/1987. Section 1 of the decision states that the list is not exhaustive and that not every product containing a listed substance meets the medicine definition, so an individual product's status turns on its own classification.
Consequences if caught: Capital exposure: none. Criminal Code chapter 44 section 5 carries the medicines offence. It sets a fine or up to one year for manufacturing, importing, storing, keeping for sale or supplying medicines contrary to the Medicines Act or the European Union medicines regulations, unless a heavier penalty is provided elsewhere. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. This row is placed outside that regime, so they are recorded as Finland's published drug penalties and not as this substance's exposure. This row in particular. It is not named in either decree and that is a measured absence, not an assumption. The Finnish forms put to both texts for this row were «Memantiini», «Memantine». Against the consolidated 543/2008, whose annexes carry 196 entries in Liite I, 192 in Liite II, 11 in Liite III, 70 in Liite IV and 1 in Liite V, and against the annex to 1130/2014 as substituted by 650/2026, no form returned an entry of its own. No near miss came back either: not one entry in either annex contains any of those forms as a substring, so there is no longer name to be mistaken for this one. The bands stated above are the narcotics bands and they are reproduced because the live cell named chapter 50. They describe the lane this row would fall into if it were listed, and on the text read here it is not.
If prescribed / medical: This row's whole answer is the prescription route, and whether an authorised product exists in a given form is a product by product question that this cell does not settle. Sections 3 and 6 of lääkelaki 395/1987 are the provisions the live Finland cell named for this route and they are kept. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. The list that does name this row is the medicines list, Finnish Medicines Agency decision 230/2025. Its Liite 1 carries the row at printed line 2209 of the annex text Finlex serves, and the printed row reads «Memantiini Memantinum Memantin Memantine». In the printed order of that annex the line above it reads Melperoni Melperonum Melperon Melperone and the line below it reads Menadiolinatriumsulfaatti Menadioli natrii sulfas Menadiolnatriumsulfat Menadiol sodium sulfate.
Documentation: Section 24 of huumausainelaki 373/2008 is written for convention listed narcotics and does not describe this row, so the ordinary medicines rules are what apply. Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The search behind the absence stated for this row was run in Finnish and the forms were «Memantiini», «Memantine». Section 24 of huumausainelaki 373/2008, the provision that would otherwise carry a traveller's own medicine past the Act's import and export rules, reaches only products «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä» that contain a substance in one of the convention lists, and this row is in none of them. The list that does name this row is the medicines list, Finnish Medicines Agency decision 230/2025. Its Liite 1 carries the row at printed line 2209 of the annex text Finlex serves, and the printed row reads «Memantiini Memantinum Memantin Memantine». In the printed order of that annex the line above it reads Melperoni Melperonum Melperon Melperone and the line below it reads Menadiolinatriumsulfaatti Menadioli natrii sulfas Menadiolnatriumsulfat Menadiol sodium sulfate. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, memantine, not a named entry of 543/2008 and not a named entry of the annex to 1130/2014, an absence measured by running the Finnish forms recorded in the documentation field against both texts · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · Lääkealan turvallisuus- ja kehittämiskeskuksen päätös lääkeluettelosta 230/2025 and its annexes, under lääkelaki 395/1987 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · finlex.fi · finlex.fi · Updated September 21, 2026

Memantine in Finland, full detail →

Mephedrone (4-MMC)

Legal status: Controlled. Mephedrone is a narcotic in Finland by name. Section 1 of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 makes the substances, preparations and plants in annexes I to V narcotics, and this row's entry sits in Liite II, the annex headed as the substances and preparations in lists I to IV of the 1971 Convention on Psychotropic Substances, under list II, which the instrument itself heads as a schedule of the 1971 Convention on Psychotropic Substances, an attribution read off the annex heading and not checked against the INCB list in this pass. The entry reads «Mefedroni (4-MMC) (4-metyylimetkatinoni)». Section 5 subsection 1 of huumausainelaki 373/2008 then forbids production, manufacture, import into Finland, export from Finland, transport, transit, distribution, trade, handling, possession and use, and allows departure from that ban only for medical, research, supervisory and industrial purposes as separately provided. The same list closes by extending itself, in the words «tämän luettelon aineiden suolat, mukaan luettuna edellä mainittujen isomeerien suolat, jos sellaisten olemassaolo on mahdollista; sekä». That annex stands as amended by 4.12.2025/1119.
Consequences if caught: Capital exposure: none. The ceiling anywhere in this regime is the ten year maximum that Criminal Code chapter 50 section 2 sets for an aggravated narcotics offence. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. This row sits in Liite II under list II of the decree, so those are the provisions its placement engages. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. They describe the offences that this row's placement brings into play. This row in particular. Its entry sits in Liite II, which the decree heads as the substances and preparations in the lists of the 1971 Convention on Psychotropic Substances, under list II of that annex, at printed position 43 of the 68 entries that list carries in the consolidated text read here, and the entry reads «Mefedroni (4-MMC) (4-metyylimetkatinoni)». In the printed order of that list the entry above it is MDMB-4en-PINACA and below it comes Meklokvaloni. The same list closes by extending itself beyond its named entries, in the words «tässä luettelossa mainittuja aineita sisältävät valmisteet.». The annex that carries this row stands as amended by 4.12.2025/1119, which is the amendment that last touched this row's annex rather than the decree as a whole. Section 5 subsection 1 of huumausainelaki 373/2008 is the prohibition that placement engages, «Huumausaineen tuotanto, valmistus, tuonti Suomen alueelle, vienti Suomen alueelta, kuljetus, kauttakuljetus, jakelu, kauppa, käsittely, hallussapito ja käyttö on kielletty.», and chapter 50 section 5 subsection 1 of the Criminal Code makes the word huumausaine in those offences mean a narcotic under huumausainelaki, so the annex entry above is what puts this row inside them. Criminal Code chapter 50 section 2 a is the small quantity limb and it opens «Joka laittomasti käyttää taikka omaa käyttöä varten pitää hallussaan tai yrittää hankkia vähäisen määrän huumausainetta, on tuomittava», so the käyttörikos reaches this row on its own terms. No quantity figure is printed anywhere in chapter 50: whether a quantity is a suuri määrä, and whether the substance is an erittäin vaarallinen huumausaine under chapter 50 section 5 subsection 2, are findings of fact and the annex position does not settle either of them. No fine figure is printed either, because a Finnish fine is a day fine set on the offender's income.
If prescribed / medical: Section 24 of huumausainelaki 373/2008 disapplies the import and export rules for a medicinal product a traveller carries for personal medication where the substance is in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, and this row is inside that carve out. Section 19 of lääkelaki 395/1987 then governs. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. This row sits in list II of the 1971 Convention annex, and section 24 of huumausainelaki 373/2008 reaches exactly that: it disapplies the import and export provisions of the Act for medicinal products containing a substance in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, the products being those «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä», and then hands the traveller to section 19 of lääkelaki 395/1987.
Documentation: Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The locator a traveller or an official would be checking is Liite II list II entry 43 of 543/2008, as that annex stands after 4.12.2025/1119, and the entry printed there reads «Mefedroni (4-MMC) (4-metyylimetkatinoni)». Because the row is in that part of the convention annexes, section 24 of huumausainelaki 373/2008 takes a traveller's own prescribed medicine out of the Act's import and export provisions and leaves section 19 of lääkelaki 395/1987 to govern how much may be carried, which is the provision this cell did not read. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, mephedrone, a named entry of Liite II list II of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 at printed position 43, that annex as amended by 4.12.2025/1119 · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · Updated September 21, 2026

Mephedrone (4-MMC) in Finland, full detail →

Mescaline

Legal status: Controlled. Mescaline is a narcotic in Finland by name. Section 1 of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 makes the substances, preparations and plants in annexes I to V narcotics, and this row's entry sits in Liite II, the annex headed as the substances and preparations in lists I to IV of the 1971 Convention on Psychotropic Substances, under list I, which the instrument itself heads as a schedule of the 1971 Convention on Psychotropic Substances, an attribution read off the annex heading and not checked against the INCB list in this pass. The entry reads «Meskaliini (3,4,5-trimetoksifenetyyliamiini)». Section 5 subsection 1 of huumausainelaki 373/2008 then forbids production, manufacture, import into Finland, export from Finland, transport, transit, distribution, trade, handling, possession and use, and allows departure from that ban only for medical, research, supervisory and industrial purposes as separately provided. The same list closes by extending itself, in the words «tämän luettelon aineiden suolat, jos sellaisen suolan muodostaminen on mahdollista; sekä». That annex stands as amended by 4.12.2025/1119.
Consequences if caught: Capital exposure: none. The ceiling anywhere in this regime is the ten year maximum that Criminal Code chapter 50 section 2 sets for an aggravated narcotics offence. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. This row sits in Liite II under list I of the decree, so those are the provisions its placement engages. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. They describe the offences that this row's placement brings into play. This row in particular. Its entry sits in Liite II, which the decree heads as the substances and preparations in the lists of the 1971 Convention on Psychotropic Substances, under list I of that annex, at printed position 16 of the 41 entries that list carries in the consolidated text read here, and the entry reads «Meskaliini (3,4,5-trimetoksifenetyyliamiini)». In the printed order of that list the entry above it is MDE,N-etyyli MDA and below it comes Metkatinoni. The same list closes by extending itself beyond its named entries, in the words «tässä luettelossa mainittuja aineita sisältävät valmisteet.». The annex that carries this row stands as amended by 4.12.2025/1119, which is the amendment that last touched this row's annex rather than the decree as a whole. Section 5 subsection 1 of huumausainelaki 373/2008 is the prohibition that placement engages, «Huumausaineen tuotanto, valmistus, tuonti Suomen alueelle, vienti Suomen alueelta, kuljetus, kauttakuljetus, jakelu, kauppa, käsittely, hallussapito ja käyttö on kielletty.», and chapter 50 section 5 subsection 1 of the Criminal Code makes the word huumausaine in those offences mean a narcotic under huumausainelaki, so the annex entry above is what puts this row inside them. This row is reached by the purpose bound cultivation limb as well. Section 7 subsection 2 of huumausainelaki 373/2008 reads «Oopiumiunikon, hampun ja meskaliinia sisältävien kaktuskasvien viljely käytettäväksi huumausaineena taikka huumausaineen valmistuksessa tai tuotannossa on kielletty.», and Criminal Code chapter 50 section 1 carries the same limb as a paragraph of the offence, «viljelee tai yrittää viljellä oopiumiunikkoa, hamppua tai meskaliinia sisältäviä kaktuskasveja käytettäväksi huumausaineena tai sen raaka-aineena taikka käytettäväksi huumausaineen valmistuksessa tai tuotannossa,». Criminal Code chapter 50 section 2 a is the small quantity limb and it opens «Joka laittomasti käyttää taikka omaa käyttöä varten pitää hallussaan tai yrittää hankkia vähäisen määrän huumausainetta, on tuomittava», so the käyttörikos reaches this row on its own terms. No quantity figure is printed anywhere in chapter 50: whether a quantity is a suuri määrä, and whether the substance is an erittäin vaarallinen huumausaine under chapter 50 section 5 subsection 2, are findings of fact and the annex position does not settle either of them. No fine figure is printed either, because a Finnish fine is a day fine set on the offender's income.
If prescribed / medical: Section 24 of huumausainelaki 373/2008 disapplies the import and export rules for a traveller's personal medication only where the substance is in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention. This row is in list I of the 1971 Convention, which that carve out does not reach. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. This row sits in list I of the 1971 Convention annex, which is the one list section 24 of huumausainelaki 373/2008 leaves out. The carve out covers lists I to III of the 1961 Convention and lists II to IV of the 1971 Convention, for the products «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä», and a list I entry of the 1971 Convention annex is outside it.
Documentation: Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The locator a traveller or an official would be checking is Liite II list I entry 16 of 543/2008, as that annex stands after 4.12.2025/1119, and the entry printed there reads «Meskaliini (3,4,5-trimetoksifenetyyliamiini)». Because the row is outside the lists section 24 names, that section does not take a traveller's own medicine out of the Act's import and export provisions for this row, and nothing read here supplies a carriage allowance in its place. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, mescaline, a named entry of Liite II list I of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 at printed position 16, that annex as amended by 4.12.2025/1119 · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · Updated September 21, 2026

Mescaline in Finland, full detail →

Methadone

Legal status: Controlled. Methadone is a narcotic in Finland by name. Section 1 of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 makes the substances, preparations and plants in annexes I to V narcotics, and this row's entry sits in Liite I, the annex headed as the substances and preparations in lists I to IV of the 1961 Single Convention on Narcotic Drugs, under list I, which the instrument itself heads as a schedule of the 1961 Single Convention, an attribution read off the annex heading and not checked against the INCB list in this pass. The entry reads «Metadoni (6-dimetyyliamino-4,4-difenyyli-3-heptanoni)». Section 5 subsection 1 of huumausainelaki 373/2008 then forbids production, manufacture, import into Finland, export from Finland, transport, transit, distribution, trade, handling, possession and use, and allows departure from that ban only for medical, research, supervisory and industrial purposes as separately provided. The same list closes by extending itself, in the words «tämän luettelon aineiden suolat mukaan luettuna edellä mainittujen esterien, eetterien ja isomeerien suolat, jos sellaisten olemassaolo on mahdollista; sekä». That annex stands as amended by 25.6.2026/651.
Consequences if caught: Capital exposure: none. The ceiling anywhere in this regime is the ten year maximum that Criminal Code chapter 50 section 2 sets for an aggravated narcotics offence. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. This row sits in Liite I under list I of the decree, so those are the provisions its placement engages. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. They describe the offences that this row's placement brings into play. This row in particular. Its entry sits in Liite I, which the decree heads as the substances and preparations in the lists of the 1961 Single Convention on Narcotic Drugs, under list I of that annex, at printed position 79 of the 145 entries that list carries in the consolidated text read here, and the entry reads «Metadoni (6-dimetyyliamino-4,4-difenyyli-3-heptanoni)». In the printed order of that list the entry above it is Levorfanoli* and below it comes Metadoni-välituote. The same list closes by extending itself beyond its named entries, in the words «tässä luettelossa mainittuja aineita sisältävät valmisteet lukuun ottamatta luettelossa III mainittuja valmisteita.». The annex that carries this row stands as amended by 25.6.2026/651, which is the amendment that last touched this row's annex rather than the decree as a whole. Section 5 subsection 1 of huumausainelaki 373/2008 is the prohibition that placement engages, «Huumausaineen tuotanto, valmistus, tuonti Suomen alueelle, vienti Suomen alueelta, kuljetus, kauttakuljetus, jakelu, kauppa, käsittely, hallussapito ja käyttö on kielletty.», and chapter 50 section 5 subsection 1 of the Criminal Code makes the word huumausaine in those offences mean a narcotic under huumausainelaki, so the annex entry above is what puts this row inside them. Criminal Code chapter 50 section 2 a is the small quantity limb and it opens «Joka laittomasti käyttää taikka omaa käyttöä varten pitää hallussaan tai yrittää hankkia vähäisen määrän huumausainetta, on tuomittava», so the käyttörikos reaches this row on its own terms. No quantity figure is printed anywhere in chapter 50: whether a quantity is a suuri määrä, and whether the substance is an erittäin vaarallinen huumausaine under chapter 50 section 5 subsection 2, are findings of fact and the annex position does not settle either of them. No fine figure is printed either, because a Finnish fine is a day fine set on the offender's income.
If prescribed / medical: Section 24 of huumausainelaki 373/2008 disapplies the import and export rules for a medicinal product a traveller carries for personal medication where the substance is in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, and this row is inside that carve out. Section 19 of lääkelaki 395/1987 then governs. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. This row sits in list I of the 1961 Convention annex, and section 24 of huumausainelaki 373/2008 reaches exactly that: it disapplies the import and export provisions of the Act for medicinal products containing a substance in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, the products being those «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä», and then hands the traveller to section 19 of lääkelaki 395/1987.
Documentation: Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The locator a traveller or an official would be checking is Liite I list I entry 79 of 543/2008, as that annex stands after 25.6.2026/651, and the entry printed there reads «Metadoni (6-dimetyyliamino-4,4-difenyyli-3-heptanoni)». Because the row is in that part of the convention annexes, section 24 of huumausainelaki 373/2008 takes a traveller's own prescribed medicine out of the Act's import and export provisions and leaves section 19 of lääkelaki 395/1987 to govern how much may be carried, which is the provision this cell did not read. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, methadone, a named entry of Liite I list I of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 at printed position 79, that annex as amended by 25.6.2026/651 · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · Updated September 21, 2026

Methadone in Finland, full detail →

Methamphetamine

Legal status: Controlled. Methamphetamine is a narcotic in Finland by name. Section 1 of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 makes the substances, preparations and plants in annexes I to V narcotics, and this row's entry sits in Liite II, the annex headed as the substances and preparations in lists I to IV of the 1971 Convention on Psychotropic Substances, under list II, which the instrument itself heads as a schedule of the 1971 Convention on Psychotropic Substances, an attribution read off the annex heading and not checked against the INCB list in this pass. The entry reads «Metamfetamiini ((+)-(S)- N,α -dimetyylifenetyyliamiini)». The instrument italicises part of that entry and the spacing around the italicised locants is as Finlex serves it. Section 5 subsection 1 of huumausainelaki 373/2008 then forbids production, manufacture, import into Finland, export from Finland, transport, transit, distribution, trade, handling, possession and use, and allows departure from that ban only for medical, research, supervisory and industrial purposes as separately provided. The same list closes by extending itself, in the words «tämän luettelon aineiden suolat, mukaan luettuna edellä mainittujen isomeerien suolat, jos sellaisten olemassaolo on mahdollista; sekä». That annex stands as amended by 4.12.2025/1119. A second entry in the same list covers the racemate and reads «Metamfetamiinirasemaatti ((±)- N, α -dimetyylifenetyyliamiini)».
Consequences if caught: Capital exposure: none. The ceiling anywhere in this regime is the ten year maximum that Criminal Code chapter 50 section 2 sets for an aggravated narcotics offence. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. This row sits in Liite II under list II of the decree, so those are the provisions its placement engages. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. They describe the offences that this row's placement brings into play. This row in particular. Its entry sits in Liite II, which the decree heads as the substances and preparations in the lists of the 1971 Convention on Psychotropic Substances, under list II of that annex, at printed position 46 of the 68 entries that list carries in the consolidated text read here, and the entry reads «Metamfetamiini ((+)-(S)-N,α-dimetyylifenetyyliamiini)». In the printed order of that list the entry above it is Metakvaloni and below it comes Metamfetamiinirasemaatti. The same list closes by extending itself beyond its named entries, in the words «tässä luettelossa mainittuja aineita sisältävät valmisteet.». The annex that carries this row stands as amended by 4.12.2025/1119, which is the amendment that last touched this row's annex rather than the decree as a whole. Section 5 subsection 1 of huumausainelaki 373/2008 is the prohibition that placement engages, «Huumausaineen tuotanto, valmistus, tuonti Suomen alueelle, vienti Suomen alueelta, kuljetus, kauttakuljetus, jakelu, kauppa, käsittely, hallussapito ja käyttö on kielletty.», and chapter 50 section 5 subsection 1 of the Criminal Code makes the word huumausaine in those offences mean a narcotic under huumausainelaki, so the annex entry above is what puts this row inside them. Criminal Code chapter 50 section 2 a is the small quantity limb and it opens «Joka laittomasti käyttää taikka omaa käyttöä varten pitää hallussaan tai yrittää hankkia vähäisen määrän huumausainetta, on tuomittava», so the käyttörikos reaches this row on its own terms. No quantity figure is printed anywhere in chapter 50: whether a quantity is a suuri määrä, and whether the substance is an erittäin vaarallinen huumausaine under chapter 50 section 5 subsection 2, are findings of fact and the annex position does not settle either of them. No fine figure is printed either, because a Finnish fine is a day fine set on the offender's income.
If prescribed / medical: Section 24 of huumausainelaki 373/2008 disapplies the import and export rules for a medicinal product a traveller carries for personal medication where the substance is in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, and this row is inside that carve out. Section 19 of lääkelaki 395/1987 then governs. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. This row sits in list II of the 1971 Convention annex, and section 24 of huumausainelaki 373/2008 reaches exactly that: it disapplies the import and export provisions of the Act for medicinal products containing a substance in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, the products being those «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä», and then hands the traveller to section 19 of lääkelaki 395/1987.
Documentation: Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The locator a traveller or an official would be checking is Liite II list II entry 46 of 543/2008, as that annex stands after 4.12.2025/1119, and the entry printed there reads «Metamfetamiini ((+)-(S)-N,α-dimetyylifenetyyliamiini)». Because the row is in that part of the convention annexes, section 24 of huumausainelaki 373/2008 takes a traveller's own prescribed medicine out of the Act's import and export provisions and leaves section 19 of lääkelaki 395/1987 to govern how much may be carried, which is the provision this cell did not read. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, methamphetamine, a named entry of Liite II list II of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 at printed position 46, that annex as amended by 4.12.2025/1119 · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · Updated September 21, 2026

Methamphetamine in Finland, full detail →

Methaqualone (Quaaludes)

Legal status: Controlled. Methaqualone is a narcotic in Finland by name. Section 1 of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 makes the substances, preparations and plants in annexes I to V narcotics, and this row's entry sits in Liite II, the annex headed as the substances and preparations in lists I to IV of the 1971 Convention on Psychotropic Substances, under list II, which the instrument itself heads as a schedule of the 1971 Convention on Psychotropic Substances, an attribution read off the annex heading and not checked against the INCB list in this pass. The entry reads «Metakvaloni (2-metyyli-3- o -tolyyli-4(3 H)-kinatsolinoni)». The instrument italicises part of that entry and the spacing around the italicised locants is as Finlex serves it. Section 5 subsection 1 of huumausainelaki 373/2008 then forbids production, manufacture, import into Finland, export from Finland, transport, transit, distribution, trade, handling, possession and use, and allows departure from that ban only for medical, research, supervisory and industrial purposes as separately provided. The same list closes by extending itself, in the words «tämän luettelon aineiden suolat, mukaan luettuna edellä mainittujen isomeerien suolat, jos sellaisten olemassaolo on mahdollista; sekä». That annex stands as amended by 4.12.2025/1119.
Consequences if caught: Capital exposure: none. The ceiling anywhere in this regime is the ten year maximum that Criminal Code chapter 50 section 2 sets for an aggravated narcotics offence. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. This row sits in Liite II under list II of the decree, so those are the provisions its placement engages. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. They describe the offences that this row's placement brings into play. This row in particular. Its entry sits in Liite II, which the decree heads as the substances and preparations in the lists of the 1971 Convention on Psychotropic Substances, under list II of that annex, at printed position 45 of the 68 entries that list carries in the consolidated text read here, and the entry reads «Metakvaloni (2-metyyli-3-o-tolyyli-4(3H)-kinatsolinoni)». In the printed order of that list the entry above it is Meklokvaloni and below it comes Metamfetamiini. The same list closes by extending itself beyond its named entries, in the words «tässä luettelossa mainittuja aineita sisältävät valmisteet.». The annex that carries this row stands as amended by 4.12.2025/1119, which is the amendment that last touched this row's annex rather than the decree as a whole. Section 5 subsection 1 of huumausainelaki 373/2008 is the prohibition that placement engages, «Huumausaineen tuotanto, valmistus, tuonti Suomen alueelle, vienti Suomen alueelta, kuljetus, kauttakuljetus, jakelu, kauppa, käsittely, hallussapito ja käyttö on kielletty.», and chapter 50 section 5 subsection 1 of the Criminal Code makes the word huumausaine in those offences mean a narcotic under huumausainelaki, so the annex entry above is what puts this row inside them. Criminal Code chapter 50 section 2 a is the small quantity limb and it opens «Joka laittomasti käyttää taikka omaa käyttöä varten pitää hallussaan tai yrittää hankkia vähäisen määrän huumausainetta, on tuomittava», so the käyttörikos reaches this row on its own terms. No quantity figure is printed anywhere in chapter 50: whether a quantity is a suuri määrä, and whether the substance is an erittäin vaarallinen huumausaine under chapter 50 section 5 subsection 2, are findings of fact and the annex position does not settle either of them. No fine figure is printed either, because a Finnish fine is a day fine set on the offender's income.
If prescribed / medical: Section 24 of huumausainelaki 373/2008 disapplies the import and export rules for a medicinal product a traveller carries for personal medication where the substance is in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, and this row is inside that carve out. Section 19 of lääkelaki 395/1987 then governs. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. This row sits in list II of the 1971 Convention annex, and section 24 of huumausainelaki 373/2008 reaches exactly that: it disapplies the import and export provisions of the Act for medicinal products containing a substance in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, the products being those «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä», and then hands the traveller to section 19 of lääkelaki 395/1987.
Documentation: Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The locator a traveller or an official would be checking is Liite II list II entry 45 of 543/2008, as that annex stands after 4.12.2025/1119, and the entry printed there reads «Metakvaloni (2-metyyli-3-o-tolyyli-4(3H)-kinatsolinoni)». Because the row is in that part of the convention annexes, section 24 of huumausainelaki 373/2008 takes a traveller's own prescribed medicine out of the Act's import and export provisions and leaves section 19 of lääkelaki 395/1987 to govern how much may be carried, which is the provision this cell did not read. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, methaqualone, a named entry of Liite II list II of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 at printed position 45, that annex as amended by 4.12.2025/1119 · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · Updated September 21, 2026

Methaqualone (Quaaludes) in Finland, full detail →

Methylone

Legal status: Controlled. Methylone is a narcotic in Finland by name. Section 1 of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 makes the substances, preparations and plants in annexes I to V narcotics, and this row's entry sits in Liite II, the annex headed as the substances and preparations in lists I to IV of the 1971 Convention on Psychotropic Substances, under list II, which the instrument itself heads as a schedule of the 1971 Convention on Psychotropic Substances, an attribution read off the annex heading and not checked against the INCB list in this pass. The entry reads «Metyloni (bk -MDMA) (3,4-metyleenidioksimetkatinoni)». The instrument italicises part of that entry and the spacing around the italicised locants is as Finlex serves it. Section 5 subsection 1 of huumausainelaki 373/2008 then forbids production, manufacture, import into Finland, export from Finland, transport, transit, distribution, trade, handling, possession and use, and allows departure from that ban only for medical, research, supervisory and industrial purposes as separately provided. The same list closes by extending itself, in the words «tämän luettelon aineiden suolat, mukaan luettuna edellä mainittujen isomeerien suolat, jos sellaisten olemassaolo on mahdollista; sekä». That annex stands as amended by 4.12.2025/1119. The live Finland cell quoted the same entry without the italic spacing, as «Metyloni (bk-MDMA)».
Consequences if caught: Capital exposure: none. The ceiling anywhere in this regime is the ten year maximum that Criminal Code chapter 50 section 2 sets for an aggravated narcotics offence. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. This row sits in Liite II under list II of the decree, so those are the provisions its placement engages. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. They describe the offences that this row's placement brings into play. This row in particular. Its entry sits in Liite II, which the decree heads as the substances and preparations in the lists of the 1971 Convention on Psychotropic Substances, under list II of that annex, at printed position 52 of the 68 entries that list carries in the consolidated text read here, and the entry reads «Metyloni (bk-MDMA) (3,4-metyleenidioksimetkatinoni)». In the printed order of that list the entry above it is Metyleenidioksipyrovaleroni and below it comes 4-Metyylietkatinoni. The same list closes by extending itself beyond its named entries, in the words «tässä luettelossa mainittuja aineita sisältävät valmisteet.». The annex that carries this row stands as amended by 4.12.2025/1119, which is the amendment that last touched this row's annex rather than the decree as a whole. Section 5 subsection 1 of huumausainelaki 373/2008 is the prohibition that placement engages, «Huumausaineen tuotanto, valmistus, tuonti Suomen alueelle, vienti Suomen alueelta, kuljetus, kauttakuljetus, jakelu, kauppa, käsittely, hallussapito ja käyttö on kielletty.», and chapter 50 section 5 subsection 1 of the Criminal Code makes the word huumausaine in those offences mean a narcotic under huumausainelaki, so the annex entry above is what puts this row inside them. Criminal Code chapter 50 section 2 a is the small quantity limb and it opens «Joka laittomasti käyttää taikka omaa käyttöä varten pitää hallussaan tai yrittää hankkia vähäisen määrän huumausainetta, on tuomittava», so the käyttörikos reaches this row on its own terms. No quantity figure is printed anywhere in chapter 50: whether a quantity is a suuri määrä, and whether the substance is an erittäin vaarallinen huumausaine under chapter 50 section 5 subsection 2, are findings of fact and the annex position does not settle either of them. No fine figure is printed either, because a Finnish fine is a day fine set on the offender's income.
If prescribed / medical: Section 24 of huumausainelaki 373/2008 disapplies the import and export rules for a medicinal product a traveller carries for personal medication where the substance is in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, and this row is inside that carve out. Section 19 of lääkelaki 395/1987 then governs. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. This row sits in list II of the 1971 Convention annex, and section 24 of huumausainelaki 373/2008 reaches exactly that: it disapplies the import and export provisions of the Act for medicinal products containing a substance in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, the products being those «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä», and then hands the traveller to section 19 of lääkelaki 395/1987.
Documentation: Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The locator a traveller or an official would be checking is Liite II list II entry 52 of 543/2008, as that annex stands after 4.12.2025/1119, and the entry printed there reads «Metyloni (bk-MDMA) (3,4-metyleenidioksimetkatinoni)». Because the row is in that part of the convention annexes, section 24 of huumausainelaki 373/2008 takes a traveller's own prescribed medicine out of the Act's import and export provisions and leaves section 19 of lääkelaki 395/1987 to govern how much may be carried, which is the provision this cell did not read. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, methylone, a named entry of Liite II list II of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 at printed position 52, that annex as amended by 4.12.2025/1119 · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · Updated September 21, 2026

Methylone in Finland, full detail →

Methylphenidate

Legal status: Controlled. Methylphenidate is a narcotic in Finland by name. Section 1 of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 makes the substances, preparations and plants in annexes I to V narcotics, and this row's entry sits in Liite II, the annex headed as the substances and preparations in lists I to IV of the 1971 Convention on Psychotropic Substances, under list II, which the instrument itself heads as a schedule of the 1971 Convention on Psychotropic Substances, an attribution read off the annex heading and not checked against the INCB list in this pass. The entry reads «Metyylifenidaatti (metyyli-α-fenyyli-2-piperidiiniasetaatti)». Section 5 subsection 1 of huumausainelaki 373/2008 then forbids production, manufacture, import into Finland, export from Finland, transport, transit, distribution, trade, handling, possession and use, and allows departure from that ban only for medical, research, supervisory and industrial purposes as separately provided. The same list closes by extending itself, in the words «tämän luettelon aineiden suolat, mukaan luettuna edellä mainittujen isomeerien suolat, jos sellaisten olemassaolo on mahdollista; sekä». That annex stands as amended by 4.12.2025/1119.
Consequences if caught: Capital exposure: none. The ceiling anywhere in this regime is the ten year maximum that Criminal Code chapter 50 section 2 sets for an aggravated narcotics offence. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. This row sits in Liite II under list II of the decree, so those are the provisions its placement engages. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. They describe the offences that this row's placement brings into play. This row in particular. Its entry sits in Liite II, which the decree heads as the substances and preparations in the lists of the 1971 Convention on Psychotropic Substances, under list II of that annex, at printed position 55 of the 68 entries that list carries in the consolidated text read here, and the entry reads «Metyylifenidaatti (metyyli-α-fenyyli-2-piperidiiniasetaatti)». In the printed order of that list the entry above it is 3-Metyylimetkatinoni and below it comes N-bentsyylipiperatsiini. The same list closes by extending itself beyond its named entries, in the words «tässä luettelossa mainittuja aineita sisältävät valmisteet.». The annex that carries this row stands as amended by 4.12.2025/1119, which is the amendment that last touched this row's annex rather than the decree as a whole. Section 5 subsection 1 of huumausainelaki 373/2008 is the prohibition that placement engages, «Huumausaineen tuotanto, valmistus, tuonti Suomen alueelle, vienti Suomen alueelta, kuljetus, kauttakuljetus, jakelu, kauppa, käsittely, hallussapito ja käyttö on kielletty.», and chapter 50 section 5 subsection 1 of the Criminal Code makes the word huumausaine in those offences mean a narcotic under huumausainelaki, so the annex entry above is what puts this row inside them. Criminal Code chapter 50 section 2 a is the small quantity limb and it opens «Joka laittomasti käyttää taikka omaa käyttöä varten pitää hallussaan tai yrittää hankkia vähäisen määrän huumausainetta, on tuomittava», so the käyttörikos reaches this row on its own terms. No quantity figure is printed anywhere in chapter 50: whether a quantity is a suuri määrä, and whether the substance is an erittäin vaarallinen huumausaine under chapter 50 section 5 subsection 2, are findings of fact and the annex position does not settle either of them. No fine figure is printed either, because a Finnish fine is a day fine set on the offender's income.
If prescribed / medical: Section 24 of huumausainelaki 373/2008 disapplies the import and export rules for a medicinal product a traveller carries for personal medication where the substance is in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, and this row is inside that carve out. Section 19 of lääkelaki 395/1987 then governs. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. This row sits in list II of the 1971 Convention annex, and section 24 of huumausainelaki 373/2008 reaches exactly that: it disapplies the import and export provisions of the Act for medicinal products containing a substance in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, the products being those «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä», and then hands the traveller to section 19 of lääkelaki 395/1987.
Documentation: Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The locator a traveller or an official would be checking is Liite II list II entry 55 of 543/2008, as that annex stands after 4.12.2025/1119, and the entry printed there reads «Metyylifenidaatti (metyyli-α-fenyyli-2-piperidiiniasetaatti)». Because the row is in that part of the convention annexes, section 24 of huumausainelaki 373/2008 takes a traveller's own prescribed medicine out of the Act's import and export provisions and leaves section 19 of lääkelaki 395/1987 to govern how much may be carried, which is the provision this cell did not read. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, methylphenidate, a named entry of Liite II list II of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 at printed position 55, that annex as amended by 4.12.2025/1119 · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · Updated September 21, 2026

Methylphenidate in Finland, full detail →

Mitragynine

Legal status: Controlled, though not as a narcotic. Section 1 of valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014 makes the substances in its annex psychoactive substances banned from the consumer market, and Mitragynine is named there. The entry reads «Mitragyniini (metyyli (E)-2-[(2S,3S,12bS)-3-etyyli-8-metoksi-1,2,3,4,6,7,12,12b-oktahydroindolo[2,3-a]kvinolitsin-2-yyli]-3-metoksiprop-2-enoaatti)». That annex stands as substituted by 650/2026. Section 5 subsection 2 of huumausainelaki 373/2008 bans manufacture, import into Finland, storage, keeping for sale and transfer, and leaves research and industrial use to be permitted separately, so possession for one's own use and use itself are not among the banned acts. Section 3 subsection 3 of the same Act defines the category as substances used for intoxication that may be dangerous to health, notified for control, and that are neither medicines nor narcotics. It is not named in any annex of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, as those annexes stand after 651/2026, 1119/2025 and 650/2026.
Consequences if caught: Capital exposure: none. Criminal Code chapter 44 section 5 a carries the separate consumer market offence. It sets a fine or up to one year for manufacturing, importing, storing, keeping for sale or transferring a psychoactive substance banned from the consumer market, contrary to the Narcotics Act. Possession for one's own use and use itself are not among the acts it names. Section 33 a of huumausainelaki 373/2008 adds import and storage duties, and section 23 b allows a university, a research institute or a trader to import and store on prior notice to the Finnish Medicines Agency. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. This row is placed outside that regime, so they are recorded as Finland's published drug penalties and not as this substance's exposure. This row in particular. Its entry sits in the annex to valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, as that annex was substituted by 650/2026, at printed line 891 of the Finnish annex text Finlex serves, and it reads «Mitragyniini». In the printed order of that annex the line above it reads 5-Metyylitiopropamiini and the line below it reads oktahydroindolo[2,3-a]kvinolitsin-2-yyli]-3-metoksiprop-2-enoaatti). Section 1 of that decree is one sentence and it does all of the work: «Kuluttajamarkkinoilta kiellettyjä psykoaktiivisia aineita ovat liitteessä mainitut aineet.». The penalty limb that placement engages is not chapter 50. It is Criminal Code chapter 44 section 5 a, which opens «Joka huumausainelain vastaisesti tahallaan tai törkeästä huolimattomuudesta valmistaa, tuo maahan, varastoi, pitää myynnissä tai luovuttaa kuluttajamarkkinoilta kiellettyä psykoaktiivista ainetta, on tuomittava» and sets a fine or up to one year, and only where no heavier penalty is provided elsewhere. Section 5 subsection 2 of huumausainelaki 373/2008 states the prohibition this row breaches, «Kuluttajamarkkinoilta kielletyn psykoaktiivisen aineen valmistus, tuonti Suomen alueelle, varastointi, myynnissä pitäminen ja luovuttaminen on kielletty.», and that list of acts does not include possession or use, so the huumausaineen käyttörikos in chapter 50 section 2 a does not reach this row. No quantity threshold and no fine figure is printed for this row in either the decree or chapter 44 section 5 a.
If prescribed / medical: A substance banned from the consumer market is by definition not a medicine, which is what section 3 subsection 3 of huumausainelaki 373/2008 says, so no prescription route follows from this listing. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. Section 24 of huumausainelaki 373/2008 writes its traveller carve out by reference to the convention lists and this row is in neither decree's convention annexes at all, so the carve out has nothing to attach to. The route in for this category is section 23 b instead, which reads «Elinkeinonharjoittaja saa tuoda maahan ja varastoida kuluttajamarkkinoilta kiellettyjä psykoaktiivisia aineita perustellusta syystä teollista toimintaansa varten, jos aineesta ja toiminnasta on tehty ennen maahantuontia ilmoitus Lääkealan turvallisuus- ja kehittämiskeskukselle.», and that is a research and industry route, not a prescription route.
Documentation: The traveller carve out in section 24 of huumausainelaki 373/2008 is written for medicinal products containing convention listed narcotics and does not describe this row. Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. What a traveller is carrying, if this row is in the bag, is a substance banned from the consumer market by name at printed line 891 of the annex to 1130/2014, reading «Mitragyniini», and import into Finland is one of the acts section 5 subsection 2 of huumausainelaki 373/2008 forbids. There is no traveller allowance to state for this row because the Act provides none for this category: the only import routes are the university and the industry notifications in section 23 b. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, mitragynine, a named entry of the annex to valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014 at printed line 891 of the Finnish annex text, that annex as substituted by 650/2026 · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · Updated September 21, 2026

Mitragynine in Finland, full detail →

Modafinil

Legal status: Not a narcotic in Finland. Modafinil is not named in any annex of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 and is not named in the annex to valtioneuvoston asetus 1130/2014, as those annexes stand after 651/2026, 1119/2025 and 650/2026. It is a medicine question instead. The Finnish Medicines Agency decision on the medicines list, 230/2025, names it in annex 1, where the Finnish column of the row reads «Modafiniili». The row gives its Latin, Swedish and English columns as Modafinilum, Modafinil, Modafinil. Section 2 subsection 1 of that decision supervises the annex 1 substances, their salts and their esters as medicines under section 3 subsection 1 or 2 of lääkelaki 395/1987. Section 1 of the decision states that the list is not exhaustive and that not every product containing a listed substance meets the medicine definition, so an individual product's status turns on its own classification.
Consequences if caught: Capital exposure: none. Criminal Code chapter 44 section 5 carries the medicines offence. It sets a fine or up to one year for manufacturing, importing, storing, keeping for sale or supplying medicines contrary to the Medicines Act or the European Union medicines regulations, unless a heavier penalty is provided elsewhere. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. This row is placed outside that regime, so they are recorded as Finland's published drug penalties and not as this substance's exposure. This row in particular. It is not named in either decree and that is a measured absence, not an assumption. The Finnish forms put to both texts for this row were «Modafiniili», «Modafinil». Against the consolidated 543/2008, whose annexes carry 196 entries in Liite I, 192 in Liite II, 11 in Liite III, 70 in Liite IV and 1 in Liite V, and against the annex to 1130/2014 as substituted by 650/2026, no form returned an entry of its own. No near miss came back either: not one entry in either annex contains any of those forms as a substring, so there is no longer name to be mistaken for this one. The bands stated above are the narcotics bands and they are reproduced because the live cell named chapter 50. They describe the lane this row would fall into if it were listed, and on the text read here it is not.
If prescribed / medical: This row's whole answer is the prescription route, and whether an authorised product exists in a given form is a product by product question that this cell does not settle. Sections 3 and 6 of lääkelaki 395/1987 are the provisions the live Finland cell named for this route and they are kept. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. The list that does name this row is the medicines list, Finnish Medicines Agency decision 230/2025. Its Liite 1 carries the row at printed line 2386 of the annex text Finlex serves, and the printed row reads «Modafiniili Modafinilum Modafinil Modafinil». In the printed order of that annex the line above it reads Mivakuriumkloridi Mivacurii chloridum Mivakuriumklorid Mivacurium chloride and the line below it reads Moeksipriili Moexiprilum Moexipril Moexipril.
Documentation: Section 24 of huumausainelaki 373/2008 is written for convention listed narcotics and does not describe this row, so the ordinary medicines rules are what apply. Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The search behind the absence stated for this row was run in Finnish and the forms were «Modafiniili», «Modafinil». Section 24 of huumausainelaki 373/2008, the provision that would otherwise carry a traveller's own medicine past the Act's import and export rules, reaches only products «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä» that contain a substance in one of the convention lists, and this row is in none of them. The list that does name this row is the medicines list, Finnish Medicines Agency decision 230/2025. Its Liite 1 carries the row at printed line 2386 of the annex text Finlex serves, and the printed row reads «Modafiniili Modafinilum Modafinil Modafinil». In the printed order of that annex the line above it reads Mivakuriumkloridi Mivacurii chloridum Mivakuriumklorid Mivacurium chloride and the line below it reads Moeksipriili Moexiprilum Moexipril Moexipril. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, modafinil, not a named entry of 543/2008 and not a named entry of the annex to 1130/2014, an absence measured by running the Finnish forms recorded in the documentation field against both texts · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · Lääkealan turvallisuus- ja kehittämiskeskuksen päätös lääkeluettelosta 230/2025 and its annexes, under lääkelaki 395/1987 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · finlex.fi · finlex.fi · Updated September 21, 2026

Modafinil in Finland, full detail →

Morphine

Legal status: Controlled. Morphine is a narcotic in Finland by name. Section 1 of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 makes the substances, preparations and plants in annexes I to V narcotics, and this row's entry sits in Liite I, the annex headed as the substances and preparations in lists I to IV of the 1961 Single Convention on Narcotic Drugs, under list I, which the instrument itself heads as a schedule of the 1961 Single Convention, an attribution read off the annex heading and not checked against the INCB list in this pass. The entry reads «Morfiini». Section 5 subsection 1 of huumausainelaki 373/2008 then forbids production, manufacture, import into Finland, export from Finland, transport, transit, distribution, trade, handling, possession and use, and allows departure from that ban only for medical, research, supervisory and industrial purposes as separately provided. The same list closes by extending itself, in the words «tämän luettelon aineiden suolat mukaan luettuna edellä mainittujen esterien, eetterien ja isomeerien suolat, jos sellaisten olemassaolo on mahdollista; sekä». That annex stands as amended by 25.6.2026/651.
Consequences if caught: Capital exposure: none. The ceiling anywhere in this regime is the ten year maximum that Criminal Code chapter 50 section 2 sets for an aggravated narcotics offence. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. A quantity threshold applies to preparations. Item 2 of list III of the 1961 Convention annex takes out cocaine preparations of no more than 0.1 per cent cocaine calculated as base, and opium or morphine preparations of no more than 0.2 per cent morphine calculated as anhydrous base, where they are compounded so the narcotic cannot readily be recovered. No fine figure is stated anywhere in chapter 50, which sets the day fine by the general rules of chapter 2 a rather than by a sum. This row sits in Liite I under list I of the decree, so those are the provisions its placement engages. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. They describe the offences that this row's placement brings into play. This row in particular. Its entry sits in Liite I, which the decree heads as the substances and preparations in the lists of the 1961 Single Convention on Narcotic Drugs, under list I of that annex, at printed position 93 of the 145 entries that list carries in the consolidated text read here, and the entry reads «Morfiini». In the printed order of that list the entry above it is Morferidiini and below it comes Morfiinimetyylibromidi ja muut viidenarvoista typpeä sisältävät morfiinijohdokset mukaan lukien erityisesti morfiini-N-oksidijohdokset, joista yksi on kodeiini-N-oksidi. The same list closes by extending itself beyond its named entries, in the words «tässä luettelossa mainittuja aineita sisältävät valmisteet lukuun ottamatta luettelossa III mainittuja valmisteita.». The annex that carries this row stands as amended by 25.6.2026/651, which is the amendment that last touched this row's annex rather than the decree as a whole. Section 5 subsection 1 of huumausainelaki 373/2008 is the prohibition that placement engages, «Huumausaineen tuotanto, valmistus, tuonti Suomen alueelle, vienti Suomen alueelta, kuljetus, kauttakuljetus, jakelu, kauppa, käsittely, hallussapito ja käyttö on kielletty.», and chapter 50 section 5 subsection 1 of the Criminal Code makes the word huumausaine in those offences mean a narcotic under huumausainelaki, so the annex entry above is what puts this row inside them. Criminal Code chapter 50 section 2 a is the small quantity limb and it opens «Joka laittomasti käyttää taikka omaa käyttöä varten pitää hallussaan tai yrittää hankkia vähäisen määrän huumausainetta, on tuomittava», so the käyttörikos reaches this row on its own terms. No quantity figure is printed anywhere in chapter 50: whether a quantity is a suuri määrä, and whether the substance is an erittäin vaarallinen huumausaine under chapter 50 section 5 subsection 2, are findings of fact and the annex position does not settle either of them. No fine figure is printed either, because a Finnish fine is a day fine set on the offender's income.
If prescribed / medical: Section 24 of huumausainelaki 373/2008 disapplies the import and export rules for a medicinal product a traveller carries for personal medication where the substance is in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, and this row is inside that carve out. Section 19 of lääkelaki 395/1987 then governs. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. This row sits in list I of the 1961 Convention annex, and section 24 of huumausainelaki 373/2008 reaches exactly that: it disapplies the import and export provisions of the Act for medicinal products containing a substance in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, the products being those «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä», and then hands the traveller to section 19 of lääkelaki 395/1987.
Documentation: Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The locator a traveller or an official would be checking is Liite I list I entry 93 of 543/2008, as that annex stands after 25.6.2026/651, and the entry printed there reads «Morfiini». Because the row is in that part of the convention annexes, section 24 of huumausainelaki 373/2008 takes a traveller's own prescribed medicine out of the Act's import and export provisions and leaves section 19 of lääkelaki 395/1987 to govern how much may be carried, which is the provision this cell did not read. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, morphine, a named entry of Liite I list I of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 at printed position 93, that annex as amended by 25.6.2026/651 · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · Updated September 21, 2026

Morphine in Finland, full detail →

MXE

Legal status: Controlled. MXE is a narcotic in Finland by name. Section 1 of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 makes the substances, preparations and plants in annexes I to V narcotics, and this row's entry sits in Liite II, the annex headed as the substances and preparations in lists I to IV of the 1971 Convention on Psychotropic Substances, under list II, which the instrument itself heads as a schedule of the 1971 Convention on Psychotropic Substances, an attribution read off the annex heading and not checked against the INCB list in this pass. The entry reads «Metoksetamiini (MXE) 2-(etyyliamino)-2-(3-metoksifenyyli)sykloheksanoni)». Section 5 subsection 1 of huumausainelaki 373/2008 then forbids production, manufacture, import into Finland, export from Finland, transport, transit, distribution, trade, handling, possession and use, and allows departure from that ban only for medical, research, supervisory and industrial purposes as separately provided. The same list closes by extending itself, in the words «tämän luettelon aineiden suolat, mukaan luettuna edellä mainittujen isomeerien suolat, jos sellaisten olemassaolo on mahdollista; sekä». That annex stands as amended by 4.12.2025/1119.
Consequences if caught: Capital exposure: none. The ceiling anywhere in this regime is the ten year maximum that Criminal Code chapter 50 section 2 sets for an aggravated narcotics offence. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. This row sits in Liite II under list II of the decree, so those are the provisions its placement engages. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. They describe the offences that this row's placement brings into play. This row in particular. Its entry sits in Liite II, which the decree heads as the substances and preparations in the lists of the 1971 Convention on Psychotropic Substances, under list II of that annex, at printed position 49 of the 68 entries that list carries in the consolidated text read here, and the entry reads «Metoksetamiini (MXE) 2-(etyyliamino)-2-(3-metoksifenyyli)sykloheksanoni)». In the printed order of that list the entry above it is Metiopropamiini and below it comes 3-Metoksifensyklidiini. The same list closes by extending itself beyond its named entries, in the words «tässä luettelossa mainittuja aineita sisältävät valmisteet.». The annex that carries this row stands as amended by 4.12.2025/1119, which is the amendment that last touched this row's annex rather than the decree as a whole. Section 5 subsection 1 of huumausainelaki 373/2008 is the prohibition that placement engages, «Huumausaineen tuotanto, valmistus, tuonti Suomen alueelle, vienti Suomen alueelta, kuljetus, kauttakuljetus, jakelu, kauppa, käsittely, hallussapito ja käyttö on kielletty.», and chapter 50 section 5 subsection 1 of the Criminal Code makes the word huumausaine in those offences mean a narcotic under huumausainelaki, so the annex entry above is what puts this row inside them. Criminal Code chapter 50 section 2 a is the small quantity limb and it opens «Joka laittomasti käyttää taikka omaa käyttöä varten pitää hallussaan tai yrittää hankkia vähäisen määrän huumausainetta, on tuomittava», so the käyttörikos reaches this row on its own terms. No quantity figure is printed anywhere in chapter 50: whether a quantity is a suuri määrä, and whether the substance is an erittäin vaarallinen huumausaine under chapter 50 section 5 subsection 2, are findings of fact and the annex position does not settle either of them. No fine figure is printed either, because a Finnish fine is a day fine set on the offender's income.
If prescribed / medical: Section 24 of huumausainelaki 373/2008 disapplies the import and export rules for a medicinal product a traveller carries for personal medication where the substance is in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, and this row is inside that carve out. Section 19 of lääkelaki 395/1987 then governs. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. This row sits in list II of the 1971 Convention annex, and section 24 of huumausainelaki 373/2008 reaches exactly that: it disapplies the import and export provisions of the Act for medicinal products containing a substance in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, the products being those «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä», and then hands the traveller to section 19 of lääkelaki 395/1987.
Documentation: Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The locator a traveller or an official would be checking is Liite II list II entry 49 of 543/2008, as that annex stands after 4.12.2025/1119, and the entry printed there reads «Metoksetamiini (MXE) 2-(etyyliamino)-2-(3-metoksifenyyli)sykloheksanoni)». Because the row is in that part of the convention annexes, section 24 of huumausainelaki 373/2008 takes a traveller's own prescribed medicine out of the Act's import and export provisions and leaves section 19 of lääkelaki 395/1987 to govern how much may be carried, which is the provision this cell did not read. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, MXE, a named entry of Liite II list II of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 at printed position 49, that annex as amended by 4.12.2025/1119 · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · Updated September 21, 2026

MXE in Finland, full detail →

Nicotine

Legal status: Not a narcotic in Finland. Nicotine is not named in any annex of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 and is not named in the annex to valtioneuvoston asetus 1130/2014, as those annexes stand after 651/2026, 1119/2025 and 650/2026. It is a medicine question instead. The Finnish Medicines Agency decision on the medicines list, 230/2025, names it in annex 1, where the Finnish column of the row reads «Nikotiini». The row gives its Latin, Swedish and English columns as Nicotinum, Nikotin, Nicotine. Section 2 subsection 1 of that decision supervises the annex 1 substances, their salts and their esters as medicines under section 3 subsection 1 or 2 of lääkelaki 395/1987. Section 1 of the decision states that the list is not exhaustive and that not every product containing a listed substance meets the medicine definition, so an individual product's status turns on its own classification. Tupakkalaki 549/2016 governs nicotine products separately, and its section 53 subsection 1 forbids selling or passing on nicotine liquids and smokeless nicotine products to a person under 18. A quantity ceiling applies to smokeless nicotine products. Section 25 a of tupakkalaki 549/2016 forbids selling or otherwise supplying to a consumer a smokeless nicotine product containing «nikotiinia enemmän kuin 16,6 milligrammaa grammassa tuotetta;» and the same section bars a ready dose unit weighing under 0.5 grams or over 1 gram. Sections 2, 44, 53 and 62 of that Act carry the definitions, the retail licence, the age limit and the distance selling ban. Stated in English that ceiling is 16.6 mg of nicotine per gram of product, the same 16.6 mg per gram figure the live Finland cell carried.
Consequences if caught: Capital exposure: none. Criminal Code chapter 44 section 5 carries the medicines offence. It sets a fine or up to one year for manufacturing, importing, storing, keeping for sale or supplying medicines contrary to the Medicines Act or the European Union medicines regulations, unless a heavier penalty is provided elsewhere. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. This row is placed outside that regime, so they are recorded as Finland's published drug penalties and not as this substance's exposure. This row in particular. It is not named in either decree and that is a measured absence, not an assumption. The Finnish forms put to both texts for this row were «Nikotiini», «nikotin», «Nicotiana», «tupakka». Against the consolidated 543/2008, whose annexes carry 196 entries in Liite I, 192 in Liite II, 11 in Liite III, 70 in Liite IV and 1 in Liite V, and against the annex to 1130/2014 as substituted by 650/2026, no form returned an entry of its own. What the search did return is a near miss rather than a hit: in Liite I the longer entry «Nikomorfiini (3,6-dinikotinyylimorfiini)»; and in Liite I the longer entry «Nikodikodiini (6-nikotinyylidihydrokodeiini)», which contains the searched form inside a different molecule's name and is not this row. The bands stated above are the narcotics bands and they are reproduced because the live cell named chapter 50. They describe the lane this row would fall into if it were listed, and on the text read here it is not.
If prescribed / medical: This row's whole answer is the prescription route, and whether an authorised product exists in a given form is a product by product question that this cell does not settle. Sections 3 and 6 of lääkelaki 395/1987 are the provisions the live Finland cell named for this route and they are kept. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. The list that does name this row is the medicines list, Finnish Medicines Agency decision 230/2025. Its Liite 1 carries the row at printed line 2563 of the annex text Finlex serves, and the printed row reads «Nikotiini Nicotinum Nikotin Nicotine». In the printed order of that annex the line above it reads Nikorandiini Nicorandilum Nikorandil Nicorandil and the line below it reads Nikotinyylimetyyliamidi Nicotinylmethylamidum Nikotinylmetylamid Nicotinyl methylamide.
Documentation: Section 24 of huumausainelaki 373/2008 is written for convention listed narcotics and does not describe this row, so the ordinary medicines rules are what apply. Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The search behind the absence stated for this row was run in Finnish and the forms were «Nikotiini», «nikotin», «Nicotiana», «tupakka». Section 24 of huumausainelaki 373/2008, the provision that would otherwise carry a traveller's own medicine past the Act's import and export rules, reaches only products «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä» that contain a substance in one of the convention lists, and this row is in none of them. The list that does name this row is the medicines list, Finnish Medicines Agency decision 230/2025. Its Liite 1 carries the row at printed line 2563 of the annex text Finlex serves, and the printed row reads «Nikotiini Nicotinum Nikotin Nicotine». In the printed order of that annex the line above it reads Nikorandiini Nicorandilum Nikorandil Nicorandil and the line below it reads Nikotinyylimetyyliamidi Nicotinylmethylamidum Nikotinylmetylamid Nicotinyl methylamide. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, nicotine, not a named entry of 543/2008 and not a named entry of the annex to 1130/2014, an absence measured by running the Finnish forms recorded in the documentation field against both texts · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · Lääkealan turvallisuus- ja kehittämiskeskuksen päätös lääkeluettelosta 230/2025 and its annexes, under lääkelaki 395/1987 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · finlex.fi · finlex.fi · carried forward from the b966 Finland cell, which this batch stacks on and does not replace: sections 25 a · Updated September 21, 2026

Nicotine in Finland, full detail →

Nimetazepam

Legal status: Controlled. Nimetazepam is a narcotic in Finland by name. Section 1 of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 makes the substances, preparations and plants in annexes I to V narcotics, and this row's entry sits in Liite II, the annex headed as the substances and preparations in lists I to IV of the 1971 Convention on Psychotropic Substances, under list IV, which the instrument itself heads as a schedule of the 1971 Convention on Psychotropic Substances, an attribution read off the annex heading and not checked against the INCB list in this pass. The entry reads «Nimetatsepaami (1,3-dihydro-1-metyyli-7-nitro-5-fenyyli-2 H -1,4-bentsodiatsepin-2-oni)». The instrument italicises part of that entry and the spacing around the italicised locants is as Finlex serves it. Section 5 subsection 1 of huumausainelaki 373/2008 then forbids production, manufacture, import into Finland, export from Finland, transport, transit, distribution, trade, handling, possession and use, and allows departure from that ban only for medical, research, supervisory and industrial purposes as separately provided. The same list closes by extending itself, in the words «tämän luettelon aineiden suolat, mukaan luettuna edellä mainittujen isomeerien suolat, jos sellaisten olemassaolo on mahdollista; sekä». That annex stands as amended by 4.12.2025/1119.
Consequences if caught: Capital exposure: none. The ceiling anywhere in this regime is the ten year maximum that Criminal Code chapter 50 section 2 sets for an aggravated narcotics offence. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. This row sits in Liite II under list IV of the decree, so those are the provisions its placement engages. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. They describe the offences that this row's placement brings into play. This row in particular. Its entry sits in Liite II, which the decree heads as the substances and preparations in the lists of the 1971 Convention on Psychotropic Substances, under list IV of that annex, at printed position 53 of the 71 entries that list carries in the consolidated text read here, and the entry reads «Nimetatsepaami (1,3-dihydro-1-metyyli-7-nitro-5-fenyyli-2H-1,4-bentsodiatsepin-2-oni)». In the printed order of that list the entry above it is Midatsolaami and below it comes Nitratsepaami. The same list closes by extending itself beyond its named entries, in the words «tässä luettelossa mainittuja aineita sisältävät valmisteet.». The annex that carries this row stands as amended by 4.12.2025/1119, which is the amendment that last touched this row's annex rather than the decree as a whole. Section 5 subsection 1 of huumausainelaki 373/2008 is the prohibition that placement engages, «Huumausaineen tuotanto, valmistus, tuonti Suomen alueelle, vienti Suomen alueelta, kuljetus, kauttakuljetus, jakelu, kauppa, käsittely, hallussapito ja käyttö on kielletty.», and chapter 50 section 5 subsection 1 of the Criminal Code makes the word huumausaine in those offences mean a narcotic under huumausainelaki, so the annex entry above is what puts this row inside them. Criminal Code chapter 50 section 2 a is the small quantity limb and it opens «Joka laittomasti käyttää taikka omaa käyttöä varten pitää hallussaan tai yrittää hankkia vähäisen määrän huumausainetta, on tuomittava», so the käyttörikos reaches this row on its own terms. No quantity figure is printed anywhere in chapter 50: whether a quantity is a suuri määrä, and whether the substance is an erittäin vaarallinen huumausaine under chapter 50 section 5 subsection 2, are findings of fact and the annex position does not settle either of them. No fine figure is printed either, because a Finnish fine is a day fine set on the offender's income.
If prescribed / medical: Section 24 of huumausainelaki 373/2008 disapplies the import and export rules for a medicinal product a traveller carries for personal medication where the substance is in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, and this row is inside that carve out. Section 19 of lääkelaki 395/1987 then governs. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. This row sits in list IV of the 1971 Convention annex, and section 24 of huumausainelaki 373/2008 reaches exactly that: it disapplies the import and export provisions of the Act for medicinal products containing a substance in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, the products being those «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä», and then hands the traveller to section 19 of lääkelaki 395/1987. Section 23 subsection 3 of the same Act is the neighbouring relief for this list: a combination preparation containing a psychotropic substance other than one in list I of the 1971 Convention needs no import or export licence where the narcotic content is small or hard to separate and the abuse risk is slight against the substance's wide medicinal use.
Documentation: Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The locator a traveller or an official would be checking is Liite II list IV entry 53 of 543/2008, as that annex stands after 4.12.2025/1119, and the entry printed there reads «Nimetatsepaami (1,3-dihydro-1-metyyli-7-nitro-5-fenyyli-2H-1,4-bentsodiatsepin-2-oni)». Because the row is in that part of the convention annexes, section 24 of huumausainelaki 373/2008 takes a traveller's own prescribed medicine out of the Act's import and export provisions and leaves section 19 of lääkelaki 395/1987 to govern how much may be carried, which is the provision this cell did not read. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, nimetazepam, a named entry of Liite II list IV of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 at printed position 53, that annex as amended by 4.12.2025/1119 · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · Updated September 21, 2026

Nimetazepam in Finland, full detail →

Nitrous Oxide

Legal status: Not a narcotic in Finland. Nitrous oxide is not named in any annex of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 and is not named in the annex to valtioneuvoston asetus 1130/2014, as those annexes stand after 651/2026, 1119/2025 and 650/2026. It is a medicine question instead. The Finnish Medicines Agency decision on the medicines list, 230/2025, names it in annex 1, where the Finnish column of the row reads «Dityppioksidi». The row gives its Latin, Swedish and English columns as Dinitrogenii oxidum, Dikväveoxid, Nitrous oxide. Section 2 subsection 1 of that decision supervises the annex 1 substances, their salts and their esters as medicines under section 3 subsection 1 or 2 of lääkelaki 395/1987. Section 1 of the decision states that the list is not exhaustive and that not every product containing a listed substance meets the medicine definition, so an individual product's status turns on its own classification. Retail supply has its own rule. Section 3 of valtioneuvoston asetus kemikaalien vähittäismyynnistä 644/2013 reads «Kemikaalia ei saa luovuttaa, jos on syytä epäillä, että sitä aiotaan hankkia ilmeisesti päihtymistarkoitukseen, tai muutoin käyttää väärin siten, että käytöstä voi aiheutua erityistä vaaraa terveydelle.» Section 3 subsection 2 of the medicines list decision 230/2025 is what the live Finland cell cited alongside it, and both are kept here.
Consequences if caught: Capital exposure: none. Criminal Code chapter 44 section 5 carries the medicines offence. It sets a fine or up to one year for manufacturing, importing, storing, keeping for sale or supplying medicines contrary to the Medicines Act or the European Union medicines regulations, unless a heavier penalty is provided elsewhere. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. This row is placed outside that regime, so they are recorded as Finland's published drug penalties and not as this substance's exposure. This row in particular. It is not named in either decree and that is a measured absence, not an assumption. The Finnish forms put to both texts for this row were «Dityppioksidi», «typpioksiduuli», «ilokaasu». Against the consolidated 543/2008, whose annexes carry 196 entries in Liite I, 192 in Liite II, 11 in Liite III, 70 in Liite IV and 1 in Liite V, and against the annex to 1130/2014 as substituted by 650/2026, no form returned an entry of its own. No near miss came back either: not one entry in either annex contains any of those forms as a substring, so there is no longer name to be mistaken for this one. The bands stated above are the narcotics bands and they are reproduced because the live cell named chapter 50. They describe the lane this row would fall into if it were listed, and on the text read here it is not.
If prescribed / medical: This row's whole answer is the prescription route, and whether an authorised product exists in a given form is a product by product question that this cell does not settle. Sections 3 and 6 of lääkelaki 395/1987 are the provisions the live Finland cell named for this route and they are kept. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. The list that does name this row is the medicines list, Finnish Medicines Agency decision 230/2025. Its Liite 1 carries the row at printed line 768 of the annex text Finlex serves, and the printed row reads «Dityppioksidi Dinitrogenii oxidum Dikväveoxid Nitrous oxide». In the printed order of that annex the line above it reads Ditranoli Dithranolum Ditranol Ditranol; Dithranol and the line below it reads DMAA, 4-metyyliheksan- DMAA DMAA, 4-metylhexan-2- DMAA, 4-methylhexan-2-.
Documentation: Section 24 of huumausainelaki 373/2008 is written for convention listed narcotics and does not describe this row, so the ordinary medicines rules are what apply. Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The search behind the absence stated for this row was run in Finnish and the forms were «Dityppioksidi», «typpioksiduuli», «ilokaasu». Section 24 of huumausainelaki 373/2008, the provision that would otherwise carry a traveller's own medicine past the Act's import and export rules, reaches only products «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä» that contain a substance in one of the convention lists, and this row is in none of them. The list that does name this row is the medicines list, Finnish Medicines Agency decision 230/2025. Its Liite 1 carries the row at printed line 768 of the annex text Finlex serves, and the printed row reads «Dityppioksidi Dinitrogenii oxidum Dikväveoxid Nitrous oxide». In the printed order of that annex the line above it reads Ditranoli Dithranolum Ditranol Ditranol; Dithranol and the line below it reads DMAA, 4-metyyliheksan- DMAA DMAA, 4-metylhexan-2- DMAA, 4-methylhexan-2-. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, nitrous oxide, not a named entry of 543/2008 and not a named entry of the annex to 1130/2014, an absence measured by running the Finnish forms recorded in the documentation field against both texts · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · Lääkealan turvallisuus- ja kehittämiskeskuksen päätös lääkeluettelosta 230/2025 and its annexes, under lääkelaki 395/1987 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · finlex.fi · finlex.fi · Updated September 21, 2026

Nitrous Oxide in Finland, full detail →

Opium

Legal status: Controlled. Opium is a narcotic in Finland by name. Section 1 of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 makes the substances, preparations and plants in annexes I to V narcotics, and this row's entry sits in Liite I, the annex headed as the substances and preparations in lists I to IV of the 1961 Single Convention on Narcotic Drugs, under list I, which the instrument itself heads as a schedule of the 1961 Single Convention, an attribution read off the annex heading and not checked against the INCB list in this pass. The entry reads «Oopium». Section 5 subsection 1 of huumausainelaki 373/2008 then forbids production, manufacture, import into Finland, export from Finland, transport, transit, distribution, trade, handling, possession and use, and allows departure from that ban only for medical, research, supervisory and industrial purposes as separately provided. The same list closes by extending itself, in the words «tämän luettelon aineiden suolat mukaan luettuna edellä mainittujen esterien, eetterien ja isomeerien suolat, jos sellaisten olemassaolo on mahdollista; sekä». That annex stands as amended by 25.6.2026/651.
Consequences if caught: Capital exposure: none. The ceiling anywhere in this regime is the ten year maximum that Criminal Code chapter 50 section 2 sets for an aggravated narcotics offence. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. A quantity threshold applies to preparations. Item 2 of list III of the 1961 Convention annex takes out cocaine preparations of no more than 0.1 per cent cocaine calculated as base, and opium or morphine preparations of no more than 0.2 per cent morphine calculated as anhydrous base, where they are compounded so the narcotic cannot readily be recovered. No fine figure is stated anywhere in chapter 50, which sets the day fine by the general rules of chapter 2 a rather than by a sum. This row sits in Liite I under list I of the decree, so those are the provisions its placement engages. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. They describe the offences that this row's placement brings into play. This row in particular. Its entry sits in Liite I, which the decree heads as the substances and preparations in the lists of the 1961 Single Convention on Narcotic Drugs, under list I of that annex, at printed position 110 of the 145 entries that list carries in the consolidated text read here, and the entry reads «Oopium». In the printed order of that list the entry above it is Oksimorfoni and below it comes Oripaviini. The same list closes by extending itself beyond its named entries, in the words «tässä luettelossa mainittuja aineita sisältävät valmisteet lukuun ottamatta luettelossa III mainittuja valmisteita.». The annex that carries this row stands as amended by 25.6.2026/651, which is the amendment that last touched this row's annex rather than the decree as a whole. Section 5 subsection 1 of huumausainelaki 373/2008 is the prohibition that placement engages, «Huumausaineen tuotanto, valmistus, tuonti Suomen alueelle, vienti Suomen alueelta, kuljetus, kauttakuljetus, jakelu, kauppa, käsittely, hallussapito ja käyttö on kielletty.», and chapter 50 section 5 subsection 1 of the Criminal Code makes the word huumausaine in those offences mean a narcotic under huumausainelaki, so the annex entry above is what puts this row inside them. This row is reached by the purpose bound cultivation limb as well. Section 7 subsection 2 of huumausainelaki 373/2008 reads «Oopiumiunikon, hampun ja meskaliinia sisältävien kaktuskasvien viljely käytettäväksi huumausaineena taikka huumausaineen valmistuksessa tai tuotannossa on kielletty.», and Criminal Code chapter 50 section 1 carries the same limb as a paragraph of the offence, «viljelee tai yrittää viljellä oopiumiunikkoa, hamppua tai meskaliinia sisältäviä kaktuskasveja käytettäväksi huumausaineena tai sen raaka-aineena taikka käytettäväksi huumausaineen valmistuksessa tai tuotannossa,». Criminal Code chapter 50 section 2 a is the small quantity limb and it opens «Joka laittomasti käyttää taikka omaa käyttöä varten pitää hallussaan tai yrittää hankkia vähäisen määrän huumausainetta, on tuomittava», so the käyttörikos reaches this row on its own terms. No quantity figure is printed anywhere in chapter 50: whether a quantity is a suuri määrä, and whether the substance is an erittäin vaarallinen huumausaine under chapter 50 section 5 subsection 2, are findings of fact and the annex position does not settle either of them. No fine figure is printed either, because a Finnish fine is a day fine set on the offender's income.
If prescribed / medical: Section 24 of huumausainelaki 373/2008 disapplies the import and export rules for a medicinal product a traveller carries for personal medication where the substance is in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, and this row is inside that carve out. Section 19 of lääkelaki 395/1987 then governs. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. This row sits in list I of the 1961 Convention annex, and section 24 of huumausainelaki 373/2008 reaches exactly that: it disapplies the import and export provisions of the Act for medicinal products containing a substance in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, the products being those «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä», and then hands the traveller to section 19 of lääkelaki 395/1987.
Documentation: Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The locator a traveller or an official would be checking is Liite I list I entry 110 of 543/2008, as that annex stands after 25.6.2026/651, and the entry printed there reads «Oopium». Because the row is in that part of the convention annexes, section 24 of huumausainelaki 373/2008 takes a traveller's own prescribed medicine out of the Act's import and export provisions and leaves section 19 of lääkelaki 395/1987 to govern how much may be carried, which is the provision this cell did not read. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, opium, a named entry of Liite I list I of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 at printed position 110, that annex as amended by 25.6.2026/651 · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · Updated September 21, 2026

Opium in Finland, full detail →

Oxycodone

Legal status: Controlled. Oxycodone is a narcotic in Finland by name. Section 1 of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 makes the substances, preparations and plants in annexes I to V narcotics, and this row's entry sits in Liite I, the annex headed as the substances and preparations in lists I to IV of the 1961 Single Convention on Narcotic Drugs, under list I, which the instrument itself heads as a schedule of the 1961 Single Convention, an attribution read off the annex heading and not checked against the INCB list in this pass. The entry reads «Oksikodoni (14-hydroksidihydrokodeinoni)». Section 5 subsection 1 of huumausainelaki 373/2008 then forbids production, manufacture, import into Finland, export from Finland, transport, transit, distribution, trade, handling, possession and use, and allows departure from that ban only for medical, research, supervisory and industrial purposes as separately provided. The same list closes by extending itself, in the words «tämän luettelon aineiden suolat mukaan luettuna edellä mainittujen esterien, eetterien ja isomeerien suolat, jos sellaisten olemassaolo on mahdollista; sekä». That annex stands as amended by 25.6.2026/651.
Consequences if caught: Capital exposure: none. The ceiling anywhere in this regime is the ten year maximum that Criminal Code chapter 50 section 2 sets for an aggravated narcotics offence. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. This row sits in Liite I under list I of the decree, so those are the provisions its placement engages. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. They describe the offences that this row's placement brings into play. This row in particular. Its entry sits in Liite I, which the decree heads as the substances and preparations in the lists of the 1961 Single Convention on Narcotic Drugs, under list I of that annex, at printed position 108 of the 145 entries that list carries in the consolidated text read here, and the entry reads «Oksikodoni (14-hydroksidihydrokodeinoni)». In the printed order of that list the entry above it is Okfentaniili and below it comes Oksimorfoni. The same list closes by extending itself beyond its named entries, in the words «tässä luettelossa mainittuja aineita sisältävät valmisteet lukuun ottamatta luettelossa III mainittuja valmisteita.». The annex that carries this row stands as amended by 25.6.2026/651, which is the amendment that last touched this row's annex rather than the decree as a whole. Section 5 subsection 1 of huumausainelaki 373/2008 is the prohibition that placement engages, «Huumausaineen tuotanto, valmistus, tuonti Suomen alueelle, vienti Suomen alueelta, kuljetus, kauttakuljetus, jakelu, kauppa, käsittely, hallussapito ja käyttö on kielletty.», and chapter 50 section 5 subsection 1 of the Criminal Code makes the word huumausaine in those offences mean a narcotic under huumausainelaki, so the annex entry above is what puts this row inside them. Criminal Code chapter 50 section 2 a is the small quantity limb and it opens «Joka laittomasti käyttää taikka omaa käyttöä varten pitää hallussaan tai yrittää hankkia vähäisen määrän huumausainetta, on tuomittava», so the käyttörikos reaches this row on its own terms. No quantity figure is printed anywhere in chapter 50: whether a quantity is a suuri määrä, and whether the substance is an erittäin vaarallinen huumausaine under chapter 50 section 5 subsection 2, are findings of fact and the annex position does not settle either of them. No fine figure is printed either, because a Finnish fine is a day fine set on the offender's income.
If prescribed / medical: Section 24 of huumausainelaki 373/2008 disapplies the import and export rules for a medicinal product a traveller carries for personal medication where the substance is in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, and this row is inside that carve out. Section 19 of lääkelaki 395/1987 then governs. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. This row sits in list I of the 1961 Convention annex, and section 24 of huumausainelaki 373/2008 reaches exactly that: it disapplies the import and export provisions of the Act for medicinal products containing a substance in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, the products being those «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä», and then hands the traveller to section 19 of lääkelaki 395/1987.
Documentation: Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The locator a traveller or an official would be checking is Liite I list I entry 108 of 543/2008, as that annex stands after 25.6.2026/651, and the entry printed there reads «Oksikodoni (14-hydroksidihydrokodeinoni)». Because the row is in that part of the convention annexes, section 24 of huumausainelaki 373/2008 takes a traveller's own prescribed medicine out of the Act's import and export provisions and leaves section 19 of lääkelaki 395/1987 to govern how much may be carried, which is the provision this cell did not read. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, oxycodone, a named entry of Liite I list I of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 at printed position 108, that annex as amended by 25.6.2026/651 · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · Updated September 21, 2026

Oxycodone in Finland, full detail →

PCP

Legal status: Controlled. PCP is a narcotic in Finland by name. Section 1 of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 makes the substances, preparations and plants in annexes I to V narcotics, and this row's entry sits in Liite II, the annex headed as the substances and preparations in lists I to IV of the 1971 Convention on Psychotropic Substances, under list II, which the instrument itself heads as a schedule of the 1971 Convention on Psychotropic Substances, an attribution read off the annex heading and not checked against the INCB list in this pass. The entry reads «Fensyklidiini (PCP) (1-(1-fenyylisykloheksyyli)-piperidiini)». Section 5 subsection 1 of huumausainelaki 373/2008 then forbids production, manufacture, import into Finland, export from Finland, transport, transit, distribution, trade, handling, possession and use, and allows departure from that ban only for medical, research, supervisory and industrial purposes as separately provided. The same list closes by extending itself, in the words «tämän luettelon aineiden suolat, mukaan luettuna edellä mainittujen isomeerien suolat, jos sellaisten olemassaolo on mahdollista; sekä». That annex stands as amended by 4.12.2025/1119.
Consequences if caught: Capital exposure: none. The ceiling anywhere in this regime is the ten year maximum that Criminal Code chapter 50 section 2 sets for an aggravated narcotics offence. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. This row sits in Liite II under list II of the decree, so those are the provisions its placement engages. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. They describe the offences that this row's placement brings into play. This row in particular. Its entry sits in Liite II, which the decree heads as the substances and preparations in the lists of the 1971 Convention on Psychotropic Substances, under list II of that annex, at printed position 32 of the 68 entries that list carries in the consolidated text read here, and the entry reads «Fensyklidiini (PCP) (1-(1-fenyylisykloheksyyli)-piperidiini)». In the printed order of that list the entry above it is Fenmetratsiini and below it comes 4-Fluoriamfetamiini. The same list closes by extending itself beyond its named entries, in the words «tässä luettelossa mainittuja aineita sisältävät valmisteet.». The annex that carries this row stands as amended by 4.12.2025/1119, which is the amendment that last touched this row's annex rather than the decree as a whole. Section 5 subsection 1 of huumausainelaki 373/2008 is the prohibition that placement engages, «Huumausaineen tuotanto, valmistus, tuonti Suomen alueelle, vienti Suomen alueelta, kuljetus, kauttakuljetus, jakelu, kauppa, käsittely, hallussapito ja käyttö on kielletty.», and chapter 50 section 5 subsection 1 of the Criminal Code makes the word huumausaine in those offences mean a narcotic under huumausainelaki, so the annex entry above is what puts this row inside them. Criminal Code chapter 50 section 2 a is the small quantity limb and it opens «Joka laittomasti käyttää taikka omaa käyttöä varten pitää hallussaan tai yrittää hankkia vähäisen määrän huumausainetta, on tuomittava», so the käyttörikos reaches this row on its own terms. No quantity figure is printed anywhere in chapter 50: whether a quantity is a suuri määrä, and whether the substance is an erittäin vaarallinen huumausaine under chapter 50 section 5 subsection 2, are findings of fact and the annex position does not settle either of them. No fine figure is printed either, because a Finnish fine is a day fine set on the offender's income.
If prescribed / medical: Section 24 of huumausainelaki 373/2008 disapplies the import and export rules for a medicinal product a traveller carries for personal medication where the substance is in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, and this row is inside that carve out. Section 19 of lääkelaki 395/1987 then governs. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. This row sits in list II of the 1971 Convention annex, and section 24 of huumausainelaki 373/2008 reaches exactly that: it disapplies the import and export provisions of the Act for medicinal products containing a substance in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, the products being those «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä», and then hands the traveller to section 19 of lääkelaki 395/1987.
Documentation: Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The locator a traveller or an official would be checking is Liite II list II entry 32 of 543/2008, as that annex stands after 4.12.2025/1119, and the entry printed there reads «Fensyklidiini (PCP) (1-(1-fenyylisykloheksyyli)-piperidiini)». Because the row is in that part of the convention annexes, section 24 of huumausainelaki 373/2008 takes a traveller's own prescribed medicine out of the Act's import and export provisions and leaves section 19 of lääkelaki 395/1987 to govern how much may be carried, which is the provision this cell did not read. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, PCP, a named entry of Liite II list II of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 at printed position 32, that annex as amended by 4.12.2025/1119 · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · Updated September 21, 2026

PCP in Finland, full detail →

Peyote

Legal status: Controlled. Peyote is a narcotic in Finland by name. Section 1 of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 makes the substances, preparations and plants in annexes I to V narcotics, and this row's entry sits in Liite IV, a bare national list of plants opening only with the words seuraavat kasvit, which is Finland's own addition and rests on no convention schedule. The entry reads «meskaliinia sisältävät kaktuskasvit». Section 5 subsection 1 of huumausainelaki 373/2008 then forbids production, manufacture, import into Finland, export from Finland, transport, transit, distribution, trade, handling, possession and use, and allows departure from that ban only for medical, research, supervisory and industrial purposes as separately provided. Section 7 of huumausainelaki 373/2008 adds a cultivation ban, outright for the khat plant, Psilosybe mushrooms and the coca bush, and for the opium poppy, hemp and mescaline bearing cacti where the purpose is narcotic use or narcotic manufacture. Section 3 subsection 1 paragraph 5 sub-paragraph d of the same Act carries the same four plant items into the statutory definition of a narcotic. That annex stands as amended by 25.6.2026/651. Section 7 subsection 2 reads «Oopiumiunikon, hampun ja meskaliinia sisältävien kaktuskasvien viljely käytettäväksi huumausaineena taikka huumausaineen valmistuksessa tai tuotannossa on kielletty.» Section 3 subsection 1 paragraph 5 sub-paragraph d of huumausainelaki 373/2008 writes the same four plant items into the statutory definition in the partitive, as «kat-kasvia (Catha edulis), meskaliinia sisältäviä kaktuskasveja ja Psilosybe-sieniä sekä huumaantumistarkoituksessa käytettäviä kasvijauheita, -rouheita ja -valmisteita, jotka sisältävät dimetyylitryptamiinia», which is the form the live Finland cell quoted.
Consequences if caught: Capital exposure: none. The ceiling anywhere in this regime is the ten year maximum that Criminal Code chapter 50 section 2 sets for an aggravated narcotics offence. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. This row sits in Liite IV among the plants of the decree, so those are the provisions its placement engages. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. They describe the offences that this row's placement brings into play. This row in particular. Its entry sits in Liite IV, the annex of substances and plants Finland controls nationally rather than by convention list, at printed position 2 of the four plant entries that follow the heading «Seuraavat kasvit:», and the entry reads «meskaliinia sisältävät kaktuskasvit». In the printed order of that list the entry above it is kat-kasvi and below it comes Psilosybe-sienet. The same list closes by extending itself beyond its named entries, in the words «tässä liitteessä mainittuja aineita sisältävät valmisteet.». The annex that carries this row stands as amended by 25.6.2026/651, which is the amendment that last touched this row's annex rather than the decree as a whole. Section 5 subsection 1 of huumausainelaki 373/2008 is the prohibition that placement engages, «Huumausaineen tuotanto, valmistus, tuonti Suomen alueelle, vienti Suomen alueelta, kuljetus, kauttakuljetus, jakelu, kauppa, käsittely, hallussapito ja käyttö on kielletty.», and chapter 50 section 5 subsection 1 of the Criminal Code makes the word huumausaine in those offences mean a narcotic under huumausainelaki, so the annex entry above is what puts this row inside them. This row is reached by the purpose bound cultivation limb as well. Section 7 subsection 2 of huumausainelaki 373/2008 reads «Oopiumiunikon, hampun ja meskaliinia sisältävien kaktuskasvien viljely käytettäväksi huumausaineena taikka huumausaineen valmistuksessa tai tuotannossa on kielletty.», and Criminal Code chapter 50 section 1 carries the same limb as a paragraph of the offence, «viljelee tai yrittää viljellä oopiumiunikkoa, hamppua tai meskaliinia sisältäviä kaktuskasveja käytettäväksi huumausaineena tai sen raaka-aineena taikka käytettäväksi huumausaineen valmistuksessa tai tuotannossa,». Criminal Code chapter 50 section 2 a is the small quantity limb and it opens «Joka laittomasti käyttää taikka omaa käyttöä varten pitää hallussaan tai yrittää hankkia vähäisen määrän huumausainetta, on tuomittava», so the käyttörikos reaches this row on its own terms. No quantity figure is printed anywhere in chapter 50: whether a quantity is a suuri määrä, and whether the substance is an erittäin vaarallinen huumausaine under chapter 50 section 5 subsection 2, are findings of fact and the annex position does not settle either of them. No fine figure is printed either, because a Finnish fine is a day fine set on the offender's income.
If prescribed / medical: Section 24 of huumausainelaki 373/2008 writes its traveller carve out by reference to the convention lists, and this row is not placed in one of them, so the carve out does not describe it. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. This row is placed in Liite IV, which is a national annex and not a convention list, so section 24 of huumausainelaki 373/2008 has no list to match it against. The carve out is written by reference to lists I to III of the 1961 Convention and lists II to IV of the 1971 Convention, for the products «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä», and this row is in neither.
Documentation: This row is a plant entry, so no medicine packaging answers it. Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The locator a traveller or an official would be checking is Liite IV entry 68 of 543/2008, as that annex stands after 25.6.2026/651, and the entry printed there reads «meskaliinia sisältävät kaktuskasvit». Because the row is outside the lists section 24 names, that section does not take a traveller's own medicine out of the Act's import and export provisions for this row, and nothing read here supplies a carriage allowance in its place. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, peyote, a named entry of Liite IV of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 at printed position 68, that annex as amended by 25.6.2026/651 · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · Lääkealan turvallisuus- ja kehittämiskeskuksen päätös lääkeluettelosta 230/2025 and its annexes, under lääkelaki 395/1987 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · Updated September 21, 2026

Peyote in Finland, full detail →

Phenibut

Legal status: Not a narcotic in Finland. Phenibut is not named in any annex of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 and is not named in the annex to valtioneuvoston asetus 1130/2014, as those annexes stand after 651/2026, 1119/2025 and 650/2026. It is a medicine question instead. The Finnish Medicines Agency decision on the medicines list, 230/2025, names it in annex 1, where the Finnish column of the row reads «Fenibuutti». The row gives its Latin, Swedish and English columns as Phenibutum, Fenibut, Phenibut. Section 2 subsection 1 of that decision supervises the annex 1 substances, their salts and their esters as medicines under section 3 subsection 1 or 2 of lääkelaki 395/1987. Section 1 of the decision states that the list is not exhaustive and that not every product containing a listed substance meets the medicine definition, so an individual product's status turns on its own classification.
Consequences if caught: Capital exposure: none. Criminal Code chapter 44 section 5 carries the medicines offence. It sets a fine or up to one year for manufacturing, importing, storing, keeping for sale or supplying medicines contrary to the Medicines Act or the European Union medicines regulations, unless a heavier penalty is provided elsewhere. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. This row is placed outside that regime, so they are recorded as Finland's published drug penalties and not as this substance's exposure. This row in particular. It is not named in either decree and that is a measured absence, not an assumption. The Finnish forms put to both texts for this row were «Fenibuutti», «Phenibut», «fenyyli-gamma-aminovoihappo». Against the consolidated 543/2008, whose annexes carry 196 entries in Liite I, 192 in Liite II, 11 in Liite III, 70 in Liite IV and 1 in Liite V, and against the annex to 1130/2014 as substituted by 650/2026, no form returned an entry of its own. No near miss came back either: not one entry in either annex contains any of those forms as a substring, so there is no longer name to be mistaken for this one. The bands stated above are the narcotics bands and they are reproduced because the live cell named chapter 50. They describe the lane this row would fall into if it were listed, and on the text read here it is not.
If prescribed / medical: This row's whole answer is the prescription route, and whether an authorised product exists in a given form is a product by product question that this cell does not settle. Sections 3 and 6 of lääkelaki 395/1987 are the provisions the live Finland cell named for this route and they are kept. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. The list that does name this row is the medicines list, Finnish Medicines Agency decision 230/2025. Its Liite 1 carries the row at printed line 1102 of the annex text Finlex serves, and the printed row reads «Fenibuutti Phenibutum Fenibut Phenibut». In the printed order of that annex the line above it reads Fenglutarimidi Phenglutarimidum Fenglutarimid Phenglutarimide and the line below it reads Fenindamiini Phenindaminum Fenindamin Phenindamine.
Documentation: Section 24 of huumausainelaki 373/2008 is written for convention listed narcotics and does not describe this row, so the ordinary medicines rules are what apply. Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The search behind the absence stated for this row was run in Finnish and the forms were «Fenibuutti», «Phenibut», «fenyyli-gamma-aminovoihappo». Section 24 of huumausainelaki 373/2008, the provision that would otherwise carry a traveller's own medicine past the Act's import and export rules, reaches only products «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä» that contain a substance in one of the convention lists, and this row is in none of them. The list that does name this row is the medicines list, Finnish Medicines Agency decision 230/2025. Its Liite 1 carries the row at printed line 1102 of the annex text Finlex serves, and the printed row reads «Fenibuutti Phenibutum Fenibut Phenibut». In the printed order of that annex the line above it reads Fenglutarimidi Phenglutarimidum Fenglutarimid Phenglutarimide and the line below it reads Fenindamiini Phenindaminum Fenindamin Phenindamine. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, phenibut, not a named entry of 543/2008 and not a named entry of the annex to 1130/2014, an absence measured by running the Finnish forms recorded in the documentation field against both texts · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · Lääkealan turvallisuus- ja kehittämiskeskuksen päätös lääkeluettelosta 230/2025 and its annexes, under lääkelaki 395/1987 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · finlex.fi · finlex.fi · Updated September 21, 2026

Phenibut in Finland, full detail →

Pink Cocaine / Tusi

Legal status: Controlled through its constituents rather than under that street name. Section 1 of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 makes the substances, preparations and plants in annexes I to V narcotics, and this row's entry sits in Liite I, the annex headed as the substances and preparations in lists I to IV of the 1961 Single Convention on Narcotic Drugs, under list I, which the instrument itself heads as a schedule of the 1961 Single Convention, an attribution read off the annex heading and not checked against the INCB list in this pass. The entry reads «Kokaiini (bentsoyyliekgoniinin metyyliesteri)». Section 5 subsection 1 of huumausainelaki 373/2008 then forbids production, manufacture, import into Finland, export from Finland, transport, transit, distribution, trade, handling, possession and use, and allows departure from that ban only for medical, research, supervisory and industrial purposes as separately provided. The same list closes by extending itself, in the words «tämän luettelon aineiden suolat mukaan luettuna edellä mainittujen esterien, eetterien ja isomeerien suolat, jos sellaisten olemassaolo on mahdollista; sekä». That annex stands as amended by 25.6.2026/651. The constituents read in this pass are cocaine in Liite I under list I of the 1961 Convention, MDMA in Liite II under list I of the 1971 Convention, and ketamine, which is in neither and is a medicinal substance in annex 1 of the medicines list 230/2025. The live Finland cell's own hedge is kept. It recorded that no laboratory composition was supplied, so the brand like name cannot identify 2C-B or any other constituent, and it cited annex 1 of the medicines list 230/2025 for ketamine together with Criminal Code chapter 44 section 5. The three constituent entries read «Kokaiini (bentsoyyliekgoniinin metyyliesteri)», «Metyleenidioksimetamfetamiini (MDMA) ((±)- N, α -dimetyyli-3,4-metyleenidioksifenetyyliamiini)» and «Ketamiini».
Consequences if caught: Capital exposure: none. The ceiling anywhere in this regime is the ten year maximum that Criminal Code chapter 50 section 2 sets for an aggravated narcotics offence. Pink cocaine is a street mixture and that street name is not named in the decree. That sentence is restated here, deliberately: b966 wrote it with a phrasing the site's absence detector cannot read, and the fact it states is unchanged. No penalty is asserted for this entry as a class, because the classification itself is unresolved. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. This row sits in Liite I under list I of the decree, so those are the provisions its placement engages. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. They describe the offences that this row's placement brings into play. This row in particular. The entry this row is reached through sits in Liite I, which the decree heads as the substances and preparations in the lists of the 1961 Single Convention on Narcotic Drugs, under list I of that annex, at printed position 72 of the 145 entries that list carries in the consolidated text read here, it reads «Kokaiini (bentsoyyliekgoniinin metyyliesteri)», and it is that entry rather than this row's own name that the decree prints. In the printed order of that list the entry above it is Kodoksiimi and below it comes Kokanlehti. The same list closes by extending itself beyond its named entries, in the words «tässä luettelossa mainittuja aineita sisältävät valmisteet lukuun ottamatta luettelossa III mainittuja valmisteita.». The annex that carries this row stands as amended by 25.6.2026/651, which is the amendment that last touched this row's annex rather than the decree as a whole. Section 5 subsection 1 of huumausainelaki 373/2008 is the prohibition that placement engages, «Huumausaineen tuotanto, valmistus, tuonti Suomen alueelle, vienti Suomen alueelta, kuljetus, kauttakuljetus, jakelu, kauppa, käsittely, hallussapito ja käyttö on kielletty.», and chapter 50 section 5 subsection 1 of the Criminal Code makes the word huumausaine in those offences mean a narcotic under huumausainelaki, so the annex entry above is what puts this row inside them. Criminal Code chapter 50 section 2 a is the small quantity limb and it opens «Joka laittomasti käyttää taikka omaa käyttöä varten pitää hallussaan tai yrittää hankkia vähäisen määrän huumausainetta, on tuomittava», so the käyttörikos reaches this row on its own terms. No quantity figure is printed anywhere in chapter 50: whether a quantity is a suuri määrä, and whether the substance is an erittäin vaarallinen huumausaine under chapter 50 section 5 subsection 2, are findings of fact and the annex position does not settle either of them. No fine figure is printed either, because a Finnish fine is a day fine set on the offender's income.
If prescribed / medical: Section 24 of huumausainelaki 373/2008 disapplies the import and export rules for a medicinal product a traveller carries for personal medication where the substance is in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, and this row is inside that carve out. Section 19 of lääkelaki 395/1987 then governs. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. The entry this row is reached through sits in list I of the 1961 Convention annex, and section 24 of huumausainelaki 373/2008 reaches exactly that: it disapplies the import and export provisions of the Act for medicinal products containing a substance in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, the products being those «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä», and then hands the traveller to section 19 of lääkelaki 395/1987. That reading is about the entry, not about this row's own name, which the decree does not print. Whether a product containing this row falls inside the carve out follows from what the product contains, and this cell does not settle it.
Documentation: Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The locator a traveller or an official would be checking is Liite I list I entry 72 of 543/2008, as that annex stands after 25.6.2026/651, and the entry printed there reads «Kokaiini (bentsoyyliekgoniinin metyyliesteri)». Because the row is in that part of the convention annexes, section 24 of huumausainelaki 373/2008 takes a traveller's own prescribed medicine out of the Act's import and export provisions and leaves section 19 of lääkelaki 395/1987 to govern how much may be carried, which is the provision this cell did not read. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, pink cocaine, a named entry of Liite I list I of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 at printed position 72, that annex as amended by 25.6.2026/651 · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · finlex.fi · finlex.fi · Updated September 21, 2026

Pink Cocaine / Tusi in Finland, full detail →

Poppers

Legal status: Not a narcotic in Finland. Poppers is a trade name for alkyl nitrite preparations and it is not named in valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, nor is any alkyl nitrite named there or in the annex to valtioneuvoston asetus 1130/2014, as those annexes stand after 651/2026, 1119/2025 and 650/2026. The nitrites themselves are medicinal substances. Annex 1 of the medicines list 230/2025 carries amyl nitrite, and the Finnish column of the row reads «Amyylinitriitti». The row gives its Latin, Swedish and English columns as Amyli nitris, Amylnitrit, Amyl nitrite. There are separate rows for butyl, hexyl, isobutyl, isopentyl, isopropyl, pentyl and cyclohexyl nitrite. Section 2 subsection 1 of that decision supervises the annex 1 substances, their salts and their esters as medicines under section 3 subsection 1 or 2 of lääkelaki 395/1987. Section 1 of the decision states that the list is not exhaustive and that not every product containing a listed substance meets the medicine definition. The other seven nitrites sit in annex 1 A, not annex 1, and section 2 subsection 3 of the decision always equates an annex 1 A substance with a prescription only medicine. Read in this pass, annex 1 A carries butyylinitriitti, heksyylinitriitti, isobutyylinitriitti, isopentyylinitriitti, isopropyylinitriitti, pentyylinitriitti and sykloheksyylinitriitti. The live Finland cell also cited KKO 2026:47 paragraphs 7 to 12 and 25 to 26 as confirming medicine status for the pentyl, isopentyl and isopropyl products before that court and not for every possible poppers formulation, and that judgment is carried forward from the live cell and was not read here. The seven annex 1 A rows read «Butyylinitriitti», «Heksyylinitriitti», «Isobutyylinitriitti», «Isopentyylinitriitti», «Isopropyylinitriitti», «Pentyylinitriitti», «Sykloheksyylinitriitti».
Consequences if caught: Capital exposure: none. Criminal Code chapter 44 section 5 carries the medicines offence. It sets a fine or up to one year for manufacturing, importing, storing, keeping for sale or supplying medicines contrary to the Medicines Act or the European Union medicines regulations, unless a heavier penalty is provided elsewhere. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. This row is placed outside that regime, so they are recorded as Finland's published drug penalties and not as this substance's exposure. This row in particular. It is not named in either decree and that is a measured absence, not an assumption. The Finnish forms put to both texts for this row were «Poppers», «Amyylinitriitti», «Isobutyylinitriitti», «nitriitti». Against the consolidated 543/2008, whose annexes carry 196 entries in Liite I, 192 in Liite II, 11 in Liite III, 70 in Liite IV and 1 in Liite V, and against the annex to 1130/2014 as substituted by 650/2026, no form returned an entry of its own. No near miss came back either: not one entry in either annex contains any of those forms as a substring, so there is no longer name to be mistaken for this one. The bands stated above are the narcotics bands and they are reproduced because the live cell named chapter 50. They describe the lane this row would fall into if it were listed, and on the text read here it is not.
If prescribed / medical: This row's whole answer is the prescription route, and whether an authorised product exists in a given form is a product by product question that this cell does not settle. Sections 3 and 6 of lääkelaki 395/1987 are the provisions the live Finland cell named for this route and they are kept. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. The list that does name this row is the medicines list, Finnish Medicines Agency decision 230/2025. Its Liite 1 carries the row at printed line 186 of the annex text Finlex serves, and the printed row reads «Amyylinitriitti Amyli nitris Amylnitrit Amyl nitrite». In the printed order of that annex the line above it reads Amyylimetakresoli Amylmetacresolum Amylmetakresol Amylmetacresol and the line below it reads Anagrelidi Anagrelidum Anagrelid Anagrelide. A second row for this substance sits in Liite 1 A of the same list at printed line 3981, reading «Isobutyylinitriitti Isobutylnitrit Isobutyl nitrite».
Documentation: Section 24 of huumausainelaki 373/2008 is written for convention listed narcotics and does not describe this row, so the ordinary medicines rules are what apply. Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The search behind the absence stated for this row was run in Finnish and the forms were «Poppers», «Amyylinitriitti», «Isobutyylinitriitti», «nitriitti». Section 24 of huumausainelaki 373/2008, the provision that would otherwise carry a traveller's own medicine past the Act's import and export rules, reaches only products «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä» that contain a substance in one of the convention lists, and this row is in none of them. The list that does name this row is the medicines list, Finnish Medicines Agency decision 230/2025. Its Liite 1 carries the row at printed line 186 of the annex text Finlex serves, and the printed row reads «Amyylinitriitti Amyli nitris Amylnitrit Amyl nitrite». In the printed order of that annex the line above it reads Amyylimetakresoli Amylmetacresolum Amylmetakresol Amylmetacresol and the line below it reads Anagrelidi Anagrelidum Anagrelid Anagrelide. A second row for this substance sits in Liite 1 A of the same list at printed line 3981, reading «Isobutyylinitriitti Isobutylnitrit Isobutyl nitrite». Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, poppers, not a named entry of 543/2008 and not a named entry of the annex to 1130/2014, an absence measured by running the Finnish forms recorded in the documentation field against both texts · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · Lääkealan turvallisuus- ja kehittämiskeskuksen päätös lääkeluettelosta 230/2025 and its annexes, under lääkelaki 395/1987 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · finlex.fi · finlex.fi · finlex.fi · Updated September 21, 2026

Poppers in Finland, full detail →

Pregabalin

Legal status: Controlled, and exempted from licensing rather than from control. Section 1 of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 makes the substances in annexes I to V narcotics, and pregabalin sits in Liite V, the annex of substances released from the licensing requirement by section 23 of huumausainelaki 373/2008. The annex heads itself «Seuraava aine, joka on vapautettu luvanvaraisuudesta huumausainelain (373/2008) 23 §:n nojalla:» and the entry reads «Pregabaliini». That annex stands as amended by 8.12.2022/1019. Being in annex V and not in annexes I to IV means the licensing requirement falls away, not the narcotic character.
Consequences if caught: Capital exposure: none. The ceiling anywhere in this regime is the ten year maximum that Criminal Code chapter 50 section 2 sets for an aggravated narcotics offence. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. Section 5 of chapter 50 defines a narcotic for the whole chapter as a narcotic within the meaning of the Narcotics Act, and section 1 of the decree names annexes I to V together, while section 23 of the Act disapplies the import and export licence and nothing more. That the chapter therefore reaches an annex V substance is a reading of those three provisions together and not a sentence any one of them states, and it is recorded here as a reading rather than as an express provision. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. They describe the offences that this row's placement brings into play. This row in particular. Its entry is the whole of Liite V, which carries one entry and no other, under the heading «Seuraava aine, joka on vapautettu luvanvaraisuudesta huumausainelain (373/2008) 23 §:n nojalla:», and the entry reads «Pregabaliini». The annex that carries this row stands as amended by 8.12.2022/1019, which is the amendment that last touched this row's annex rather than the decree as a whole. Liite V is the licence exemption annex and not a control annex: section 1 of the decree still makes an entry in it a narcotic, and section 23 of huumausainelaki 373/2008 is what releases it from the licence, which is why the heading quoted above names that section. Section 5 subsection 1 of huumausainelaki 373/2008 is the prohibition that placement engages, «Huumausaineen tuotanto, valmistus, tuonti Suomen alueelle, vienti Suomen alueelta, kuljetus, kauttakuljetus, jakelu, kauppa, käsittely, hallussapito ja käyttö on kielletty.», and chapter 50 section 5 subsection 1 of the Criminal Code makes the word huumausaine in those offences mean a narcotic under huumausainelaki, so the annex entry above is what puts this row inside them. Criminal Code chapter 50 section 2 a is the small quantity limb and it opens «Joka laittomasti käyttää taikka omaa käyttöä varten pitää hallussaan tai yrittää hankkia vähäisen määrän huumausainetta, on tuomittava», so the käyttörikos reaches this row on its own terms. No quantity figure is printed anywhere in chapter 50: whether a quantity is a suuri määrä, and whether the substance is an erittäin vaarallinen huumausaine under chapter 50 section 5 subsection 2, are findings of fact and the annex position does not settle either of them. No fine figure is printed either, because a Finnish fine is a day fine set on the offender's income.
If prescribed / medical: Pregabalin is dispensed as a medicine and is also listed in annex 1 of the medicines list 230/2025. Section 23 of huumausainelaki 373/2008 is what releases it from the import and export licence. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. Liite V is not a control annex at all. Its heading is «Seuraava aine, joka on vapautettu luvanvaraisuudesta huumausainelain (373/2008) 23 §:n nojalla:», so this row is a narcotic that section 23 of huumausainelaki 373/2008 releases from the licence requirement, which is a different thing from being outside the decree.
Documentation: Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The locator a traveller or an official would be checking is Liite V entry 1 of 543/2008, as that annex stands after 8.12.2022/1019, and the entry printed there reads «Pregabaliini». Because Liite V is the licence exemption annex, the import and export licence of the Act is not what a traveller would be asked for here. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, pregabalin, a named entry of Liite V of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 at printed position 1, that annex as amended by 8.12.2022/1019 · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · Lääkealan turvallisuus- ja kehittämiskeskuksen päätös lääkeluettelosta 230/2025 and its annexes, under lääkelaki 395/1987 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · finlex.fi · Updated September 21, 2026

Pregabalin in Finland, full detail →

Psilocybin

Legal status: Controlled. Psilocybin is a narcotic in Finland by name. Section 1 of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 makes the substances, preparations and plants in annexes I to V narcotics, and this row's entry sits in Liite II, the annex headed as the substances and preparations in lists I to IV of the 1971 Convention on Psychotropic Substances, under list I, which the instrument itself heads as a schedule of the 1971 Convention on Psychotropic Substances, an attribution read off the annex heading and not checked against the INCB list in this pass. The entry reads «Psilosybiini (3-[2-(dimetyyliamino)etyyli]indol-4-yylidivetyfosfaatti)». Section 5 subsection 1 of huumausainelaki 373/2008 then forbids production, manufacture, import into Finland, export from Finland, transport, transit, distribution, trade, handling, possession and use, and allows departure from that ban only for medical, research, supervisory and industrial purposes as separately provided. The same list closes by extending itself, in the words «tämän luettelon aineiden suolat, jos sellaisen suolan muodostaminen on mahdollista; sekä». That annex stands as amended by 4.12.2025/1119.
Consequences if caught: Capital exposure: none. The ceiling anywhere in this regime is the ten year maximum that Criminal Code chapter 50 section 2 sets for an aggravated narcotics offence. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. This row sits in Liite II under list I of the decree, so those are the provisions its placement engages. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. They describe the offences that this row's placement brings into play. This row in particular. Its entry sits in Liite II, which the decree heads as the substances and preparations in the lists of the 1971 Convention on Psychotropic Substances, under list I of that annex, at printed position 27 of the 41 entries that list carries in the consolidated text read here, and the entry reads «Psilosybiini (3-[2-(dimetyyliamino)etyyli]indol-4-yylidivetyfosfaatti)». In the printed order of that list the entry above it is Psilosiini, psilotsiini and below it comes Rolisyklidiini. The same list closes by extending itself beyond its named entries, in the words «tässä luettelossa mainittuja aineita sisältävät valmisteet.». The annex that carries this row stands as amended by 4.12.2025/1119, which is the amendment that last touched this row's annex rather than the decree as a whole. Section 5 subsection 1 of huumausainelaki 373/2008 is the prohibition that placement engages, «Huumausaineen tuotanto, valmistus, tuonti Suomen alueelle, vienti Suomen alueelta, kuljetus, kauttakuljetus, jakelu, kauppa, käsittely, hallussapito ja käyttö on kielletty.», and chapter 50 section 5 subsection 1 of the Criminal Code makes the word huumausaine in those offences mean a narcotic under huumausainelaki, so the annex entry above is what puts this row inside them. This row is reached by the cultivation limb as well. Section 7 subsection 1 of huumausainelaki 373/2008 reads «Kat-kasvin (Catha edulis), Psilosybe-sienien ja kokapensaan viljely on kielletty.», and Criminal Code chapter 50 section 1 carries the same limb as a paragraph of the offence, «viljelee tai yrittää viljellä kokapensasta, kat-kasvia (Catha edulis) tai Psilosybe-sieniä,». Criminal Code chapter 50 section 2 a is the small quantity limb and it opens «Joka laittomasti käyttää taikka omaa käyttöä varten pitää hallussaan tai yrittää hankkia vähäisen määrän huumausainetta, on tuomittava», so the käyttörikos reaches this row on its own terms. No quantity figure is printed anywhere in chapter 50: whether a quantity is a suuri määrä, and whether the substance is an erittäin vaarallinen huumausaine under chapter 50 section 5 subsection 2, are findings of fact and the annex position does not settle either of them. No fine figure is printed either, because a Finnish fine is a day fine set on the offender's income.
If prescribed / medical: Section 24 of huumausainelaki 373/2008 disapplies the import and export rules for a traveller's personal medication only where the substance is in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention. This row is in list I of the 1971 Convention, which that carve out does not reach. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. This row sits in list I of the 1971 Convention annex, which is the one list section 24 of huumausainelaki 373/2008 leaves out. The carve out covers lists I to III of the 1961 Convention and lists II to IV of the 1971 Convention, for the products «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä», and a list I entry of the 1971 Convention annex is outside it.
Documentation: Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The locator a traveller or an official would be checking is Liite II list I entry 27 of 543/2008, as that annex stands after 4.12.2025/1119, and the entry printed there reads «Psilosybiini (3-[2-(dimetyyliamino)etyyli]indol-4-yylidivetyfosfaatti)». Because the row is outside the lists section 24 names, that section does not take a traveller's own medicine out of the Act's import and export provisions for this row, and nothing read here supplies a carriage allowance in its place. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, psilocybin, a named entry of Liite II list I of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 at printed position 27, that annex as amended by 4.12.2025/1119 · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · Updated September 21, 2026

Psilocybin in Finland, full detail →

Quetiapine

Legal status: Not a narcotic in Finland. Quetiapine is not named in any annex of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 and is not named in the annex to valtioneuvoston asetus 1130/2014, as those annexes stand after 651/2026, 1119/2025 and 650/2026. It is a medicine question instead. The Finnish Medicines Agency decision on the medicines list, 230/2025, names it in annex 1, where the Finnish column of the row reads «Ketiapiini». The row gives its Latin, Swedish and English columns as Quetiapinum, Ketiapin, Quetiapine. Section 2 subsection 1 of that decision supervises the annex 1 substances, their salts and their esters as medicines under section 3 subsection 1 or 2 of lääkelaki 395/1987. Section 1 of the decision states that the list is not exhaustive and that not every product containing a listed substance meets the medicine definition, so an individual product's status turns on its own classification.
Consequences if caught: Capital exposure: none. Criminal Code chapter 44 section 5 carries the medicines offence. It sets a fine or up to one year for manufacturing, importing, storing, keeping for sale or supplying medicines contrary to the Medicines Act or the European Union medicines regulations, unless a heavier penalty is provided elsewhere. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. This row is placed outside that regime, so they are recorded as Finland's published drug penalties and not as this substance's exposure. This row in particular. It is not named in either decree and that is a measured absence, not an assumption. The Finnish forms put to both texts for this row were «Ketiapiini», «Quetiapine». Against the consolidated 543/2008, whose annexes carry 196 entries in Liite I, 192 in Liite II, 11 in Liite III, 70 in Liite IV and 1 in Liite V, and against the annex to 1130/2014 as substituted by 650/2026, no form returned an entry of its own. No near miss came back either: not one entry in either annex contains any of those forms as a substring, so there is no longer name to be mistaken for this one. The bands stated above are the narcotics bands and they are reproduced because the live cell named chapter 50. They describe the lane this row would fall into if it were listed, and on the text read here it is not.
If prescribed / medical: This row's whole answer is the prescription route, and whether an authorised product exists in a given form is a product by product question that this cell does not settle. Sections 3 and 6 of lääkelaki 395/1987 are the provisions the live Finland cell named for this route and they are kept. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. The list that does name this row is the medicines list, Finnish Medicines Agency decision 230/2025. Its Liite 1 carries the row at printed line 1804 of the annex text Finlex serves, and the printed row reads «Ketiapiini Quetiapinum Ketiapin Quetiapine». In the printed order of that annex the line above it reads Ketatsolaami Ketazolamum Ketazolam Ketazolam and the line below it reads Ketobemidoni Cetobemidonum Ketobemidon Ketobemidone.
Documentation: Section 24 of huumausainelaki 373/2008 is written for convention listed narcotics and does not describe this row, so the ordinary medicines rules are what apply. Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The search behind the absence stated for this row was run in Finnish and the forms were «Ketiapiini», «Quetiapine». Section 24 of huumausainelaki 373/2008, the provision that would otherwise carry a traveller's own medicine past the Act's import and export rules, reaches only products «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä» that contain a substance in one of the convention lists, and this row is in none of them. The list that does name this row is the medicines list, Finnish Medicines Agency decision 230/2025. Its Liite 1 carries the row at printed line 1804 of the annex text Finlex serves, and the printed row reads «Ketiapiini Quetiapinum Ketiapin Quetiapine». In the printed order of that annex the line above it reads Ketatsolaami Ketazolamum Ketazolam Ketazolam and the line below it reads Ketobemidoni Cetobemidonum Ketobemidon Ketobemidone. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, quetiapine, not a named entry of 543/2008 and not a named entry of the annex to 1130/2014, an absence measured by running the Finnish forms recorded in the documentation field against both texts · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · Lääkealan turvallisuus- ja kehittämiskeskuksen päätös lääkeluettelosta 230/2025 and its annexes, under lääkelaki 395/1987 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · finlex.fi · finlex.fi · Updated September 21, 2026

Quetiapine in Finland, full detail →

Salvia divinorum

Legal status: Controlled, though not as a narcotic. Section 1 of valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014 makes the substances in its annex psychoactive substances banned from the consumer market, and Salvia divinorum is named there. The entry reads «Salvia Divinorum (sisältäen salvinoriini A ja B)». That annex stands as substituted by 650/2026. Section 5 subsection 2 of huumausainelaki 373/2008 bans manufacture, import into Finland, storage, keeping for sale and transfer, and leaves research and industrial use to be permitted separately, so possession for one's own use and use itself are not among the banned acts. Section 3 subsection 3 of the same Act defines the category as substances used for intoxication that may be dangerous to health, notified for control, and that are neither medicines nor narcotics. It is not named in any annex of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, as those annexes stand after 651/2026, 1119/2025 and 650/2026.
Consequences if caught: Capital exposure: none. Criminal Code chapter 44 section 5 a carries the separate consumer market offence. It sets a fine or up to one year for manufacturing, importing, storing, keeping for sale or transferring a psychoactive substance banned from the consumer market, contrary to the Narcotics Act. Possession for one's own use and use itself are not among the acts it names. Section 33 a of huumausainelaki 373/2008 adds import and storage duties, and section 23 b allows a university, a research institute or a trader to import and store on prior notice to the Finnish Medicines Agency. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. This row is placed outside that regime, so they are recorded as Finland's published drug penalties and not as this substance's exposure. This row in particular. Its entry sits in the annex to valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, as that annex was substituted by 650/2026, at printed line 1023 of the Finnish annex text Finlex serves, and it reads «Salvia Divinorum (sisältäen salvinoriini A ja B)». In the printed order of that annex the line above it reads Ro 07-3953 and the line below it reads SDB-005. Section 1 of that decree is one sentence and it does all of the work: «Kuluttajamarkkinoilta kiellettyjä psykoaktiivisia aineita ovat liitteessä mainitut aineet.». The penalty limb that placement engages is not chapter 50. It is Criminal Code chapter 44 section 5 a, which opens «Joka huumausainelain vastaisesti tahallaan tai törkeästä huolimattomuudesta valmistaa, tuo maahan, varastoi, pitää myynnissä tai luovuttaa kuluttajamarkkinoilta kiellettyä psykoaktiivista ainetta, on tuomittava» and sets a fine or up to one year, and only where no heavier penalty is provided elsewhere. Section 5 subsection 2 of huumausainelaki 373/2008 states the prohibition this row breaches, «Kuluttajamarkkinoilta kielletyn psykoaktiivisen aineen valmistus, tuonti Suomen alueelle, varastointi, myynnissä pitäminen ja luovuttaminen on kielletty.», and that list of acts does not include possession or use, so the huumausaineen käyttörikos in chapter 50 section 2 a does not reach this row. No quantity threshold and no fine figure is printed for this row in either the decree or chapter 44 section 5 a.
If prescribed / medical: A substance banned from the consumer market is by definition not a medicine, which is what section 3 subsection 3 of huumausainelaki 373/2008 says, so no prescription route follows from this listing. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. Section 24 of huumausainelaki 373/2008 writes its traveller carve out by reference to the convention lists and this row is in neither decree's convention annexes at all, so the carve out has nothing to attach to. The route in for this category is section 23 b instead, which reads «Elinkeinonharjoittaja saa tuoda maahan ja varastoida kuluttajamarkkinoilta kiellettyjä psykoaktiivisia aineita perustellusta syystä teollista toimintaansa varten, jos aineesta ja toiminnasta on tehty ennen maahantuontia ilmoitus Lääkealan turvallisuus- ja kehittämiskeskukselle.», and that is a research and industry route, not a prescription route.
Documentation: The traveller carve out in section 24 of huumausainelaki 373/2008 is written for medicinal products containing convention listed narcotics and does not describe this row. Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. What a traveller is carrying, if this row is in the bag, is a substance banned from the consumer market by name at printed line 1023 of the annex to 1130/2014, reading «Salvia Divinorum (sisältäen salvinoriini A ja B)», and import into Finland is one of the acts section 5 subsection 2 of huumausainelaki 373/2008 forbids. There is no traveller allowance to state for this row because the Act provides none for this category: the only import routes are the university and the industry notifications in section 23 b. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, Salvia divinorum, a named entry of the annex to valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014 at printed line 1023 of the Finnish annex text, that annex as substituted by 650/2026 · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · Updated September 21, 2026

Salvia divinorum in Finland, full detail →

Scopolamine (Devil's Breath)

Legal status: Not a narcotic in Finland. Scopolamine is not named in any annex of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 and is not named in the annex to valtioneuvoston asetus 1130/2014, as those annexes stand after 651/2026, 1119/2025 and 650/2026. It is a medicine question instead. The Finnish Medicines Agency decision on the medicines list, 230/2025, names it in annex 1, where the Finnish column of the row reads «Skopolamiini». The row gives its Latin, Swedish and English columns as Scopolaminum, Skopolamin, Scopolamine. Section 2 subsection 1 of that decision supervises the annex 1 substances, their salts and their esters as medicines under section 3 subsection 1 or 2 of lääkelaki 395/1987. Section 1 of the decision states that the list is not exhaustive and that not every product containing a listed substance meets the medicine definition, so an individual product's status turns on its own classification.
Consequences if caught: Capital exposure: none. Criminal Code chapter 44 section 5 carries the medicines offence. It sets a fine or up to one year for manufacturing, importing, storing, keeping for sale or supplying medicines contrary to the Medicines Act or the European Union medicines regulations, unless a heavier penalty is provided elsewhere. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. This row is placed outside that regime, so they are recorded as Finland's published drug penalties and not as this substance's exposure. This row in particular. It is not named in either decree and that is a measured absence, not an assumption. The Finnish forms put to both texts for this row were «Skopolamiini», «Hyoskiini», «Scopolamine». Against the consolidated 543/2008, whose annexes carry 196 entries in Liite I, 192 in Liite II, 11 in Liite III, 70 in Liite IV and 1 in Liite V, and against the annex to 1130/2014 as substituted by 650/2026, no form returned an entry of its own. No near miss came back either: not one entry in either annex contains any of those forms as a substring, so there is no longer name to be mistaken for this one. The bands stated above are the narcotics bands and they are reproduced because the live cell named chapter 50. They describe the lane this row would fall into if it were listed, and on the text read here it is not.
If prescribed / medical: This row's whole answer is the prescription route, and whether an authorised product exists in a given form is a product by product question that this cell does not settle. Sections 3 and 6 of lääkelaki 395/1987 are the provisions the live Finland cell named for this route and they are kept. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. The list that does name this row is the medicines list, Finnish Medicines Agency decision 230/2025. Its Liite 1 carries the row at printed line 3310 of the annex text Finlex serves, and the printed row reads «Skopolamiini Scopolaminum Skopolamin Scopolamine». In the printed order of that annex the line above it reads Sitalopraami Citalopramum Citalopram Citalopram and the line below it reads Skopolamiinihydrobromidi Scopolamini Skopolaminhydrobromid Scopolamine hydrobromide.
Documentation: Section 24 of huumausainelaki 373/2008 is written for convention listed narcotics and does not describe this row, so the ordinary medicines rules are what apply. Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The search behind the absence stated for this row was run in Finnish and the forms were «Skopolamiini», «Hyoskiini», «Scopolamine». Section 24 of huumausainelaki 373/2008, the provision that would otherwise carry a traveller's own medicine past the Act's import and export rules, reaches only products «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä» that contain a substance in one of the convention lists, and this row is in none of them. The list that does name this row is the medicines list, Finnish Medicines Agency decision 230/2025. Its Liite 1 carries the row at printed line 3310 of the annex text Finlex serves, and the printed row reads «Skopolamiini Scopolaminum Skopolamin Scopolamine». In the printed order of that annex the line above it reads Sitalopraami Citalopramum Citalopram Citalopram and the line below it reads Skopolamiinihydrobromidi Scopolamini Skopolaminhydrobromid Scopolamine hydrobromide. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, scopolamine, not a named entry of 543/2008 and not a named entry of the annex to 1130/2014, an absence measured by running the Finnish forms recorded in the documentation field against both texts · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · Lääkealan turvallisuus- ja kehittämiskeskuksen päätös lääkeluettelosta 230/2025 and its annexes, under lääkelaki 395/1987 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · finlex.fi · finlex.fi · Updated September 21, 2026

Scopolamine (Devil's Breath) in Finland, full detail →

Synthetic Cannabinoids (K2 / Spice)

Legal status: Controlled through named members rather than as a class. The decree names no class term for this row. Section 1 of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 makes the substances, preparations and plants in annexes I to V narcotics, and this row's entry sits in Liite II, the annex headed as the substances and preparations in lists I to IV of the 1971 Convention on Psychotropic Substances, under list II, which the instrument itself heads as a schedule of the 1971 Convention on Psychotropic Substances, an attribution read off the annex heading and not checked against the INCB list in this pass. The entry reads «5F-MDMB-PINACA (5F-ADB) (metyyli (2S)-2-{[1-(5-fluoripentyyli)-1 H -indatsoli-3-karbonyyli]amino}-3,3-dimetyylibutanoaatti)». The instrument italicises part of that entry and the spacing around the italicised locants is as Finlex serves it. Section 5 subsection 1 of huumausainelaki 373/2008 then forbids production, manufacture, import into Finland, export from Finland, transport, transit, distribution, trade, handling, possession and use, and allows departure from that ban only for medical, research, supervisory and industrial purposes as separately provided. The same list closes by extending itself, in the words «tämän luettelon aineiden suolat, mukaan luettuna edellä mainittujen isomeerien suolat, jos sellaisten olemassaolo on mahdollista; sekä». That annex stands as amended by 4.12.2025/1119. The members read in this pass sit in three places at once. Liite II list II names 5F-MDMB-PINACA, 5F-MDMB-PICA, 5F-AMB-PINACA, 5F-APINACA, 5F-PB-22, AB-CHMINACA and 4F-MDMB-BINACA. Liite III names 4F-MDMB-BICA. The 1130/2014 annex names a further long tail including HU-210 and the FUBINACA family. The live Finland cell's wider reading is kept. It recorded JWH-018, JWH-073 and HU-210 by name, the annex to valtioneuvoston asetus 1130/2014, and sections 1 to 3 of the medicines list 230/2025 with lääkelaki 395/1987 sections 3 and 6, and it recorded that no blanket receptor activity test covers an undefined class and that no finite member or structure set was supplied.
Consequences if caught: Capital exposure: none. The ceiling anywhere in this regime is the ten year maximum that Criminal Code chapter 50 section 2 sets for an aggravated narcotics offence. No penalty is asserted for this entry as a class, because the classification itself is unresolved. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. This row sits in Liite II under list II of the decree, so those are the provisions its placement engages. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. They describe the offences that this row's placement brings into play. This row in particular. The entry this row is reached through sits in Liite II, which the decree heads as the substances and preparations in the lists of the 1971 Convention on Psychotropic Substances, under list II of that annex, at printed position 5 of the 68 entries that list carries in the consolidated text read here, it reads «5F-MDMB-PINACA (5F-ADB) (metyyli (2S)-2-{[1-(5-fluoripentyyli)-1H-indatsoli-3-karbonyyli]amino}-3,3-dimetyylibutanoaatti)», and it is that entry rather than this row's own name that the decree prints. In the printed order of that list the entry above it is 5F-MDMB-PICA and below it comes 5F-PB-22. The same list closes by extending itself beyond its named entries, in the words «tässä luettelossa mainittuja aineita sisältävät valmisteet.». The annex that carries this row stands as amended by 4.12.2025/1119, which is the amendment that last touched this row's annex rather than the decree as a whole. Section 5 subsection 1 of huumausainelaki 373/2008 is the prohibition that placement engages, «Huumausaineen tuotanto, valmistus, tuonti Suomen alueelle, vienti Suomen alueelta, kuljetus, kauttakuljetus, jakelu, kauppa, käsittely, hallussapito ja käyttö on kielletty.», and chapter 50 section 5 subsection 1 of the Criminal Code makes the word huumausaine in those offences mean a narcotic under huumausainelaki, so the annex entry above is what puts this row inside them. Criminal Code chapter 50 section 2 a is the small quantity limb and it opens «Joka laittomasti käyttää taikka omaa käyttöä varten pitää hallussaan tai yrittää hankkia vähäisen määrän huumausainetta, on tuomittava», so the käyttörikos reaches this row on its own terms. No quantity figure is printed anywhere in chapter 50: whether a quantity is a suuri määrä, and whether the substance is an erittäin vaarallinen huumausaine under chapter 50 section 5 subsection 2, are findings of fact and the annex position does not settle either of them. No fine figure is printed either, because a Finnish fine is a day fine set on the offender's income.
If prescribed / medical: Section 24 of huumausainelaki 373/2008 disapplies the import and export rules for a medicinal product a traveller carries for personal medication where the substance is in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, and this row is inside that carve out. Section 19 of lääkelaki 395/1987 then governs. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. The entry this row is reached through sits in list II of the 1971 Convention annex, and section 24 of huumausainelaki 373/2008 reaches exactly that: it disapplies the import and export provisions of the Act for medicinal products containing a substance in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, the products being those «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä», and then hands the traveller to section 19 of lääkelaki 395/1987. That reading is about the entry, not about this row's own name, which the decree does not print. Whether a product containing this row falls inside the carve out follows from what the product contains, and this cell does not settle it.
Documentation: Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The locator a traveller or an official would be checking is Liite II list II entry 5 of 543/2008, as that annex stands after 4.12.2025/1119, and the entry printed there reads «5F-MDMB-PINACA (5F-ADB) (metyyli (2S)-2-{[1-(5-fluoripentyyli)-1H-indatsoli-3-karbonyyli]amino}-3,3-dimetyylibutanoaatti)». Because the row is in that part of the convention annexes, section 24 of huumausainelaki 373/2008 takes a traveller's own prescribed medicine out of the Act's import and export provisions and leaves section 19 of lääkelaki 395/1987 to govern how much may be carried, which is the provision this cell did not read. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, synthetic cannabinoids, a named entry of Liite II list II of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 at printed position 5, that annex as amended by 4.12.2025/1119 · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · finlex.fi · finlex.fi · Updated September 21, 2026

Synthetic Cannabinoids (K2 / Spice) in Finland, full detail →

THC-P

Legal status: Controlled, though not as a narcotic. Section 1 of valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014 makes the substances in its annex psychoactive substances banned from the consumer market, and THC-P is named there. The entry reads «∆-9-Tetrahydrokannabiforoli (∆-9-THCP) (3-heptyyli-6a,7,8,10a-tetrahydro-6,6,9-trimetyyli-6H-dibentso[b,d]pyran-1-oli)». That annex stands as substituted by 650/2026. Section 5 subsection 2 of huumausainelaki 373/2008 bans manufacture, import into Finland, storage, keeping for sale and transfer, and leaves research and industrial use to be permitted separately, so possession for one's own use and use itself are not among the banned acts. Section 3 subsection 3 of the same Act defines the category as substances used for intoxication that may be dangerous to health, notified for control, and that are neither medicines nor narcotics. It is not named in any annex of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, as those annexes stand after 651/2026, 1119/2025 and 650/2026. The same annex carries the delta 8 variant, which reads «∆-8-Tetrahydrokannabiforoli (∆-8-THCP) (3-heptyyli-6a,7,10,10a-tetrahydro-6,6,9-trimetyyli-6H-dibentso[b,d]pyran-1-oli)».
Consequences if caught: Capital exposure: none. Criminal Code chapter 44 section 5 a carries the separate consumer market offence. It sets a fine or up to one year for manufacturing, importing, storing, keeping for sale or transferring a psychoactive substance banned from the consumer market, contrary to the Narcotics Act. Possession for one's own use and use itself are not among the acts it names. Section 33 a of huumausainelaki 373/2008 adds import and storage duties, and section 23 b allows a university, a research institute or a trader to import and store on prior notice to the Finnish Medicines Agency. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. This row is placed outside that regime, so they are recorded as Finland's published drug penalties and not as this substance's exposure. This row in particular. Its entry sits in the annex to valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, as that annex was substituted by 650/2026, at printed line 1056 of the Finnish annex text Finlex serves, and it reads «∆-9-Tetrahydrokannabiforoli (∆-9-THCP)». In the printed order of that annex the line above it reads trimetyyli-6H-dibentso[b,d]pyran-1-oli) and the line below it reads trimetyyli-6H-dibentso[b,d]pyran-1-oli)∆-8-THCP-O-asetaatti. Section 1 of that decree is one sentence and it does all of the work: «Kuluttajamarkkinoilta kiellettyjä psykoaktiivisia aineita ovat liitteessä mainitut aineet.». The penalty limb that placement engages is not chapter 50. It is Criminal Code chapter 44 section 5 a, which opens «Joka huumausainelain vastaisesti tahallaan tai törkeästä huolimattomuudesta valmistaa, tuo maahan, varastoi, pitää myynnissä tai luovuttaa kuluttajamarkkinoilta kiellettyä psykoaktiivista ainetta, on tuomittava» and sets a fine or up to one year, and only where no heavier penalty is provided elsewhere. Section 5 subsection 2 of huumausainelaki 373/2008 states the prohibition this row breaches, «Kuluttajamarkkinoilta kielletyn psykoaktiivisen aineen valmistus, tuonti Suomen alueelle, varastointi, myynnissä pitäminen ja luovuttaminen on kielletty.», and that list of acts does not include possession or use, so the huumausaineen käyttörikos in chapter 50 section 2 a does not reach this row. No quantity threshold and no fine figure is printed for this row in either the decree or chapter 44 section 5 a.
If prescribed / medical: A substance banned from the consumer market is by definition not a medicine, which is what section 3 subsection 3 of huumausainelaki 373/2008 says, so no prescription route follows from this listing. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. Section 24 of huumausainelaki 373/2008 writes its traveller carve out by reference to the convention lists and this row is in neither decree's convention annexes at all, so the carve out has nothing to attach to. The route in for this category is section 23 b instead, which reads «Elinkeinonharjoittaja saa tuoda maahan ja varastoida kuluttajamarkkinoilta kiellettyjä psykoaktiivisia aineita perustellusta syystä teollista toimintaansa varten, jos aineesta ja toiminnasta on tehty ennen maahantuontia ilmoitus Lääkealan turvallisuus- ja kehittämiskeskukselle.», and that is a research and industry route, not a prescription route.
Documentation: The traveller carve out in section 24 of huumausainelaki 373/2008 is written for medicinal products containing convention listed narcotics and does not describe this row. Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. What a traveller is carrying, if this row is in the bag, is a substance banned from the consumer market by name at printed line 1056 of the annex to 1130/2014, reading «∆-9-Tetrahydrokannabiforoli (∆-9-THCP)», and import into Finland is one of the acts section 5 subsection 2 of huumausainelaki 373/2008 forbids. There is no traveller allowance to state for this row because the Act provides none for this category: the only import routes are the university and the industry notifications in section 23 b. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, THC-P, a named entry of the annex to valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014 at printed line 1056 of the Finnish annex text, that annex as substituted by 650/2026 · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · Updated September 21, 2026

THC-P in Finland, full detail →

Tobacco

Legal status: Controlled by its own statute rather than by the narcotics schedule. Tupakkalaki 549/2016 section 53 subsection 1 reads «Tupakkatuotteita, nikotiininesteitä ja savuttomia nikotiinituotteita ei saa myydä tai muutoin luovuttaa eikä välittää alle 18-vuotiaalle.» Section 118 adds that a person under 18 may not possess a tobacco product or a tobacco substitute, and section 44 makes retail sale licensable. Tobacco is not named in any annex of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 and not named in the annex to valtioneuvoston asetus 1130/2014, as those annexes stand after 651/2026, 1119/2025 and 650/2026. Section 118 reads «Alle 18-vuotias ei saa pitää hallussaan tupakkatuotetta tai tupakan vastiketta.»
Consequences if caught: Capital exposure: none. Tupakkalaki 549/2016 section 109 sets a fine or up to six months for a tobacco sales offence, which includes selling, supplying for consideration or passing on a tobacco product, nicotine liquid or smokeless nicotine product to a person under 18 contrary to section 53 subsection 1. Section 113 makes smoking on after a warning in a place where section 74 forbids it a tupakointirikkomus punishable by a fine. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. This row is placed outside that regime, so they are recorded as Finland's published drug penalties and not as this substance's exposure. This row in particular. Tobacco is not carried by either drug decree, so neither the chapter 50 lane nor the chapter 44 section 5 a lane is the one that describes this row. The statute that does is tupakkalaki 549/2016, and the bands stated above are the narcotics bands, reproduced because the live cell named chapter 50 and they are what that citation means, not because this row sits in them. It is not named in either decree and that is a measured absence, not an assumption. The Finnish forms put to both texts for this row were «Tupakka», «Nicotiana», «Nikotiini», «nikotin». Against the consolidated 543/2008, whose annexes carry 196 entries in Liite I, 192 in Liite II, 11 in Liite III, 70 in Liite IV and 1 in Liite V, and against the annex to 1130/2014 as substituted by 650/2026, no form returned an entry of its own. What the search did return is a near miss rather than a hit: in Liite I the longer entry «Nikomorfiini (3,6-dinikotinyylimorfiini)»; and in Liite I the longer entry «Nikodikodiini (6-nikotinyylidihydrokodeiini)», which contains the searched form inside a different molecule's name and is not this row.
If prescribed / medical: Tobacco is not a prescription medicine here, although nicotine as a substance is listed separately in the medicines list. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. Neither decree names this row, so section 24 of huumausainelaki 373/2008 has no list to match it against: that section is written by reference to the convention lists and takes out of the Act's import and export provisions only medicinal products «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä» containing a substance in one of them. The medicines list 230/2025 was read for this row as well, in its Liite 1, Liite 1 A and Liite 2, and the Finnish forms recorded in the documentation field return no row of its own there either.
Documentation: No document is carried for tobacco. Age is the operative control and sections 53 and 118 set it at 18. Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The search behind the absence stated for this row was run in Finnish and the forms were «Tupakka», «Nicotiana», «Nikotiini», «nikotin». Section 24 of huumausainelaki 373/2008, the provision that would otherwise carry a traveller's own medicine past the Act's import and export rules, reaches only products «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä» that contain a substance in one of the convention lists, and this row is in none of them. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, tobacco, not a named entry of either drug decree and governed by tupakkalaki 549/2016 · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · finlex.fi · carried forward from the b966 Finland cell, which this batch stacks on and does not replace: sections 44 · Updated September 21, 2026

Tobacco in Finland, full detail →

Tramadol

Legal status: Not a narcotic in Finland. Tramadol is not named in any annex of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 and is not named in the annex to valtioneuvoston asetus 1130/2014, as those annexes stand after 651/2026, 1119/2025 and 650/2026. It is a medicine question instead. The Finnish Medicines Agency decision on the medicines list, 230/2025, names it in annex 1, where the Finnish column of the row reads «Tramadoli». The row gives its Latin, Swedish and English columns as Tramadolum, Tramadol, Tramadol. Section 2 subsection 1 of that decision supervises the annex 1 substances, their salts and their esters as medicines under section 3 subsection 1 or 2 of lääkelaki 395/1987. Section 1 of the decision states that the list is not exhaustive and that not every product containing a listed substance meets the medicine definition, so an individual product's status turns on its own classification.
Consequences if caught: Capital exposure: none. Criminal Code chapter 44 section 5 carries the medicines offence. It sets a fine or up to one year for manufacturing, importing, storing, keeping for sale or supplying medicines contrary to the Medicines Act or the European Union medicines regulations, unless a heavier penalty is provided elsewhere. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. This row is placed outside that regime, so they are recorded as Finland's published drug penalties and not as this substance's exposure. This row in particular. It is not named in either decree and that is a measured absence, not an assumption. The Finnish forms put to both texts for this row were «Tramadoli», «Tramadol». Against the consolidated 543/2008, whose annexes carry 196 entries in Liite I, 192 in Liite II, 11 in Liite III, 70 in Liite IV and 1 in Liite V, and against the annex to 1130/2014 as substituted by 650/2026, no form returned an entry of its own. No near miss came back either: not one entry in either annex contains any of those forms as a substring, so there is no longer name to be mistaken for this one. The bands stated above are the narcotics bands and they are reproduced because the live cell named chapter 50. They describe the lane this row would fall into if it were listed, and on the text read here it is not.
If prescribed / medical: This row's whole answer is the prescription route, and whether an authorised product exists in a given form is a product by product question that this cell does not settle. Sections 3 and 6 of lääkelaki 395/1987 are the provisions the live Finland cell named for this route and they are kept. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. The list that does name this row is the medicines list, Finnish Medicines Agency decision 230/2025. Its Liite 1 carries the row at printed line 3663 of the annex text Finlex serves, and the printed row reads «Tramadoli Tramadolum Tramadol Tramadol». In the printed order of that annex the line above it reads Tralokinumabi Tralokinumabum Tralokinumab Tralokinumab and the line below it reads Trametinibi Trametinibum Trametinib Trametinib.
Documentation: Section 24 of huumausainelaki 373/2008 is written for convention listed narcotics and does not describe this row, so the ordinary medicines rules are what apply. Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The search behind the absence stated for this row was run in Finnish and the forms were «Tramadoli», «Tramadol». Section 24 of huumausainelaki 373/2008, the provision that would otherwise carry a traveller's own medicine past the Act's import and export rules, reaches only products «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä» that contain a substance in one of the convention lists, and this row is in none of them. The list that does name this row is the medicines list, Finnish Medicines Agency decision 230/2025. Its Liite 1 carries the row at printed line 3663 of the annex text Finlex serves, and the printed row reads «Tramadoli Tramadolum Tramadol Tramadol». In the printed order of that annex the line above it reads Tralokinumabi Tralokinumabum Tralokinumab Tralokinumab and the line below it reads Trametinibi Trametinibum Trametinib Trametinib. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, tramadol, not a named entry of 543/2008 and not a named entry of the annex to 1130/2014, an absence measured by running the Finnish forms recorded in the documentation field against both texts · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · Lääkealan turvallisuus- ja kehittämiskeskuksen päätös lääkeluettelosta 230/2025 and its annexes, under lääkelaki 395/1987 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · finlex.fi · finlex.fi · Updated September 21, 2026

Tramadol in Finland, full detail →

Xanax (Alprazolam)

Legal status: Controlled. Alprazolam is a narcotic in Finland by name. Section 1 of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 makes the substances, preparations and plants in annexes I to V narcotics, and this row's entry sits in Liite II, the annex headed as the substances and preparations in lists I to IV of the 1971 Convention on Psychotropic Substances, under list IV, which the instrument itself heads as a schedule of the 1971 Convention on Psychotropic Substances, an attribution read off the annex heading and not checked against the INCB list in this pass. The entry reads «Alpratsolaami (8-kloori-1-metyyli-6-fenyyli-4 H - s -triatsolo[4,3- a ][1,4]bentsodiatsepiini)». The instrument italicises part of that entry and the spacing around the italicised locants is as Finlex serves it. Section 5 subsection 1 of huumausainelaki 373/2008 then forbids production, manufacture, import into Finland, export from Finland, transport, transit, distribution, trade, handling, possession and use, and allows departure from that ban only for medical, research, supervisory and industrial purposes as separately provided. The same list closes by extending itself, in the words «tämän luettelon aineiden suolat, mukaan luettuna edellä mainittujen isomeerien suolat, jos sellaisten olemassaolo on mahdollista; sekä». That annex stands as amended by 4.12.2025/1119.
Consequences if caught: Capital exposure: none. The ceiling anywhere in this regime is the ten year maximum that Criminal Code chapter 50 section 2 sets for an aggravated narcotics offence. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. This row sits in Liite II under list IV of the decree, so those are the provisions its placement engages. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. They describe the offences that this row's placement brings into play. This row in particular. Its entry sits in Liite II, which the decree heads as the substances and preparations in the lists of the 1971 Convention on Psychotropic Substances, under list IV of that annex, at printed position 2 of the 71 entries that list carries in the consolidated text read here, and the entry reads «Alpratsolaami (8-kloori-1-metyyli-6-fenyyli-4H-s-triatsolo[4,3-a][1,4]bentsodiatsepiini)». In the printed order of that list the entry above it is Allobarbitaali and below it comes Amfepramoni. The same list closes by extending itself beyond its named entries, in the words «tässä luettelossa mainittuja aineita sisältävät valmisteet.». The annex that carries this row stands as amended by 4.12.2025/1119, which is the amendment that last touched this row's annex rather than the decree as a whole. Section 5 subsection 1 of huumausainelaki 373/2008 is the prohibition that placement engages, «Huumausaineen tuotanto, valmistus, tuonti Suomen alueelle, vienti Suomen alueelta, kuljetus, kauttakuljetus, jakelu, kauppa, käsittely, hallussapito ja käyttö on kielletty.», and chapter 50 section 5 subsection 1 of the Criminal Code makes the word huumausaine in those offences mean a narcotic under huumausainelaki, so the annex entry above is what puts this row inside them. Criminal Code chapter 50 section 2 a is the small quantity limb and it opens «Joka laittomasti käyttää taikka omaa käyttöä varten pitää hallussaan tai yrittää hankkia vähäisen määrän huumausainetta, on tuomittava», so the käyttörikos reaches this row on its own terms. No quantity figure is printed anywhere in chapter 50: whether a quantity is a suuri määrä, and whether the substance is an erittäin vaarallinen huumausaine under chapter 50 section 5 subsection 2, are findings of fact and the annex position does not settle either of them. No fine figure is printed either, because a Finnish fine is a day fine set on the offender's income.
If prescribed / medical: Section 24 of huumausainelaki 373/2008 disapplies the import and export rules for a medicinal product a traveller carries for personal medication where the substance is in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, and this row is inside that carve out. Section 19 of lääkelaki 395/1987 then governs. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. This row sits in list IV of the 1971 Convention annex, and section 24 of huumausainelaki 373/2008 reaches exactly that: it disapplies the import and export provisions of the Act for medicinal products containing a substance in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, the products being those «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä», and then hands the traveller to section 19 of lääkelaki 395/1987. Section 23 subsection 3 of the same Act is the neighbouring relief for this list: a combination preparation containing a psychotropic substance other than one in list I of the 1971 Convention needs no import or export licence where the narcotic content is small or hard to separate and the abuse risk is slight against the substance's wide medicinal use.
Documentation: Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The locator a traveller or an official would be checking is Liite II list IV entry 2 of 543/2008, as that annex stands after 4.12.2025/1119, and the entry printed there reads «Alpratsolaami (8-kloori-1-metyyli-6-fenyyli-4H-s-triatsolo[4,3-a][1,4]bentsodiatsepiini)». Because the row is in that part of the convention annexes, section 24 of huumausainelaki 373/2008 takes a traveller's own prescribed medicine out of the Act's import and export provisions and leaves section 19 of lääkelaki 395/1987 to govern how much may be carried, which is the provision this cell did not read. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, alprazolam, a named entry of Liite II list IV of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 at printed position 2, that annex as amended by 4.12.2025/1119 · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · Updated September 21, 2026

Xanax (Alprazolam) in Finland, full detail →

Xylazine

Legal status: Not a narcotic in Finland. Xylazine is not named in any annex of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 and is not named in the annex to valtioneuvoston asetus 1130/2014, as those annexes stand after 651/2026, 1119/2025 and 650/2026. It is a medicine question instead. The Finnish Medicines Agency decision on the medicines list, 230/2025, names it in annex 1, where the Finnish column of the row reads «Ksylatsiini». The row gives its Latin, Swedish and English columns as Xylazinum, Xylazin, Xylazine. Section 2 subsection 1 of that decision supervises the annex 1 substances, their salts and their esters as medicines under section 3 subsection 1 or 2 of lääkelaki 395/1987. Section 1 of the decision states that the list is not exhaustive and that not every product containing a listed substance meets the medicine definition, so an individual product's status turns on its own classification.
Consequences if caught: Capital exposure: none. Criminal Code chapter 44 section 5 carries the medicines offence. It sets a fine or up to one year for manufacturing, importing, storing, keeping for sale or supplying medicines contrary to the Medicines Act or the European Union medicines regulations, unless a heavier penalty is provided elsewhere. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. This row is placed outside that regime, so they are recorded as Finland's published drug penalties and not as this substance's exposure. This row in particular. It is not named in either decree and that is a measured absence, not an assumption. The Finnish forms put to both texts for this row were «Ksylatsiini», «Xylazine». Against the consolidated 543/2008, whose annexes carry 196 entries in Liite I, 192 in Liite II, 11 in Liite III, 70 in Liite IV and 1 in Liite V, and against the annex to 1130/2014 as substituted by 650/2026, no form returned an entry of its own. No near miss came back either: not one entry in either annex contains any of those forms as a substring, so there is no longer name to be mistaken for this one. The bands stated above are the narcotics bands and they are reproduced because the live cell named chapter 50. They describe the lane this row would fall into if it were listed, and on the text read here it is not.
If prescribed / medical: This row's whole answer is the prescription route, and whether an authorised product exists in a given form is a product by product question that this cell does not settle. Sections 3 and 6 of lääkelaki 395/1987 are the provisions the live Finland cell named for this route and they are kept. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. The list that does name this row is the medicines list, Finnish Medicines Agency decision 230/2025. Its Liite 1 carries the row at printed line 1969 of the annex text Finlex serves, and the printed row reads «Ksylatsiini Xylazinum Xylazin Xylazine». In the printed order of that annex the line above it reads Ksipamidi Xipamidum Xipamid Xipamide and the line below it reads Ksylometatsoliini Xylometazolinum Xylometazolin Xylometazoline.
Documentation: Section 24 of huumausainelaki 373/2008 is written for convention listed narcotics and does not describe this row, so the ordinary medicines rules are what apply. Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The search behind the absence stated for this row was run in Finnish and the forms were «Ksylatsiini», «Xylazine». Section 24 of huumausainelaki 373/2008, the provision that would otherwise carry a traveller's own medicine past the Act's import and export rules, reaches only products «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä» that contain a substance in one of the convention lists, and this row is in none of them. The list that does name this row is the medicines list, Finnish Medicines Agency decision 230/2025. Its Liite 1 carries the row at printed line 1969 of the annex text Finlex serves, and the printed row reads «Ksylatsiini Xylazinum Xylazin Xylazine». In the printed order of that annex the line above it reads Ksipamidi Xipamidum Xipamid Xipamide and the line below it reads Ksylometatsoliini Xylometazolinum Xylometazolin Xylometazoline. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, xylazine, not a named entry of 543/2008 and not a named entry of the annex to 1130/2014, an absence measured by running the Finnish forms recorded in the documentation field against both texts · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · Lääkealan turvallisuus- ja kehittämiskeskuksen päätös lääkeluettelosta 230/2025 and its annexes, under lääkelaki 395/1987 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · finlex.fi · finlex.fi · Updated September 21, 2026

Xylazine in Finland, full detail →

Zolpidem

Legal status: Controlled. Zolpidem is a narcotic in Finland by name. Section 1 of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 makes the substances, preparations and plants in annexes I to V narcotics, and this row's entry sits in Liite II, the annex headed as the substances and preparations in lists I to IV of the 1971 Convention on Psychotropic Substances, under list IV, which the instrument itself heads as a schedule of the 1971 Convention on Psychotropic Substances, an attribution read off the annex heading and not checked against the INCB list in this pass. The entry reads «Tsolpideemi (N, N,6-trimetyyli-2- p -tolyyli-imidatso[1,2- α ]pyridiini-3-asetamidi)». The instrument italicises part of that entry and the spacing around the italicised locants is as Finlex serves it. Section 5 subsection 1 of huumausainelaki 373/2008 then forbids production, manufacture, import into Finland, export from Finland, transport, transit, distribution, trade, handling, possession and use, and allows departure from that ban only for medical, research, supervisory and industrial purposes as separately provided. The same list closes by extending itself, in the words «tämän luettelon aineiden suolat, mukaan luettuna edellä mainittujen isomeerien suolat, jos sellaisten olemassaolo on mahdollista; sekä». That annex stands as amended by 4.12.2025/1119.
Consequences if caught: Capital exposure: none. The ceiling anywhere in this regime is the ten year maximum that Criminal Code chapter 50 section 2 sets for an aggravated narcotics offence. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. This row sits in Liite II under list IV of the decree, so those are the provisions its placement engages. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. They describe the offences that this row's placement brings into play. This row in particular. Its entry sits in Liite II, which the decree heads as the substances and preparations in the lists of the 1971 Convention on Psychotropic Substances, under list IV of that annex, at printed position 67 of the 71 entries that list carries in the consolidated text read here, and the entry reads «Tsolpideemi (N,N,6-trimetyyli-2-p-tolyyli-imidatso[1,2-α]pyridiini-3-asetamidi)». In the printed order of that list the entry above it is Triatsolaami and below it comes Vinyylibitaali. The same list closes by extending itself beyond its named entries, in the words «tässä luettelossa mainittuja aineita sisältävät valmisteet.». The annex that carries this row stands as amended by 4.12.2025/1119, which is the amendment that last touched this row's annex rather than the decree as a whole. Section 5 subsection 1 of huumausainelaki 373/2008 is the prohibition that placement engages, «Huumausaineen tuotanto, valmistus, tuonti Suomen alueelle, vienti Suomen alueelta, kuljetus, kauttakuljetus, jakelu, kauppa, käsittely, hallussapito ja käyttö on kielletty.», and chapter 50 section 5 subsection 1 of the Criminal Code makes the word huumausaine in those offences mean a narcotic under huumausainelaki, so the annex entry above is what puts this row inside them. Criminal Code chapter 50 section 2 a is the small quantity limb and it opens «Joka laittomasti käyttää taikka omaa käyttöä varten pitää hallussaan tai yrittää hankkia vähäisen määrän huumausainetta, on tuomittava», so the käyttörikos reaches this row on its own terms. No quantity figure is printed anywhere in chapter 50: whether a quantity is a suuri määrä, and whether the substance is an erittäin vaarallinen huumausaine under chapter 50 section 5 subsection 2, are findings of fact and the annex position does not settle either of them. No fine figure is printed either, because a Finnish fine is a day fine set on the offender's income.
If prescribed / medical: Section 24 of huumausainelaki 373/2008 disapplies the import and export rules for a medicinal product a traveller carries for personal medication where the substance is in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, and this row is inside that carve out. Section 19 of lääkelaki 395/1987 then governs. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. This row sits in list IV of the 1971 Convention annex, and section 24 of huumausainelaki 373/2008 reaches exactly that: it disapplies the import and export provisions of the Act for medicinal products containing a substance in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, the products being those «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä», and then hands the traveller to section 19 of lääkelaki 395/1987. Section 23 subsection 3 of the same Act is the neighbouring relief for this list: a combination preparation containing a psychotropic substance other than one in list I of the 1971 Convention needs no import or export licence where the narcotic content is small or hard to separate and the abuse risk is slight against the substance's wide medicinal use.
Documentation: Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The locator a traveller or an official would be checking is Liite II list IV entry 67 of 543/2008, as that annex stands after 4.12.2025/1119, and the entry printed there reads «Tsolpideemi (N,N,6-trimetyyli-2-p-tolyyli-imidatso[1,2-α]pyridiini-3-asetamidi)». Because the row is in that part of the convention annexes, section 24 of huumausainelaki 373/2008 takes a traveller's own prescribed medicine out of the Act's import and export provisions and leaves section 19 of lääkelaki 395/1987 to govern how much may be carried, which is the provision this cell did not read. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Finland, zolpidem, a named entry of Liite II list IV of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008 at printed position 67, that annex as amended by 4.12.2025/1119 · the entry text, the closing extension clause of its list and the statutory wording are quoted in the other fields and are not repeated here, because this field is split into citation chips on every semicolon · Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, section 1 and annexes I to V · Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, section 1 and its annex · Huumausainelaki 373/2008, sections 3, 5, 7, 23, 23 b and 24 · Rikoslaki 39/1889, chapter 44 sections 5 and 5 a and chapter 50 sections 1, 2, 2 a, 3, 4, 4 a, 5 and 7 · finlex.fi · finlex.fi · finlex.fi · finlex.fi · 543/2008 read in the consolidated Finlex text carrying amendments up to 25.6.2026/651, the version identified as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin and in force from 10 July 2026, read on 21 September 2026 · 1130/2014 read in the consolidated Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026 · Finlex is the Ministry of Justice public legal database, its data is published under CC BY 4.0 and the statutes themselves are outside copyright under section 9 of the Copyright Act 404/1961 · read on 21 September 2026 · Updated September 21, 2026

Zolpidem in Finland, full detail →

Drug laws and enforcement change and vary by country. This is not legal advice. Always confirm with the destination’s embassy or official drug authority before traveling; penalties can be severe, including imprisonment.

Before you travel

Verify current rules with the destination country’s official drug authority and your own country’s embassy before traveling. Find the destination’s U.S. embassy & official country guidance →
Non-U.S. travelers: check your own government’s travel advisory and embassy.

If you’re detained or arrested abroad

Contact your own country’s embassy or consulate in the destination immediately, not the destination’s authorities. U.S. citizens: contact the nearest U.S. embassy/consulate and the U.S. State Department at +1-202-501-4444 (from abroad). If a U.S. citizen is arrested or detained abroad →

← All countries Drug index